FIP makes it a priority to publish the latest developments in pharmacy practice, pharmaceutical sciences, related global news and prominent events. Our multi-media approach to keeping members, partners and peers informed of what is and will be affecting their area of practice or science is key to keeping information flowing through the FIP network.
FIP makes it a priority to publish the latest developments in pharmacy practice, pharmaceutical sciences, related global news and prominent events. Our multi-media approach to keeping members, partners and peers informed of what is and will be affecting their area of practice or science is key to keeping information flowing through the FIP network.
Lastest Publications
2023Intervention on provisional agenda item 7. on substandard and falsified medical products (152nd WHO Executive Board)
2023Joint statement on strengthening WHO preparedness for and response to health emergencies (152nd WHO Executive Board)
2023Military pharmacy may be niche, but its contributions to our profession and well-being cannot be denied
FIP has a section representing military and emergency pharmacy. But have you ever wondered how the specialty of military pharmacy evolved? Uroš Čakar, from the Faculty of Pharmacy at the University of Belgrade, Serbia, provides a potted history.
FIP is committed to supporting countries to develop policies that enable pharmacies and pharmacists to deliver integrated vaccination services throughout the life-course and as part of wider national immunisation policies. This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.
The success of pharmacy-based vaccination depends on various policy factors, one of which is access to data and vaccination records. FIP data shows that pharmacists’ access to patient vaccination records vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature pharmacy leadership bodies from across the world explaining their progress with access to records and how this impacts access to vaccination through pharmacies.
Panellists: - Sarah Sorum, Executive Vice President & CEO, Pharmacy Society of Wisconsin, an ASHP state-affiliate, United States - Marisol Flores Campos, Pharmacovigilance Officer, Punto Seguro, Costa Rica - Pedro Costa e Silva, Manager - Health Services Business Unit, Associação Nacional das Farmácias (ANF), Portugal - Omaima Arab, Scientific evaluation expert, Saudi Food and Drug Authority, Saudi Arabia
This webinar will focus on how to develop innovative pharmacy education curricula to better respond to global public health needs. It will also discuss the importance of covering all pharmacy fields and specialties in the pharmacy program, and how to integrate digital health in the global pharmacy education to continuously enhance the quality of education and competencies of the pharmaceutical workforce, as having competent pharmaceutical workforce is critical to providing quality health care services
1. Highlight the importance of quality of education for pharmaceutical workforce to provide high quality health services 2. Understand the innovative pharmacy education curricula 3. Providing effective strategies for comprehensive pharmacy education and training 4. Examining global tools and approaches to integrate e-learning and digital health to enhance the quality of pharmacy education and competencies of health
Moderators: - Hanane Kebaili, President of the Algerian Early Career Pharmacists Group , Fédération Algérienne de Pharmacie, Algeria - Abby A. kahaleh, PhD, MS, BPharm, MPH, FAACP, Board of Trustees Faculty & Tenured Faculty of Clinical and Administrative Sciences, RUCSHP, USA
Panellists: - Abeer Al-Ghananeem, Professor of Pharmaceutics and Biopharmaceutics, Associate Dean for Research College of Pharmacy and Health Sciences, Sullivan University, Louisville, Kentucky, USA - Anisha Sandhu, FIP AcPS Communication & Collaboration Working Group Member, FIP Technology Forum Committee Member; Assistant Lecturer, Monash University Malaysia School of Pharmacy, Malaysia - Martin Henman, Associate Professor in the Practice of Pharmacy, The School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Ireland - Carl Schneider, Associate Professor in Pharmacy Practice, The University of Sydney School of Pharmacy, Faculty of Medicine and Health, Australia
Research has shown that women may receive less intensive, less effective and lower quality treatment due to stereotyped responses attributed to women, such as dramatising, overemphasising their experiences of pain, being more willing to report pain, inaccurately reporting pain or being less tolerant to pain than men. It results in the underestimation and undertreatment of women’s pain worldwide. This is often referred to as the “gender pain gap”.
Regarding the gender pain gap, self-awareness and training are not issues owned only by pharmacists; they should be shared with all healthcare professionals and the public.
Pharmacists can be supported to address the gender pain gap through education and partnerships. Good understanding of the variety of pain symptoms can support unbiased pain management. Pharmacists also have a responsibility to educate the public on where and how to seek help for pain management, thus further addressing the gender pain gap.
The event aims to
Define the gender pain gap
Increase awareness about gender pain gap
Describe how pharmacists can be supported to address the issue
Describe the knowledge and training for pharmacists to close the gender pain gap
Learning objectives:
Understand the gender inequalities in pain research
Increase their awareness of gender gap in treatment offers for pain management
Describe knowledge and training status on unconscious bias towards women in pain management
Define knowledge, attitudes and practices that pharmacists have, to close the gender pain gap
Describe how pharmacists can be supported with e.g. training, tools to address gender inequalities in pain management, bring close the gender pain gap, achieve behavioural change towards women
Chair: - Parisa Aslani, Professor, The University of Sydney School of Pharmacy, Australia
Facilitator: - Aysu Selcuk, FIP Education and Primary Health Care Policies Specialist, The Netherlands
Panellists: - Catherine Duggan, FIP CEO, The Netherlands - Jonathan Penm, Senior lecturer, The University of Sydney School of Pharmacy, Australia - Jack Collins, Postdoctoral Research Associate, The University of Sydney, Australia - Leticia Caligaris, Community pharmacist lead, Executive committee member, member of Pharmacist Association of Uruguay - Miranda Sertic, Associate Professor, Faculty of Pharmacy and Biochemistry, University of Zagreb, Croatia - Roger Knaggs, Associate Professor in Clinical Pharmacy Practice, University of Nottingham, UK
Pharmacists have an important role in supporting the management of minor ailments in the community and promoting informed and responsible self-care. Gastroesophageal reflux is a common reason for consultations to community pharmacists, and symptoms associated with reflux can often be managed through non-prescription medicines. Pharmacists can assess and provide advice on both the pharmacological and non-pharmacological options that patients might follow, check for possible interactions with medication that patients might be taking, and provide education for improved self-care.
Attendees will learn about:
1. The resources FIP developed on reflux management 2. Understand the main therapeutic options to support relief of reflux-like symptoms 3. Explore pharmacists’ perspectives of reflux management
Moderator: - Luís Lourenço, FIP Professional Secretary FIP, Portugal
Panellists: - Rúben Viegas, Practice Development and Transformation, Projects Coordinator FIP, The Netherlands - Kai Zhen Yap, Lecturer, National University of Singapore, Department of Pharmacy, Singapore - Ana Zovko, Member of the ExCo of CPS of the FIP, Owner and director , Pharmacy institution Afarm, Bosnia and Herzegovina - Pali Hungin, Emeritus professor, Institute of Health and Society, Faculty of Medical Sciences, Newcastle University, UK - Peter Kahrilas, Professor of medicine,, Northwestern University, Feinberg School of Medicine, USA
The COVID-19 pandemic highlighted the requirement for current and future pharmacy education to be improved to strengthen the pharmacy profession and improve resilience. With the demand and options at higher education increasing, enrolment strategies have become more critical to pharmacy institutions.
FIP AIM has developed a handbook to support academic pharmacy leaders to update enrolment management strategies in schools of pharmacy. The webinar will officially launch the handbook and go through the background of the handbook development and how it can help global health leaders to implement new enrolment methods.
• Develop strategies to recruit more and better students into pharmacy schools using traditional and social media • Advocate for the profession, its scope of practice, and its importance in the healthcare system • Reflect on a global integrated approach to foster student interest and improve admissions
Moderator: - Pierre Moreau, Dean FIP, Kuwait University, Kuwait
Panellists: - Lilian Azzopardi, FIP AIM Chair-elect & AIM Advisory Committee member, Head, Department of Pharmacy University of Malta-Malta - Brian Hemstreet, Associate Dean for Student Affairs University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences-USA - Frank Moriarty, Pharmacist and senior research fellow RCSI School of Pharmacy and Biomolecular Sciences-Ireland - Gea Abigail U. Ecoy, Assistant Professor and Chair University of San Carlos-Philippines - Hanan Refaat, Dean Future University-Egypt - Marlon Prince, FIP AIM member, Director of Admissions at Howard University College of Pharmacy-USA - Mohd Zulkefeli Mat Jusoh, FIP AIM member, Dean International Medical University-Malaysia - Rajani Shakya, Head of Department of Pharmacy Kathmandu University-Nepal - Wendy Cox,Assoc. Dean, Admissions and Accreditation, University of North Carolina at Chapel Hill Eshelman School of Pharmacy-USA
FIP is committed to supporting countries to develop policies that enable pharmacies and pharmacists to deliver integrated vaccination services throughout the life-course and as part of wider national immunisation policies. This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.
Regulations of pharmacy practice is a critical determinant of pharmacists’ authority to administer and/or prescribe vaccines. FIP data shows that regulations on pharmacy-based vaccination vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature a number of pharmacy leadership bodies describing how pharmacy-based vaccination, including prescribing, is regulated in their countries.
Panellists: - Hanne Andresen, Director Pharmaceutical Affairs Norwegian Pharmacy Association, Norway - Fei Sim, National President Pharmaceutical Society of Australia, Australia - Luna Bizri, Founder and manager of community pharmacy; Clinical Assistant professor; Adjunct faculty member Lunapharm pharmacy; Lebanese International University; Lebanese American University, Lebanon - Joyce Mariama Kallon, Team Lead for the supply Chain and logistics vaccine unit Immunisation unit, Sierra Leone
Telepharmacy has gained increasing importance in the delivery of pharmaceutical care, largely due to the COVID-19 pandemic which has placed enormous pressures on healthcare systems globally. There are some innovative models of telepharmacy services aimed at optimizing and improving access to pharmaceutical care, resulting in improved patient safety and outcomes. However, despite these benefits, major barriers for implementation of telepharmacy remain such as patient confidentiality and privacy of health information.
Attendees will learn about:
1. The global role of telehealth in supporting primary health care services 2. The current trends in telepharmacy around the globe 3. Examples of good practice in telepharmacy
Moderator: - Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation, Sweden
Panellists: - Rúben Viegas, Practice Development and Transformation Projects Coordinator, The Netherlands - Sarah Dineen-Griffin, FIP CPS ExCo member, Australia - Jaime Acosta, Community pharmacist Farmacia Acosta, Spain - Josep M. Guiu-Segura, Vice-president Euro, Hospital Pharmacy Section, International Pharmaceutical Federation, Director of Pharmacy and Medicines, Consortium of Health and Social Care of Catalonia, Spain - Derrick Muneene, Unit Head, Digital Health Capacity Building and Collaboration, WHO, Switzerland
Biorelevant in vitro performance testing of orally administered dosage forms has become an important tool for the assessment of drug product in vivo behavior. An in vitro performance test which mimics the intraluminal performance of an oral dosage form is termed biorelevant. Biorelevant tests have been utilized to decrease the number of in vivo studies required during the drug development process and to mitigate the risk related to in vivo bioequivalence studies.
Prediction of intraluminal performance of an orally administered dosage form and the active pharmaceutical ingredient with biorelevant in vitro performance testing requires appropriate simulation of luminal conditions. Key luminal parameters to be simulated may vary with the process to be simulated, the structure of the active pharmaceutical ingredient and the type of dosage form. A variety of biorelevant media have been proposed, making it now possible to simulate most regions in the gastrointestinal tract in both prandial states. The levels of biorelevance and accompanying decision tree may serve as a useful tool during formulation development, in order to ensure high quality, predictive performance results without unnecessary complexity of media.
• Participants will be introduced in biorelevant dissolution testing • Participants will be informed on dissolution media that simulates the physicochemical characteristics of the contents of the gastrointestinal lumen • Participants will be informed on the in vitro methodologies that have been shown to be useful in simulating the intraluminal environment
Chair: - Horst-Dieter Friedel, FIP Chair Regulatory Sciences and Quality, Director Former at Bayer AG, Germany
Moderator: - Christos Reppas, Professor in Pharmaceutics National and Kapodistrian University of Athens, Greece
Guests: - Maria Vertzoni, Associate Professor in Pharmaceutical Technology and Biopharmaceutics National and Kapodistrian University of Athens, Greece
One year after the launch of the FIP global call to action on advancing pharmaceutical education, FIP will report on each region’s progress against the call to action, building on the results of the FIP-UNITWIN inter-regional impact workshops held in November 2022. The event will also host the launch of the FIP Education transformation toolkit, which will be a collection of FIP’s relevant publications and digital events to implement the FIP global call to action on advancing pharmaceutical education.
Objectives: 1. Present progress since 2021 on priority FIP Development Goals of the regions in the context of pharmaceutical education 2. Present progress on FIP-UNITWIN regional roadmaps 2021 and the impact on FIP global call to action on pharmaceutical education 3. Discuss the way forward for the delivery of each regions’ roadmaps with establishment of regional FIP-UNITWIN centres for excellence programme in the months ahead 4. Launch the FIP Education transformation toolkit
Moderators: - Ralph J. Altiere, FIPEd Chair FIP and University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences- USA - Lilian Azzopardi, FIP AIM Chair-elect , University of Malta -Malta
Panellists: - Toyin Tofade, President Albany College of Pharmacy and Health Sciences, USA - Silvana Nair Leite, Professor Federal University of Santa Catarina, Brazil - Arinola Joda, Assistant Secretary & Editor-in- Chief, African Pharmaceutical Forum, Faculty of Pharmacy, University of Lagos, Nigeria - Rajani Shakya, Ass.Prof. Department of Pharmacy, Kathmandu University, Nepal - Mohamad Rahal, Dean School of Pharmacy, Lebanese International University, Lebanon - Paul Gallagher, Prof.Department of Pharmacy, National University of Singapore, Singapure - Nilhan Uzman, FIP Lead for Education & Primary Health Policies, Turkey - Alison Etukakpan, Educational Partnership Specialist International Pharmaceutical Federation, Nigeria
Pharmacists as athlete support personnel have rooted themselves as key players in medical teams serving athletes. Sports pharmacy evolved from a niche practice during the establishment of WADA two decades ago, gaining traction with the publication of the FIP guidelines “The Role of the Pharmacist in the Fight against Doping in Sport” in 2014. Today, we recognise sports pharmacy as a specialty practice, fundamental to the antidoping movement and athlete health. Pharmacists provide accurate sports drug information, avoid inadvertent doping, and coordinate pharmacy services at sporting events. We present two successful models in education and proper training of pharmacists to work with athletes.
Attendees will learn about:
1. Exploring the specialty of sports pharmacy based on expert consensus 2. Discussing a foundation for sports pharmacy curricula 3. Describing a successful example of sports pharmacy practice
Moderator: - Daragh Connolly, Chair Board of Pharmaceutical Practice, Ireland
Panellists: - Ashley Anderson, Clinical Sports Pharmacy Specialist / Antidoping Pharmacist International Sports Pharmacists Network, USA - David Mottram, Emeritus Professor- Liverpool John Moores University, UK - Mark Stuart, Pharmacist to the International Olympic Committee Medical Commission International Olympic Committee, UK - Claire May, Academic University of Brighton, UK - Somer Helvaci, Lecturer IOC accredited sports pharmacist, Turkey - Shigeo Yamamura, Specially-Appointed Professor Josai International University, Japan
Often, the most vulnerable population groups experience severe or even lethal forms of vaccine-preventable diseases, as well as losses in quality of life, functional ability and productivity. It is essential to identify these groups and their specific vaccination needs, and to take measures to improve vaccine confidence and uptake among them. Pharmacists play a key role in raising awareness and building confidence in vaccines, and in promoting a convenient access to vaccinations. Over several months, FIP organised a series of events focusing on the vaccination needs of several special-risk population groups. With this final event, we invite you to engage with an intersectoral roundtable on this topic and witness the launch of a summary publication and a series of short videos to support pharmacists in these roles.
By the end of the session participants will: - Understand the specific vaccination needs of several special-risk population groups - Become familiar with FIP’s resources on vaccination for special-risk groups - Discuss the role of pharmacists in promoting vaccination uptake among different special-risk groups
Panellists: - Jean-Luc Eiselé, CEO World Heart Federation, Switzerland - Siân Williams, Chief Executive Officer International Primary Care Respiratory Group (IPCRG), Scotland (working internationally) - Iryna Vlasenko, Vice president- International Diabetes Federation-Ukraine - Howard Catton, Chief Executive Officer, International Council of Nurses, Switzerland/ United Kingdom - Jane Barratt, Secretary-General International Federation on Ageing, Canada - Rúben Viegas, FIP Practice Development and Transformation Projects Coordinator, Portugal - Mary Ann Lumsden, FIGO Chief Executive, International Federation of Gynecology and Obstetrics (FIGO), UK
Often, the most vulnerable population groups experience severe or even lethal forms of vaccine-preventable diseases, as well as losses in quality of life, functional ability and productivity. It is essential to identify these groups and their specific vaccination needs, and to take measures to improve vaccine confidence and uptake among them. Pharmacists play a key role in raising awareness and building confidence in vaccines, and in promoting a convenient access to vaccinations. Over several months, FIP organised a series of events focusing on the vaccination needs of several special-risk population groups. With this final event, we invite you to engage with an intersectoral roundtable on this topic and witness the launch of a summary publication and a series of short videos to support pharmacists in these roles.
By the end of the session participants will: - Understand the specific vaccination needs of several special-risk population groups - Become familiar with FIP’s resources on vaccination for special-risk groups - Discuss the role of pharmacists in promoting vaccination uptake among different special-risk groups
Panellists: - Jean-Luc Eiselé, CEO World Heart Federation, Switzerland - Siân Williams, Chief Executive Officer International Primary Care Respiratory Group (IPCRG), Scotland (working internationally) - Iryna Vlasenko, Vice president- International Diabetes Federation-Ukraine - Howard Catton, Chief Executive Officer, International Council of Nurses, Switzerland/ United Kingdom - Jane Barratt, Secretary-General International Federation on Ageing, Canada - Rúben Viegas, FIP Practice Development and Transformation Projects Coordinator, Portugal - Mary Ann Lumsden, FIGO Chief Executive, International Federation of Gynecology and Obstetrics (FIGO), UK
Remuneration of pharmacy vaccinations is one of the key policy enablers of pharmacy-based vaccinations, and thus life-course immunisation. FIP data shows that remuneration models vary widely across countries and regions. Understanding the different models and country experiences is key to wider implementation. This event will feature a number of pharmacy leadership bodies sharing their remuneration models and journeys for the benefit of policy-enablement everywhere.
This event is delivered as part of a new FIP programme supported by Pfizer, which aims to provide our members with approaches and tools for tackling key policy enablers that determine equity, access and sustainability of pharmacy-based life-course immunisation.
Moderator: - Sari Westermarck, Community pharmacist FIP Community Pharmacy Section, Finland
Panellists: - Eleftherios Marinos, General Secretary-Federation of Pharmacists’ Cooperatives of Greece, Greece - Ahmad Al-Rusasi, General manager/Lecturer Alnoor Drug Store, Jordan - Sham Moodley, Pharmacist Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa - Susan O’Dwyer, Head of Governance and Pharmacy Service, Irish Pharmacy Union, Ireland - Luís Lourenço, President of the South and Autonomous Regions Branch of the Portuguese Pharmaceutical Society, Portuguese Pharmaceutical Society, Portugal
The COVID-19 pandemic is one of the greatest public health emergencies of our time. The development of new diagnostics, treatments and vaccinations has arguably required greater innovation and collaboration across research, pharmaceutical industry and healthcare sectors than ever before. This event reflects on innovations and collaborations during the COVID-19 pandemic. Consideration will be given to applying what has been learnt to future pandemics.
Aim To reflect on innovations and collaborations in pharmaceutical science that have made an impact against COVID-19. To consider how to apply this learning to our response to future pandemics.
Learning objectives:
• Explain how pharmaceutical scientists innovated and collaborated in the fight against COVID-19. • List challenges and opportunities for the development of diagnostics, treatments and vaccinations during the COVID-19 pandemic; • Discuss approaches for fast-tracking diagnostics, treatments and vaccinations in future pandemics without compromising patient safety. • Reflect on what has been learned from innovative and collaborative approaches during the COVID-19 pandemic that can be used for future pandemics.
Moderator: - Chris John, FIP Lead for Data and Intelligence, UK
Panellists: - Louise Druedahl, Researcher University of Copenhagen, Denmark - N Udupa, Research Director Shri Dharmasthala Manjunatheshwara University, India - Yvonne Perrie, Professor of Drug Delivery University of Strathclyde, UK
This event will discuss pharmacists’ roles in infectious & tropical disease prevention, and management by improving pharmacists’ knowledge in these diseases as well as showcasing practices across different countries with regards to policy, pharmaceutical care and services delivery and digital health applications across Africa in the context of infectious and tropical diseases. Pharmacists are uniquely positioned to provide a wide array of services to prevent, and manage infectious and tropical diseases. This event aims to improve pharmacists' knowledge, improve pharmaceutical services delivery and overall health outcomes of the public in the context of infectious & tropical disease.
Learning objectives 1. Improve knowledge of pharmacists in the scope of infectious & tropical diseases as well as anti-infectives within the African region; 2. Showcase practices across different countries with regards to policy, pharmaceutical care and services delivery and digital health applications in the context of infectious & tropical diseases as well as anti-infectives within the African region; 3. Identify the needs and priorities of pharmacists in the prevention and management of infectious & tropical diseases within the African region.
Moderator: - Jocelyn Chaibva, Vice president African Pharmaceutical Forum, Zimbabwe
Facilitators: - Nilhan Uzman, FIP Lead for Education and Primary Health Policies, Turkey - Alison Etukakpan, FIP Educational Partnership Specialist, Nigeria
Guests: - Mirfin Mpundu, Director ReAct Africa, Kenya - Natalie Schellack, Head of the Department of Pharmacology, University of Pretoria, South Africa - Arinola Joda, Associate Professor University of Lagos, Nigeria
This event will discuss pharmacists’ roles in infectious & tropical disease prevention, and management by improving pharmacists’ knowledge in these diseases as well as showcasing practices across different countries with regards to policy, pharmaceutical care and services delivery and digital health applications across Africa in the context of infectious and tropical diseases. Pharmacists are uniquely positioned to provide a wide array of services to prevent, and manage infectious and tropical diseases. This event aims to improve pharmacists' knowledge, improve pharmaceutical services delivery and overall health outcomes of the public in the context of infectious & tropical disease.
Learning objectives 1. Improve knowledge of pharmacists in the scope of infectious & tropical diseases as well as anti-infectives within the African region; 2. Showcase practices across different countries with regards to policy, pharmaceutical care and services delivery and digital health applications in the context of infectious & tropical diseases as well as anti-infectives within the African region; 3. Identify the needs and priorities of pharmacists in the prevention and management of infectious & tropical diseases within the African region.
Moderator: - Jocelyn Chaibva, Vice president African Pharmaceutical Forum, Zimbabwe
Facilitators: - Nilhan Uzman, FIP Lead for Education and Primary Health Policies, Turkey - Alison Etukakpan, FIP Educational Partnership Specialist, Nigeria
Guests: - Mirfin Mpundu, Director ReAct Africa, Kenya - Natalie Schellack, Head of the Department of Pharmacology, University of Pretoria, South Africa - Arinola Joda, Associate Professor University of Lagos, Nigeria
The first of December commemorates World AIDS day and this year FIP will join this campaign by launching a toolkit for pharmacists on HIV prevention, screening and management. It is now possible to effectively prevent the transmission of HIV through pharmacological strategies (preexposure and postexposure prophylaxis). New HIV tests have also become available, including point-of-care tests and self-tests. Pharmacists’ expertise and accessibility can be leveraged for a variety of important roles in the prevention and screening of HIV infections. Join this event to learn about these roles and be inspired by examples from different countries.
By the end of the session participants should be able to: • Understand the roles pharmacists can play in HIV prevention, screening and management • Recognise some resources and tools that pharmacists can use in this area • Find and use the FIP toolkit on HIV prevention, screening and management
Moderator: - Sham Moodley, FIP CPS Exco Member, Pharmacist Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa
Panellists: - Rúben Viegas, FIP Practice Development and Transformation Projects Coordinator, Portugal - Ali Ahmed, Ph.D. Final Year Student (Clinical Pharmacy) Monash University Malaysia, Malaysia - Alicia Krüger, Clinical pharmacist Brazilian federal council of pharmacy, Brazil - Elise HARO-BRUNET, Employed pharmacist CESPHARM (prevention committee) / French Chamber of pharmacists, France - Romeo Ongpoy Jr, Dean Emilio Aguinaldo College - Cavite Campus, Philippines - Katrina F. Ortblad, Assistant Professor Fred Hutchinson Cancer Research Center, USA - Hamish Bowden, Senior Clinical Pharmacist (HIV & Sexual Health) The Albion Centre NSW Health, Australia
Long covid, also known as post COVID-19 condition, is estimated to affect 10-20% of people who develop COVID-19. While the majority go on to fully recover, this group of people suffer a variety of physical, physiological and cognitive symptoms for many weeks, months and sometimes longer. The condition can be debilitating and recovery requires a holistic and personalised care approach, including pharmaceutical care.
This event by FIP aims to explore in more depth what long covid is, what the key characteristics and symptoms are and how these symptoms can be managed in the pharmacy. The panellists include a public health expert on long-covid-19, a clinical pharmacist who is recovering from long covid, a physiotherapist and more.
Learning objectives: 1. Describe the key characteristics and symptoms of long COVID-19 2. Understand the latest research and evidence concerning treatment and care 3. Discuss ways long covid symptoms can be managed in the pharmacy 4. Identify the importance of pharmacists' understanding of the condition and care needs
Moderator: - Leonila Ocampo, FIP Community Pharmacy Section, Asia Pacific Institute for Medication Management Philippine Pharmacists Association, Philippines
Panellists: - Darren Brown, Clinical Academic Physiotherapist, Chelsea and Westminster Hospital NHS Foundation Trust; Long COVID Physio, United Kingdom - Rani Khatib, Consultant Cardiology Pharmacist and Associate Professor University of Leeds, United Kingdom - Lucette Cysique, Associate Professor The University of New South Wales, Australia
Webinar video • 24 November 2022, 14:00 - 15:30 CET
Supporting pharmacy leaders and educators for implementing competency-based education in pharmacy and pharmaceutical sciences education: Launch of the FIP CBE implementation handbook
Competent pharmaceutical workforce is vital to ensure healthy lives and promote well-being. This is aligned with the FIP Development Goals. Competency-base education (CBE) model became a core of healthcare professions education and training globally.
Some challenges are encountered relating to the implementation of CBE model to initial pharmacy and pharmaceutical education and training (IPET). Hence, FIPEd team has developed the handbook to support pharmacy leaders and educators for their journey of CBE implementation in their education programme. The webinar will officially launch the handbook and go through the background of the handbook development and how it can help them implement CBE.
Learning objectives: • Understand the importance of CBE in pharmacy and pharmaceutical education • Describe the structure of FIPEd CBE Implementation Handbook • Identify how the Handbook can support oneself for their CBE implementation journey
Panellists: - Naoko Arakawa, Assistant Professor in International Pharmacy University of Nottingham, UK - Jessica McMullen, Pharmacist and PhD Student University of Nottingham, UK - Andries Koster, Associate Professor of Pharmacology Dept. Pharmaceutical Sciences, Utrecht University, The Netherlands - Pierre Moreau, Professor of pharmacology and therapeutics College of pharmacy Kuwait University, Kuwait - Shaun Gleason, Global Lead for Academic Capacity, FIP Workforce Development Hub, Assistant Dean for Distance Degrees and Programs; Associate Professor of Clinical Pharmacy University of Colorado Skaggs School of Pharmacy, USA
Our final event will celebrate the success of the AMS in Action Webinar series as we reflect on the great work being done globally to tackle AMR.
We will showcase our competition winners who will share their innovative ideas and tools to help support AMS and prevent the spread of AMR.
Join us in our Call to Action! Make a pledge with Antibiotic Guardian about how you’ll make better use of antibiotics and help save these vital medicines from becoming obsolete.
With the potential to be the next ‘silent’ pandemic, antimicrobial resistance (AMR) is a global threat. The ONE FIP Commitment to AMR and antimicrobial stewardship (AMS) includes actions for education, practice, scientific research and workforce development. These commitments will also enable themes to be actioned across nations and regions. FIP commits to increase the awareness of AMR, strengthen AMS and support for evidence-based interventions. With two events on 21 and 22 November, in the form of workshops, FIP aims to: • Provide education and development • Provide the priority FIP Development Goals (FIP DGs) areas and the priority commitments to devise the 2023 plans. • Inform the 2023 Commitment to Action and Health Ministers Summit.
Learning objectives: With a regional focus on the Eastern Mediterranean, European and Americas regions, participants in this workshop will be able to:
Outline regional educational and development headline needs in AMR and AMS,
Outline FIP DGs areas and the priority commitments for pharmacists’ organisations,
Input on how they can contribute to the FIP AMR 2023 plans.
Chair: - Manjiri Gharat, FIP Vice President & Chair of the FIP Commission on AMR, India
Guest: - Victoria Rutter, Executive Director, CPA, UK
Facilitators: - Dalia Bajis, FIP Lead for Provision and Partnerships, Bahrain - Chin-Yen Yeo, Senior AMS Pharmacist, Concord Repatriation General Hospital, Australia - Fiona Doukas, Senior Project Officer, ACSQHC, Australia
Panellists: - Usman Ebubakar, Senior Lecturer, Universiti Sains Malaysia, Malaysia - Michelle Gijzelaar, National Clinical Pharmacy Manager, Life Healthcare, South Africa - Onyeka Chinwuba Obidiegwu, Lecturer, Nnamdi Azikiwe University, Awka, Nigeria - Roop Gupta, Vice President, IPA, India - Syamhanin Adnan, Leader, AMS Focus Group for Pharmacist, MPS, Malaysia - Fitria Nur Hidayah, Clinical Pharmacist, Cipto Mangunkusumo Hospital, Indonesia
With the potential to be the next ‘silent’ pandemic, antimicrobial resistance (AMR) is a global threat. The ONE FIP Commitment to AMR and antimicrobial stewardship (AMS) includes actions for education, practice, scientific research and workforce development. These commitments will also enable themes to be actioned across nations and regions. FIP commits to increase the awareness of AMR, strengthen AMS and support for evidence-based interventions. With two events on 21 and 22 November, in the form of workshops, FIP aims to: • Provide education and development • Provide the priority FIP Development Goals (FIP DGs) areas and the priority commitments to devise the 2023 plans. • Inform the 2023 Commitment to Action and Health Ministers Summit.
Learning objectives: With a regional focus on the Eastern Mediterranean, European and Americas regions, participants in this workshop will be able to:
Outline regional educational and development headline needs in AMR and AMS,
Outline FIP DGs areas and the priority commitments for pharmacists’ organisations,
Input on how they can contribute to the FIP AMR 2023 plans.
Chair: - Daragh Connolly, FIP BPP Chair, Ireland
Guest: - Victoria Rutter, Executive Director, CPA, UK
Facilitators: - Aysu Selcuk, FIP Education and PHC Policies Specialist, Turkey - Cátia Caneiras, Professor, University of Lisbon, Portugal - Khalid Eljaaly, Associate Professor, King Abdulaziz University, Saudi Arabia
Panellists: - Alison Etukakpan, FIP Educational Partnership Specialist, Nigeria - Katarina M. Kostadinovic, Chairman, Assembly of Pharmaceutical Chamber of Montenegro, Montenegro - Olfat Fakih, Instructor, Al Razi University, Yemen - Saed Nuh, Chairman of Medicines Regulatory Authority, Ministry of Health Development, Somalia - Cristina Fernández, Hospital Pharmacist, San Juan de Dios Hospital, Costa Rica - José Pablo Díaz Madriz, AMS Director, Clínica Bíblica Hospital, Costa Rica - Brigid K. Groves, Senior Director, Practice&Professional Affairs, APA, USA - Curtis D. Collins, Pharmacy Specialist, Infectious Diseases Trinity Health Ann Arbor, USA
As busy health care professionals we are always looking for tools and resources to make our jobs more efficient and effective. This session will look at some tools and resources that are used in practice across the globe to support AMS initiatives, inspiring you to think about what you could develop or apply in your own practice to help support the more appropriate use of antimicrobials with both patients and colleagues.
Learning objectives: ● Discuss innovative tools for sharing information ● Learn about the development and deployment of an innovative and fun teaching tool ● Describe how you can use different platforms to engage healthcare professionals and communities
Moderator: - Meghna Joshi-von Heyden, Strategic Lead: Partnerships and Advocacy Commonwealth Pharmacists Association, Switzerland - Maxencia Nabiryo, Project Manager Commonwealth Pharmacists Association, Uganda - Israel Sefah, Lecturer and Specialist Pharmacist, Department of Pharmacy Practice in the School of Pharmacy of the University of Health and Allied Sciences, Ghana - Akello Zainab, Lead pharmacist and AMS Technical Lead Gulu Regional Referral Hospital, Uganda - Andrew Balamba, Pharmacist University Teaching Hospital, Zambia - Jessica Fraser, Programmes Coordinator Tropical Health & Education Trust, UK - Ugyen Tashi, Chief Program Officer Essential Medicines and Technology Division (EMTD), Ministry of Health, Bhutan - Bridget Kebirungi, Project Manager Commonwealth Pharmacists Association, Uganda
Para abogar por una implementación más amplia y armonizada de bioexenciones basadas en el sistema de clasificación biofarmacéutica (BCS) en los países de América Latina, la FIP está apoyando a los líderes regionales en la sensibilización sobre esta vía reguladora basada en la ciencia diseñada para acelerar la aprobación del mercado de productos farmacéuticos genéricos seguros y eficaces. La segunda parte de esta serie de seminarios web diseñados específicamente para la región de América Latina destaca ejemplos de vías de aprobación regulatoria de bioexenciones basadas en BCS que se implementan actualmente en países seleccionados de América Latina. Los expertos abordarán la base legislativa de las regulaciones de bioexenciones y discutirán las oportunidades de armonización dentro de la región.
Este webinar tiene los objetivos:
• Diferenciar entre la bioequivalencia in vivo y las estrategias reguladoras de bioexención basadas en BCS para la aprobación de medicamentos genéricos. • Comprender las implicaciones para la salud pública de la vía reguladora de la bioexención basada en BCS. Delinear oportunidades y desafíos para la implementación de un proceso armonizado de aprobación regulatoria de bioexenciones dentro de la región de América Latina. Delinear las contribuciones de solubilidad, permeabilidad y disolución para aplicaciones de bioexención basadas en BCS.
Moderadora: - Talita Ferreira, Coordinadora de Proyectos de bioexención en Latinoamérica International Pharmaceutical Federation (FIP), Brazil
Panelista: - Diego Alejandro Gutierrez Triana, Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) Director de medicamentos y productos biológicos, Colombia
The US public benefits from reduced costs and improved access to treatment enabled by availability of generics drug products. Patients offer a unique perspective when advocating for accessibility to high-quality and affordable generics. As critical stakeholders, it is important that the FDA Office of Generic Drugs (OGD) captures patient perspectives, needs, and priorities to help better inform patients. This session will explore the role of patients in generic drug development, OGD’s patient engagement sessions to date and the opportunities that can be used to improve patient engagement.
Learning objectives:
The FDA’s perspectives on patient’s role in drug development
How Office of Generic Drugs (OGD) is working on patient engagement
Moderator: - Mathew Cherian, FIP IPS ExCo Member for Webinars, Consultant, USA
Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, people living with diabetes have particular vaccination needs that will be highlighted at this event.
By the end of the session participants should be able to: - Understand the most important vaccines for people living with diabetes - Recognise the role of pharmacists in promoting vaccination to people living with diabetes - Discuss strategies for pharmacists to support people living with diabetes with their vaccination needs.
Moderator: - Astrid Czock, CEO QualiCCare, Switzerland
Panelists: - Marco Goeijenbier, Medical doctor internal medicine and intensive care, Spaarne Gasthuis Haarlem/Hoofddorp & Erasmus Medical Center Rotterdam, The Netherlands - Sallianne Kavanagh, Senior Lecturer- Clinical Pharmacy and Pharmacy Practice. Advanced Clinical Pharmacist, University of Huddersfield and Sheffield Teaching Hospitals NHSFT, United Kingdom - Iryna Vlasenko, Vice president International Diabetes Federation, Ukraine - Francisco Javier Jiménez Ramírez, Professor / Pharmacist University of Puerto Rico School of Pharmacy, Puerto Rico
Pharmacists are well placed as members of the multidisciplinary team but are also key and accessible healthcare professionals for members of the public. Webinar 4 will explore and consider how pharmacists can support AMS in community practice around the globe.
Learning objectives: - Define how pharmacists working in the community can support AMS and IPC initiatives as part of the wider multidisciplinary team; - Explain how different forms of education and awareness raising can support the AMR agenda in the community setting; - Discuss learning opportunities for reducing the risks of AMR that can be harnessed from experiences in treating and managing other infectious diseases such as TB, malaria and HIV; - Describe how you can inspire and engage members of the community in a call to action on AMR; - Demonstrate how AMR can impact patients at an individual, community and global level; and - Apply behaviour change techniques to improve AMS initiatives in community practice.
Moderators
- Claire Brandish, Senior Antimicrobial Resistance Technical Advisor, The Commonwealth Pharmacist Association - Dalia Bajis, Lead for Provision and Partnerships, International Pharmaceutical Federation
Speakers
- Amy Chan, Clinical Academic Pharmacist, University of Auckland - Tadeo Tumusiime, National Programs Coordinator, Makerere University School of Public Health - Erick Venant, Founder- Roll Back Antimicrobial Initiative & Lead Coordinator-BSAC’s-Stop Superbugs, Roll Back Antimicrobial Initiative - Manjiri Gharat, Principal of K M Kundnani Pharmacy Polytechnic, VP of Indian Pharmaceutical Association and VP of FIP, K M Kundnani Pharmacy Polytechnic, FIP and IPA - David Musoke, Senior Lecturer, Makerere University School of Public Health - Ella Balasa, Patient Advocate and Consultant
As we approach a post-pandemic world, the global supply chain has been greatly influenced by various factors. Many different drug and product shortages have been exacerbated in recent years due to supply chain issues. Through this webinar, we want to give a better overview of understanding the current global supply chain, current threats to the supply chain such as drug shortages, natural disasters, counterfeit medicines, and how to create a resilient supply chain as we move forward in society. We also want to emphasize the value of a pharmacist in this area and the difference they can make.
Learning Objectives: 1. Describe the current global pharmacy supply chain 2. Compare the contrast the different threats to the pharmacy supply chain such as drug shortages, natural disasters, and counterfeit medicines 3. Understand how these threats can interrupt the supply chain from each panel member’s perspective/countries 4. Outline how to create a resilient supply chain and future endeavours taking place to protect the supply chain (i.e., automation and technology)
Moderator: - Rob Moss, PharmD, Immediate past president, FIP Hospital Pharmacy Section, FIP, European Association of Hospital Pharmacists, The Netherlands
Panellists: - Yuh Lih Chang, PhD, RPh Director, Department of Pharmacy, Taipei Veterans General Hospital; Principal Investigator, National Drug Shortage management Project; Associate Professor, National Yang-Ming Chiao-Tung University, Taiwan Veterans General Hospital, National Yang-Ming Chiao-Tung University, Taiwan - Dr. Sohail Fitieh, Ph.D, MS PLA, RPh, Pharmacy & Supply Chain Consultant, United Arab of Emirates - Michael Ganio, Pharm.D., M.S., BCPS, FASHP, Senior Director, Pharmacy Practice and Quality, American Society for Health-System Pharmacists, USA
What methods and data can be captured to elucidate how antimicrobials are used in different healthcare settings? How do we know if antimicrobials are being used appropriately and whether there is scope to make improvements? Webinar 3 will consider point prevalence data to understand antimicrobial use, how the data can be utilised to implement change and how to embed that change to create sustainable action.
Learning objectives:
Define the Global Point Prevalence Survey tool and discuss the benefits of using this for data capture;
Appraise different tools for antimicrobial use data capture and understand the pros and cons of each;
Explain challenges to data capture and how to work around these;
Examine how local data can be used to drive positive changes and support AMS initiatives; and
Recognise how continuous quality improvement methodology can be used to help with Point Prevalence Survey data collection and to bring about sustainable behaviour changes as a result.
The FIP Development Goal 3 (Quality Assurance) Leads have developed a pharmacy education quality assurance tool. It can be used as a self-assessment tool, and for data collection to better understand quality assurance of pharmacy education programmes in different countries around the world.
The questions relate to the pharmacy degrees for initial entry to practice and/or licensure of pharmacists, reflected in three core sections: 1. Accreditation processes and accrediting bodies 2. Standards for quality assurance 3. Views on the value, relevance and outcomes of accreditation in the country
Learning Objectives: 1. To provide the rationale for conducting the FIP Quality Assurance in Pharmacy Education survey 2. To describe the three core sections in the QA tool 3. To provide information on completing the survey and potential benefits
Moderator: - Abby A. Kahaleh, PhD, MS, BPharm, MPH, FAACP Tenured Faculty & Board of Trustees Faculty Roosevelt University College of Science, Health, & Pharmacy, USA
Panellists: - Abeer M. AlGhananeem, DG3 Global Lead at FIP Workforce Development Hub, Associate Dean and Professor Sullivan University College of Pharmacy and Health Sciences, USA - Banan Mukhalalati, Global lead for FIP Development Goal 3: quality assurance Assistant Professor Qatar University, Qatar
How nutrition impacts heart health is the focus of this event, the last and final one in the 'Food for thought: Pharmacists' role in healthy nutrition.' The webinar aims to examine the interlinks between nutrition and heart health, its role in the prevention and management of cardiovascular diseases, how pharmacy-based nutrition services can support patients with heart conditions.
The event aims to:
Understand how nutrition impacts heart health
Describe the importance of pharmaceutical care for heart health with a focus on supplements
Highlight the important role of pharmacists in improving heart health and preventing cardiac disease.
Moderator: - Jaime Acosta, FIP-CPS Professional Secretary, Community pharmacist Farmacia Acosta, Spain
Panellists: - Philip Calder, President, Federation of European Nutrition Societies, Head of the School of Human Development and Health at the University of Southampton, UK - Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager, Portugal - Esraa Altawil, Consultant Clinical Pharmacist King Saud University Medical City, Saudi Arabia
The FIP Global Competency Framework for Educators & Trainers in Pharmacy (FIP-GCFE) is a new tool to support advancement and competence development for our colleagues around the world, serving in any sector of pharmaceutical education. It was initiated by the Academic Pharmacy Section of FIP and created in collaboration across FIP, involving our leads, experts, volunteers across the Federation. This works is authored by experienced authors, global leaders in pharmaceutical education who are active in academic, practice and science fields of the pharmacy profession. The commitment to gather their knowledge, experience, values, and efforts, inspiring our colleagues to advance in the field of education, resulted in comprehensive and evidence-based framework.
Participants will be able to: • Understand how to empower our individual and institutional members, focused on those involved in creating, delivering and assuring quality of pharmaceutical education. • Learn about the valuable source of information and guide for educators and trainers in pharmacy at individual, organizational, national, and global levels. • Understand how to use the Framework for their own personal and professional development. • Start the application, research, and validation of the Framework • Conduct the self-assessment of competencies according to the Framework
Moderators: - Astrid Czock, FIP WDH Global Lead; CEO QualiCCare, Switzerland - Marwan Akel, Projects Manager–Workforce development, evidence & impact Journal Editor – PEJ, Lebanon
Panellists: - Arijana Mestrovic, FIP AcPS Vice President, FIP WDH Global lead for Competency Development; Director, Professional services Pharma Expert, Croatia - Mike Rouse, Director, International Services Accreditation Council for Pharmacy Education. USA - Martin Charles Henman, FIP AcPS ExCO member Adjunct Assoc. Prof. Trinity College Dublin, Ireland - Ian Bates, Chair of pharmacy education-University College London, UK - Catherine Duggan, FIP CEO, Netherlands
Pharmacists have key roles in hospital multidisciplinary teams. Webinar 2 will explore how pharmacists can play a lead role in these teams and drive AMS initiatives in their place of work. How can we implement small day-to-day changes that lead to better patient outcomes? Learn more about the importance of collaboration in hospitals between healthcare professionals and how pharmacists fit into this collaborative work.
Learning objectives:
- Explain the importance of governance structures for successful AMS programmes; - Learn how to set up medicines and therapeutics subcommittees and infection prevention control subcommittees; and - Recognise the impact of AMR on patients when treatment fails.
Guests: - Freddy Eric Kitutu, Senior Lecturer Makerere University, Uganda - Mary Millard, USA - Elaine Cloutman-Green, Consultant Clinical Scientist, Deputy Director of Infection Prevention and Control and Lead Healthcare Scientist, Great Ormond Street Hospital for Children, NHS Foundation Trust, UK - Abraham Weeks, Senior Technical Specialist, Organization of Eastern Caribbean States Pharmaceutical Pooled Procurement Unit Organization of Eastern Caribbean States Commission (OECS Commission), St Lucia - Andrea Kwa Lay Hoon, Assistant Director (Research)/Specialist Pharmacist (Infectious Diseases)/Director of Infectious Diseases Pharmacotherapy Residency. Associate Professor Singapore General Hospital & Duke-NUS Medical School, Department of Emerging Infectious Diseases/NUS Pharmacy, Singapore
This special event is held during a week which marks two significant dates for global health. We will have passed the 1000 days since 30 January 2020 when the World Health Organization declared the COVID-19 outbreak at the time as a Public Health Emergency. The same week will also mark the 4th anniversary since the world, including FIP, came together in Astana in 2018 to endorse the new Declaration of Astana emphasizing the critical role of primary health care. Join us on this special launch event on pandemic preparedness to learn about global pharmacy’s response to COVID-19 and discuss the important of resilient pharmacy and health systems.
Learning objectives: 1. Understand how FIP supported (and continues to support) its members during the pandemic 2. Describe how pharmacy leadership bodies responded to the pandemic across the world 3. Discuss country best practices and lessons for future pandemic preparedness 4. Learn about FIP’s map of primary health care, focusing on strengthening health systems and recovery
Moderator:
- Lina Bader, FIP Lead for Equity, Sustainability Policy and Development, Saudi Arabia
Panellists: - Mariet Eksteen, Professional Development and Support, Pharmaceutical Society of South Africa (PSSA), South Africa - Hala Sacre, CEO, INSPECT-LB, Lebanon - Clare Fitzel, Head of Professional Services, Irish Pharmacy Union, Ireland - Teresa Almeida, Member of the board of directors, Associação Nacional das Farmácias, Portugal - Mary Ann Sant Fournier, President, Malta Chamber of Pharmacists, Malta - Leonor Soares, Leonor Soares, International Affairs, Portuguese Pharmaceutical Society, Portugal - Nobuo Yamamoto, President, Japan Pharmaceutical Association, Japan - Atsushi Toyomi, Executive Director, Japan Pharmaceutical Association, Japan - Sofía Segura, Professor, University of Costa Rica and College of Pharmacists of Costa Rica, Costa Rica - Roop Gupta, Chairman, Hospital Pharmacy Division and Vice President, India - Jack Shen Lim, Treasurer, Malaysian Pharmacists Association, Malaysia - Daragh Connolly, FIP Chair of BPP, Ireland
FIP staff: - Catherine Duggan, FIP Chief Executive Officer, UK/Netherlands - Nour Eltahla, FIP Projects coordinator – Equity, sustainability policy and development, Saudi Arabia - Farah Aqqad, FIP Regional Engagement, Support and Development Manager, Jordan - Sherly Meilianti, FIP Data and Intelligence Specialist, Indonesia - Nilhan Uzman, FIP lead for education and primary health care policies, The Netherlands
The World Health Organization estimate that 17.9 million people die from cardiovascular diseases each year, representing 32% of all global deaths. Pharmacists have a role to play in the prevention, care and management of cardiovascular diseases and their complications. FIP has developed a new handbook to support pharmacists and their organisations in providing a range of cardiovascular diseases-related services. This handbook — which will be launched at this event — also identifies the knowledge and skills that pharmacists require for the provision of such services, thus offering guidance to academic institutions and CPD providers. This handbook is part of the FIP Practice Transformation Programme on Non-Communicable Diseases.
Learning objectives:
Explore the role of pharmacists in the prevention, care and management of cardiovascular diseases and their complications;
Identify the challenges and opportunities for pharmacists in addressing cardiovascular diseases;
Identify the relevant knowledge and skills required for the delivery of cardiovascular diseases-related services.
Moderator: - Paul Sinclair, Chair Board of Pharmaceutical Practice FIP, Australia
Panellists: - Jean-Luc Eiselé, CEO World Heart Federation, Geneva, Switzerland - Pedro Amariles, Full professor and researcher on Pharmaceutical Care and Clinical Pharmacy Universidad de Antioquia, Colombia - Francesca Wirth, Senior Lecturer Department of Pharmacy, University of Malta, Malta - Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager FIP, Portugal - Dalia Bajis, FIP Lead for Provision and Partnerships, Australia
Summary of “Creating development goal indicators – bridging data and outcomes” events
FIP member organisations of each region across the globe, selected some of the FIP Development Goals which are the priorities of their region. Western Pacific region: DG 1 (Academic capacity), DG 2 (Early career training strategy), DG 4 (Advanced and specialist development), DG 7 (Advancing integrated services), DG 12 (Pharmacy intelligence), DG 19 (Patient safety), and DG 20 (Digital health).
FIP Global Pharmaceutical Observatory (GPO) team members have designed and developed indicators to support tracking progress towards the development goals. This globally validated list of indicators across all DGs will monitor progress worldwide and support each country in the process of transformation of their workforce, education, practice, and pharmaceutical science. FIP is developing a framework for selecting indicators and a monitoring and evaluating DGs. This will enable the design of global Atlas (data visualisation) dashboards that will drive and inform improvement and monitor trends over time.
The process for tracking the development goals is first is to select priority DGs by identifying general, broad areas where there are active, ongoing national policies or projects mapped to the FIP DGs. The next step is to select the right indicators. Indicators are useful to provide measurable progress towards DGs, identify areas that need attention and support continuous improvement. After that, a monitoring and evaluation framework can be developed. Lastly, continuous development can be provided by regularly updating Atlas dashboards to present how the data changes over time. Atlas dashboards can include an actionable overview of a limited set of key indicators with novel ways of bringing attention to those areas that are advancing the profession or experiencing challenges. These have significant potential to support regular reviews of DG progress and improve the data quality.
Western Pacific Panel Discussion on DG priorities and data requirements:
There are 4 DGs that are the foundation of other DGs, specifically for Western Pacific but can also apply globally: 1) DG 1 (Academic capacity), 2) DG 5 (Competency development), 3) DG 9 (Continuing professional development strategies), 4) DG 6 (Leadership development).
DG 12 (Pharmacy intelligence) is very important because much research is being undertaken but attention is needed on how to use the collected data, how it could be applied and operationalized.
DG 18 (Access to medicines, devices, and services) is also a priority, because there is still a challenge to achieve equity and equality in terms of accessing their medicines devices and services.
In terms of DG 1 (Academic capacity), Australia has 47 accredited pharmacy programs offered by 20 providers and 125 pharmacists per 100.000 people. However, about 40% workforce are less than 35 years old and there is an increased proportion on this population who do not intend to practice beyond the next 10 years. There is a need to find out why young people are leaving the profession and whether we have been investing sufficiently to support the young graduates to advance further in their career. The government needs to work together with professional bodies and academic institution to invest more in pharmacy education and training to meet the demands of current and future health care needs.
The development in early career strategy such as residency training programs by Society of Hospital Pharmacy in Australia (SHPA), early career pharmacists (ECP) forum and communities of specialty interests (CSIS) are aligned with the DG 2 (Early career training strategy).
It is much better to have longitudinal data and track things rather than a snapshot. There are some readily available data such as the number of students coming in and go out successfully that might reflect academic capacity. There is a need for a common set of assessment that can be used across the region.
For DG 7 (Advancing integrated services), we need to look at what policies and strategies are needed for strengthening and transforming pharmacy workforce education and systematic training on trainers and educators.
There are some DGs that can be quantified numerically for the monitoring process such as in DG 9 (Continuing professional development strategies) we can count the attendance in continuing professional development events as a ratio to the total membership of the profession.
Summary of “Creating development goal indicators – bridging data and outcomes” events
FIP member organisations of each region selected some of the FIP Development Goals which are the priorities of their region. Eastern Mediterranean region: DG 2 (Early career training strategy), DG 5 (Competency development), DG 9 (Continuing professional development strategies), DG 13 (Policy development), and DG 19 (Patient safety).
FIP Global Pharmaceutical Observatory (GPO) team members have designed and developed indicators to support tracking progress towards the development goals. This globally validated list of indicators across all DGs will monitor progress worldwide and support each country in the process of transformation of their workforce, education, practice, and pharmaceutical science. FIP is developing a framework for selecting indicators and a monitoring and evaluating DGs. This will enable the design of global Atlas (data visualisation) dashboards that will drive and inform improvement and monitor trends over time.
The process for tracking the development goals is first is to select priority DGs by identifying general, broad areas where there are active, ongoing national policies or projects mapped to the FIP DGs. The next step is to select the right indicators. Indicators are useful to provide measurable progress towards DGs, identify areas that need attention and support continuous improvement. After that, a monitoring and evaluation framework can be developed. Lastly, continuous development can be provided by regularly updating Atlas dashboards to present how the data changes over time. Atlas dashboards can include an actionable overview of a limited set of key indicators with novel ways of bringing attention to those areas that are advancing the profession or experiencing challenges. These have significant potential to support regular reviews of DG progress and improve the data quality.
East Mediterranean Region Panel Discussion on DG priorities and data requirements:
In Qatar, there is a gap in DG 2 (Early career training strategy) i.e. there is a need for training for the early career pharmacists. This also aligns with the competency framework, which is needed for both early graduated pharmacists and advanced pharmacists.
Qatar have done well so far on DG 1 (Academic capacity) and DG 3 (Quality assurance). In terms of quality assurance, College of Pharmacy at Qatar University have gone through accreditation at Canadian Council for Accreditation of Pharmacy Programs (CCAP).
The top priority is to develop a practice framework for pharmacist practitioners whether they are in early or advanced career.
Data needed are the number of pharmacists in the country within different sectors, and whether they are following professional development program or certifying system for continuing their education. Currently Qatar also has a committee which is focusing on professional development not only for pharmacists but also for all health care profession in general. Qatar can also learn to create the framework from FIP and neighbouring countries such as Saudi Arabia.
There is a gap between science, education and workforce which need to be connected in EMR. The competency of pharmacists at work is important. More efforts relating to pharmacy education are needed such as accreditation for the educational level, continuous education, certification, and competency framework as a standard. The variation in pharmacy education globally also needs to be unified.
To advocate for a broader and more harmonized implementation of Biopharmaceutical Classification System (BCS)-based biowaivers in Latin American countries, the FIP is supporting regional leaders in raising awareness of this science-based regulatory pathway designed to accelerate market approval of safe and effective generic pharmaceuticals. The second part of this series of webinars designed specifically for the Latin American region highlights examples of BCS-based biowaiver regulatory approval pathways currently being implemented in select Latin American countries. Experts will address the legislative basis for biowaiver regulations and discuss harmonization opportunities within the region.
This webinar has the objectives:
• Differentiate between in vivo bioequivalence and BCS-based biowaiver regulatory strategies for generic drug approval. • Understand the public health implications of the BCS-based biowaiver regulatory pathway. • Outline opportunities and challenges for the implementation of a harmonized biowaiver regulatory approval process within the Latin American region. • Outline solubility, permeability, and dissolution contributions for BCS-based biowaiver applications.
Moderator: Talita Ferreira, Coordinator Latin America Biowaiver Project International Pharmaceutical Federation (FIP), Brazil
Panelist: Eduardo Agostinho Freitas Fernandes, Specialist in health regulation and surveillance ANVISA - Brazilian Health Regulatory Agency, Brazil
Para abogar por una implementación más amplia y armonizada de bioexenciones basadas en el sistema de clasificación biofarmacéutica (BCS) en los países de América Latina, la FIP está apoyando a los líderes regionales en la sensibilización sobre esta vía reguladora basada en la ciencia diseñada para acelerar la aprobación del mercado de productos farmacéuticos genéricos seguros y eficaces. La segunda parte de esta serie de seminarios web diseñados específicamente para la región de América Latina destaca ejemplos de vías de aprobación regulatoria de bioexenciones basadas en BCS que se implementan actualmente en países seleccionados de América Latina. Los expertos abordarán la base legislativa de las regulaciones de bioexenciones y discutirán las oportunidades de armonización dentro de la región.
Este webinar tiene los objetivos:
• Diferenciar entre la bioequivalencia in vivo y las estrategias reguladoras de bioexención basadas en BCS para la aprobación de medicamentos genéricos. • Comprender las implicaciones para la salud pública de la vía reguladora de la bioexención basada en BCS. • Delinear oportunidades y desafíos para la implementación de un proceso armonizado de aprobación regulatoria de bioexenciones dentro de la región de América Latina. • Delinear las contribuciones de solubilidad, permeabilidad y disolución para aplicaciones de bioexención basadas en BCS.
Moderadora: - Talita Ferreira, Coordinadora de Proyectos de bioexención en Latinoamérica International Pharmaceutical Federation (FIP), Brazil
Panelista: - Andrés Figueroa Campos, Gerente SD Registro Sanitario de Productos Farmacéuticos Bioequivalentesy, ANAMED ISPch – Agencia Nacional de Vigilancia Sanitaria de Chile
In 2019, the FIP Advisory Committee for the Pharmacy Technician and Support Workforce Strategic Platform was established and took on the responsibility to host future Symposia. Since 2020, the Pharmacy Technicians’ Symposium has been hosted and delivered as a digital event to promote widespread access to this learning forum. The committee is once again pleased to host, on October 18th and 19th,, the 2022 Pharmacy Technicians’ Symposium. This digital event will offer 2 half day sessions showcasing global roles and practice models among the pharmacy technician workforce, built on a theme of resiliency and contribution by working with other members of the pharmaceutical workforce toward recovery of the healthcare system. More here.
Pharmacists have a key role in leading antimicrobial stewardship initiatives to help tackle antimicrobial resistance. In Webinar 1, you will learn more about the magnitude of this recognised global health threat, its impact on real life, and how our profession can overcome challenges and make the most of opportunities to work collaboratively and shine in this space.
Learning objectives:
Identify the problem of AMR globally and some of the initiatives in place to tackle this;
Describe the importance of multidisciplinary teams and the role pharmacists play within them in the context of AMS;
Become familiar with how pharmacists from different geographical regions are helping to address AMR; and
Recognise the impact of AMR on patients when treatment fails.
In 2019, the FIP Advisory Committee for the Pharmacy Technician and Support Workforce Strategic Platform was established and took on the responsibility to host future Symposia. Since 2020, the Pharmacy Technicians’ Symposium has been hosted and delivered as a digital event to promote widespread access to this learning forum. The committee is once again pleased to host, on October 18th and 19th,, the 2022 Pharmacy Technicians’ Symposium. This digital event will offer 2 half day sessions showcasing global roles and practice models among the pharmacy technician workforce, built on a theme of resiliency and contribution by working with other members of the pharmaceutical workforce toward recovery of the healthcare system. More here.
Summary of “Creating development goal indicators – bridging data and outcomes” events
FIP member organisations of each region selected some of the FIP Development Goals which are the priorities of their region. Southeast Asia region: DG 12 (Pharmacy intelligence), DG 15 (People-centred care), and DG 19 (Patient safety).
FIP Global Pharmaceutical Observatory (GPO) team members have designed and developed indicators to support tracking progress towards the development goals. This globally validated list of indicators across all DGs will monitor progress worldwide and support each country in the process of transformation of their workforce, education, practice, and pharmaceutical science. FIP is developing a framework for selecting indicators and a monitoring and evaluating DGs. This will enable the design of global Atlas (data visualization) dashboards that will drive and inform improvement and monitor trends over time.
The process for tracking the development goals is first is to select priority DGs by identifying general, broad areas where there are active, ongoing national policies or projects mapped to the FIP DGs. The next step is to select the right indicators. Indicators are useful to provide measurable progress towards DGs, identify areas that need attention and support continuous improvement. After that, a monitoring and evaluation framework can be developed. Lastly, continuous development can be provided by regularly updating Atlas dashboards to present how the data changes over time. Atlas dashboards can include an actionable overview of a limited set of key indicators with novel ways of bringing attention to those areas that are advancing the profession or experiencing challenges. These have significant potential to support regular reviews of DG progress and improve the data quality.
Southeast Asian Region Panel Discussion on DG priorities and data requirements:
The 21 DGs are aligned with the health system transformation in Indonesia, especially for DG 4 (Advanced and specialist development), DG 12 (Pharmacy intelligence and DG 20 (Digital health). DG 4 (Advanced and specialist development) is the most aligned DG in relation with transformation agenda on health human resources in Indonesia.
In Sri Lanka, the priority goals are DG 1 (Academic capacity), DG 2 (Early career training strategy), DG 5 (Competency development), and DG 9 (Continuing professional development strategies). DG 1 is important because Sri Lanka has different pathways of creating pharmacists with most of the other countries, there are 3 programs with different qualification.
Sri Lanka needs is to collect the data of pharmacists working in different sectors, because all pharmacists are having the same certificate and this not mention the area of practice.
Currently, Sri Lanka does not have a well-organized education and training program to support early career pharmacists, or a development framework to support career development and no continuing professional development program for pharmacists.
All 21 DGs resonate with the needs in India. The priority areas are DG 12 (Pharmacy Intelligence), DG 15 (People-centred care) and DG 19 (Patient safety). Pharmacy council of India is maintaining the data about number of pharmacists and number of colleges which needs to be updated regularly and available to the policy makers as well as the people.
India is currently developing the data regarding available pharmacists and their area of work.
Indonesia needs the data of pharmacists that provide services across nation, their competencies profile and progress on the career. Indonesian Pharmacists Association already created the information system to provide the data on number of pharmacists, however, the data is still lacking the competencies profile and the progress on their career pathway for advanced practice perspective.
Despite a temporary drop in the incidence of seasonal influenza during the pandemic, it will continue to represent a heavy burden for healthcare systems and societies overall. In a post-pandemic scenario, it will be crucial to protect and further advance the progress that had been achieved globally in terms of flu vaccination rates. This event will discuss why flu vaccination remains a priority, and how co-administration of flu and COVID-19 vaccines can provide a convenient and effective solution for driving vaccination uptake for both diseases. The event will also explore how pharmacists can contribute to flu vaccination strategies.
By the end of the session participants should be able to: • Understand the importance of flu vaccination, especially for vulnerable population groups, like the elderly • Recognize the need for improving vaccination coverage rates for both the flu and COVID-19. • Discuss pharmacists’ contribution to flu vaccination strategies.
Moderator: - Lars-Åke Söderlund, FIP Vice President International Pharmaceutical Federation, Sweden
Panelists: - Joshua A. Mott, Technical Advisor for Influenza and Pandemic Preparedness, WHO, Department of Epidemic and Pandemic Preparedness and Prevention, Switzerland - Lyn Morgan, Coordinator, Policy & Communications group, Influenza Vaccines Suppliers International Federation of Pharmaceutical Manufacturers’ Associations, France - Maria Mendes, Area Manager at the Centre for Medicines Information and Health Interventions (CEDIME) at the National Association of Pharmacies, Portugal National Association of Pharmacies, Portugal
Summary of “Creating development goal indicators – bridging data and outcomes” events
FIP member organisations of each region selected some of the FIP Development Goals which are the priorities of their region. Africa region: DG 1 (Academic capacity), DG 3 (Quality assurance), DG 9 (Continuing professional development strategies), and DG 18 (Access to medicines, devices, and services).
FIP Global Pharmaceutical Observatory (GPO) team members have designed and developed indicators to support tracking progress towards the development goals. This globally validated list of indicators across all DGs will monitor progress worldwide and support each country in the process of transformation of their workforce, education, practice, and pharmaceutical science. FIP is developing a framework for selecting indicators and a monitoring and evaluating DGs. This will enable the design of global Atlas (data visualisation) dashboards that will drive and inform improvement and monitor trends over time.
The process for tracking the development goals is first is to select priority DGs by identifying general, broad areas where there are active, ongoing national policies or projects mapped to the FIP DGs. The next step is to select the right indicators. Indicators are useful to provide measurable progress towards DGs, identify areas that need attention and support continuous improvement. After that, a monitoring and evaluation framework can be developed. Lastly, continuous development can be provided by regularly updating Atlas dashboards to present how the data changes over time. Atlas dashboards can include an actionable overview of a limited set of key indicators with novel ways of bringing attention to those areas that are advancing the profession or experiencing challenges. These have significant potential to support regular reviews of DG progress and improve the data quality.
African Region Panel Discussion on DG priorities and data requirements:
All FIP DGs are relevant. The first and the main priority from FIP DGs is the DG 1 (Academic capacity). Academic capacity is the first step for developing the profession. There is a need to collect the data on education such as the number of people in academia, university lecturers, and hours of courses. The second one is the strong regulation for quality assurance of the medicines.
In Ghana, there is a need to improve access to quality medicines (DG 18). DG 18 (Access to medicines, devices, and services) is the main priority in the continent.
Three most prioritized goals are: 1) DG 4 (Advanced and specialist development), to enforce the law established in 2012; 2) DG 5 (Competency development) to standardize the competency of pharmacy graduates; 3) DG 20 (Digital health) to control substandard and falsified medicines.
The Pharmacy Council of Ghana is also developing the e-pharmacy policy and subsequently have developed national electronic pharmacy platform.
For DG 4 (Advanced and specialist development), there’s a need to get the baseline data in terms of available capacities and specialists. After having the baseline data as well as the needs assessment results, pharmacies can be trained based on their interests and we can track the implementation after the training.
Summary of “Creating development goal indicators – bridging data and outcomes” events
FIP member organisations of each region selected some of the FIP Development Goals which are the priorities of their region. European region: DG 1 (Academic capacity), DG 4 (Advanced and specialist development), DG 7 (Advancing integrated services), DG 13 (Policy development), DG 15 (People centred care), DG 19 (Patient safety), DG 20 (Digital health), and DG 21 (Sustainability in pharmacy).
FIP Global Pharmaceutical Observatory (GPO) team members have designed and developed indicators to support tracking progress towards the development goals. This globally validated list of indicators across all DGs will monitor progress worldwide and support each country in the process of transformation of their workforce, education, practice, and pharmaceutical science. FIP is developing a framework for selecting indicators and a monitoring and evaluating DGs. This will enable the design of global Atlas (data visualization) dashboards that will drive and inform improvement and monitor trends over time.
The process for tracking the development goals is first is to select priority DGs by identifying general, broad areas where there are active, ongoing national policies or projects mapped to the FIP DGs. The next step is to select the right indicators. Indicators are useful to provide measurable progress towards DGs, identify areas that need attention and support continuous improvement. After that, a monitoring and evaluation framework can be developed. Lastly, continuous development can be provided by regularly updating Atlas dashboards to present how the data changes over time. Atlas dashboards can include an actionable overview of a limited set of key indicators with novel ways of bringing attention to those areas that are advancing the profession or experiencing challenges. These have significant potential to support regular reviews of DG progress and improve the data quality.
European Region Panel Discussion on DG priorities and data requirements
FIP DGs are aligned with national priorities, which also to achieve the United Nation’s health related Sustainable DGs. Nowadays there is an organizational shift which reduces the boundaries and encourage integrated care according to the patient needs, this is also one of the reasons why FIP DGs are really aligned to the national priorities.
In the UK, DG 2 (Early career training strategy), DG 7 (Advancing integrated services) and DG 21 (Sustainability in pharmacy) resonates with the national needs.
In Portugal, DG 5 (Competency development), DG 7 (Advancing integrated services) and DG 13 (Policy development) are the DGs that mostly aligned with three national priorities, which are to: 1) increase access to patient information, 2) guarantee successful implementation of pharmaceutical career in national health system, and 3) promote implementation and reimbursement of new pharmaceutical services.
In Northern Cyprus, DG 9 (Continuing professional development strategies), DG 13 (Policy development), DG 19 (Patient safety), and DG 4 (Advanced and specialist development) are the DGs that are mostly resonates with the national priorities.
Data needed to track the progress are: 1) quantitative and qualitative data of pharmacists’ placement in undergraduate curriculum, 2) competencies measurement and the real impact of pharmacists from holding a specific competency and 3) qualitative data regarding continuous professional development and specialists (i.e., sport pharmacists).
Summary of “Creating development goal indicators – bridging data and outcomes” events
FIP member organisations of each region selected some of the FIP Development Goals which are the priorities of their region. Americas region: DG 1 (Academic capacity), DG 3 (Quality assurance), DG 13 (Policy development), and DG 15 (People-centred care).
FIP Global Pharmaceutical Observatory (GPO) team members have designed and developed indicators to support tracking progress towards the development goals. This globally validated list of indicators across all DGs will monitor progress worldwide and support each country in the process of transformation of their workforce, education, practice, and pharmaceutical science. FIP is developing a framework for selecting indicators and a monitoring and evaluating DGs. This will enable the design of global Atlas (data visualisation) dashboards that will drive and inform improvement and monitor trends over time.
The process for tracking the development goals is first is to select priority DGs by identifying general, broad areas where there are active, ongoing national policies or projects mapped to the FIP DGs. The next step is to select the right indicators. Indicators are useful to provide measurable progress towards DGs, identify areas that need attention and support continuous improvement. After that, a monitoring and evaluation framework can be developed. Lastly, continuous development can be provided by regularly updating Atlas dashboards to present how the data changes over time. Atlas dashboards can include an actionable overview of a limited set of key indicators with novel ways of bringing attention to those areas that are advancing the profession or experiencing challenges. These have significant potential to support regular reviews of DG progress and improve the data quality.
Americas Region Panel Discussion on DG priorities and data requirements
Progress was highlighted with DG 18 (Access to medicines, devices, and services), DG 19 (Patient safety) and DG 20 (Digital health). For DG 20, there are electronic health records and apps about Coronavirus information. Current needs are not only to generate new data but also to make more data available to public. However, this is limited by the regulatory agency.
It is difficult to assess only specific DG priority because each of the DGs is often connected to another. For example, DG 15 (People centred care) is linked to DG 8 (Working with others), DG 7 (Advancing integrated services) and DG 11 (Impact and outcomes).
In the Americas, there is often a lack of data related to the multi-employment of pharmacists. There is also lack of professionals presents in community pharmacy.
There is a need for data related to pharmacies participation in immunization and occupation and renumeration related to gender.
To implement strategic plans, we need the data before and after the implementation
The COVID19 pandemic has highlighted that we need better antiviral therapies, especially for respiratory viral diseases. We have developed inhalation therapies consisting of siRNA nanoparticles which inhibit the viral genome of coronaviruses. The advantage over vaccination is the therapeutic index for virus variants and new coronaviruses. Other so far undruggable targets are transcription factors which are often drivers of tumorigenesis. Accordingly, examples for pulmonary delivery of therapeutic RNA in asthma, targeting GATA-3, and in lung cancer, targeting mutated KRAS, will be discussed.
Learning objectives: *siRNA nanoparticles for inhalation delivery *Application to un- druggable targets like transcription factors
Co-moderator: Kaushik Desai, Associate ExCo Member, Industrial Pharmacy Section, Secretary General International Pharmaceutical Excipients’ Council of India-India
Panelist: Olivia Merkel, Professor of Drug Delivery Ludwig Maxmillian University (LMU) Munich, Germany
This webinar is the second of the Precision Medicine Webinar Series, which will discuss the current state and future of precision medicine in research and practice, including the ongoing technological advances and challenges and opportunities for the pharmacy profession to address. This webinar will cover: - Ongoing technological developments, including: o Multi-omics o Single-cell sequencing o High-resolution imaging o Combinatorial drug screens o Biostatistics, machine learning and open software repositories - Examples of clinical translation of the above technologies in a research context - Thoughts on future directions of the field, and unaddressed gaps.
At the end of this session, participants will: 1. Have an awareness of some of the key technological advances driving the evolution of precision medicine. 2. Be familiar with some examples of its potential implementation 3. Be aware of current limitations and remaining challenges to be addressed
Co-Chairs: -Donnacha Fitzgerald, FIP Technology Forum member, Predoctoral Fellow The European Molecular Biology Laboratory (EMBL) and Heidelberg University Hospital, Germany -R. Stephanie Huang, Professor Department of Experimental and Clinical Pharmacology, University of Minnesota, USA
Panellists: -Wolfgang Huber, Co-Director, Molecular Medicine Partnership Unit Group Leader ad Senior Scientist The European Molecular Biology Laboratory (EMBL), Germany -Christoph Merten, Associate Professor Swiss Federal Institute of Technology Lausanne (EPFL), Switzerland
Cancer is the second leading cause of death globally, according to the World Health Organization. Prevention and early screening are crucial elements of interprofessional strategies to reduce the burden, morbidity and mortality associated with cancer, as are medication management for optimal outcomes, and patient support. Pharmacists have a key role to play in all these areas. At this digital event, FIP will be publishing a new handbook to support pharmacists and their organisations in providing a range of cancer-related services. In addition, the handbook will be accompanied by the knowledge and skills (K&S) reference guide in cancer which identifies the K&S that pharmacists require for the provision of such services, thus offering guidance to pharmacists, academic institutions and CPD providers. Both publications will be launched at this event, and they are part of the FIP Practice Transformation Programme on Non-Communicable Diseases.
Attendees will learn about:
1. The role of pharmacists in the prevention, screening, care and management of cancer; 2. Challenges and opportunities for pharmacists in implementing cancer-related services; 3. The knowledge and skills pharmacists need to acquire to support their role in the delivery of cancer-related services.
Moderator:
-Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager FIP, Portugal
Panelists: -Evelyn Handel, ISOPP President (2022-2024) International Society of Oncology Pharmacy Practitioners (ISOPP), USA -Folakemi T. Odedina, Professor of Oncology Mayo Clinic Cancer Center, USA -Matthew Hung, Clinical Staff Pharmacist St. Mary’s Hospital, Montreal West Island Integrated University Health and Social Services Centre, Canada -Dalia Bajis, Lead for provision and partnerships FIP, Australia
Vaccination is one of the most effective measures to prevent disease transmission and help people remain healthy and retain functional ability as they grow older. Adopting a life-course approach to vaccination and providing convenient and accessible vaccination pathways for older adults is essential to achieve high vaccination coverage rates in this particular population group. Pharmacists increasingly offer reliable information and vaccination services around the world. Among the different special-risk population groups, older adults have specific vaccination needs that will be discussed in this event.
By the end of the session participants should be able to: 1. Understand the most important vaccines for older adults 2. Recognise the role of pharmacists in promoting vaccination to the elderly 3. Discuss strategies for the promotion of a life-course approach to vaccination
Moderator: - Lina Bader, Lead for Equity, sustainability policy and development International Pharmaceutical Federation (FIP), Saudi Arabia
Panelists: - Jean-Pierre MICHEL, Honorary Professor of Medicine University of Geneva, Switzerland - David Sinclair, Chief Executive ILC. UK - Jane Barratt, Secretary General International Federation on Ageing, Canada - Ruggli Martine, President pharmaSuisse, Switzerland
Strengthening our patients' immune systems has never been more important, and healthy nutrition is one critical factor. This event focuses on how nutrition impacts immunity and its importance in supporting a strong and responsive immune system. It is the second event in the 2022 FIP series 'Food for thought: Pharmacists' role in healthy nutrition'.
Moderator: Jaime Acosta, Community Pharmacist Farmacia Acosta- Spain
Panelists: -Philip Calder, President, Federation of European Nutrition Societies Head of the School of Human Development and Health at the University of Southampton, United Kingdom -Joanna Harnett, Senior Lecturer Sydney Pharmacy School, Australia -Basma Abdulsamad, Clinical Pharmacist – MSc. Immunology and Allergy – Harvard Associate Alumni Medical Research Institute, Alexandria Egypt, Egypt
Asthma and chronic obstructive pulmonary disease are common chronic respiratory diseases (CRD) that affect millions of people worldwide. Pharmacists have a role to play in the prevention, care and management of CRD. FIP will be publishing a new handbook to support pharmacists and their organisations in providing a range of CRD-related services. This will be accompanied by a reference guide which identifies the knowledge and skills that pharmacists require for the provision of such services. Both publications will be launched at this event, and they are part of the FIP Practice Transformation Programme on Non-Communicable Diseases.
Attendees will learn about: 1. The role of pharmacists in the prevention, screening, care and management of chronic respiratory diseases and their complications; 2. Challenges and opportunities for pharmacists in addressing chronic respiratory diseases-related services; 3. The knowledge and skills pharmacists need for the delivery of chronic respiratory diseases services.
Moderator: - Gonçalo Sousa Pinto, FIP Lead for Practice Development and Transformation, Portugal
Panelists: - Ema Paulino, President Portuguese National Pharmacy Association, Portugal - Siân Williams, Chief Executive Officer International Primary Care Respiratory Group (IPCRG), Scotland - Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager, Portugal - Dalia Bajis, FIP Lead for provision and partnerships, Australia - Richard Sammy, Pharmacist Changu Pharmacy Ltd, Kenya
Webinar video • 12 September 2022, 10:00 - 11:30 CEST
‘How can digital health support national pharmaceutical care delivery?’ A regional and global assessment of priorities and challenges in the Western Pacific region
Substandard and falsified medicines, along with a lack of adherence to medication regimens, pose a threat to public health worldwide. It is possible to deliver pharmaceutical care services that address these challenges using digital healthcare techniques and approaches. Globally, digital health faces many challenges and concerns, despite its potential to impact pharmaceutical care. FIP and the Global Pharmaceutical Observatory are launching a new needs assessment programme entitled "How can digital health support national pharmaceutical care delivery? A regional and global assessment of priorities and challenges", with an emphasis on medication adherence and fighting SF medicines. This regional and global needs assessment programme will include a series of six regional events, culminating in a private global roundtable and a summary report.
Aim: Facilitate a regional discussion about ongoing digital health interventions or solutions that detect, report, and act against false or substandard medicines, and how to facilitate patient adherence, as well as the challenges leadership bodies and nations face in implementing digital health solutions in pharmaceutical care delivery in the Western Pacific.
Webinar video • 9 September 2022, 13:00 - 14:30 CEST
Achieve equitable, inclusive and quality pharmaceutical education for all: Launch of the FIP toolkit for addressing inequities in pharmaceutical education
Inequity has been identified as one of the most serious issues in education worldwide, with multiple causes and consequences. Recent evidence and findings from FIP research indicate that inequities in pharmaceutical education need to be addressed, and this FIP toolkit for addressing inequities in pharmaceutical education intends to motivate, assess, and inform forward thinking changes targeted at transforming pharmaceutical education through addressing inequities globally, across all regions and locally.
At the end of this session, participants will: 1. Learn about the vital inequity themes that impact pharmaceutical education; 2. Understand the importance of having equitable pharmaceutical education; 3. Discuss with the toolkit authors and high-level speakers how to take action towards enabling equitable pharmaceutical education nationally, regionally and globally
Moderator: - Ralph J. Altiere, FIPEd Chair FIP and University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, USA
Guests: -Catherine Duggan, FIP CEO, The Netherlands
Panelists: - Nilhan Uzman, FIP Lead for education and primary health care policies, The Netherlands - Alison Ubong Etukakpan, FIP Educational Partnership Specialist, Nigeria - Karima Bennara, Chairperson of pharmacy education, International Pharmaceutical Students Federation, Algeria - Khalid Garba Mohammed, Post doctoral Fellow, Pharmaceutical Engineering Group, School of Pharmacy, Queens University Belfast, UK - Oliver Grundmann, Clinical Professor The College of Pharmacy, University of Florida, USA - Neelaveni Padayachee, Senior lecturer and Researcher Department of Pharmacy and Pharmacology, Pharmacy Practice Division, The University of Witwatersrand, South Africa - Aysu Selcuk, FIP Education and Primary Health Care Policies Specialist, Turkey - Dalal Hammoudi, Associate Dean for Assessment Lebanese International University, School of Pharmacy, Lebanon
Webinar video • 8 September 2022, 16:00 - 17:30 CEST
‘How can digital health support national pharmaceutical care delivery?’ A regional and global assessment of priorities and challenges in the Americas region
Substandard and falsified medicines, along with a lack of adherence to medication regimens, pose a threat to public health worldwide. It is possible to deliver pharmaceutical care services that address these challenges using digital healthcare techniques and approaches. Globally, digital health faces many challenges and concerns, despite its potential to impact pharmaceutical care.
FIP and the Global Pharmaceutical Observatory are launching a new needs assessment programme entitled "How can digital health support national pharmaceutical care delivery? A regional and global assessment of priorities and challenges", with an emphasis on medication adherence and fighting SF medicines.
This regional and global needs assessment programme will include a series of six regional events, culminating in a private global roundtable and a summary report.
In this regional event we will facilitate a regional discussion about ongoing digital health interventions or solutions that detect, report, and act against false or substandard medicines, and how to facilitate patient adherence, as well as the challenges leadership bodies and nations face in implementing digital health solutions in pharmaceutical care delivery in the Americas.
Moderator: - Magaly Rodrigu, Vice president Pharmaceutical Forum of the Americas, USA
Panelists: - Patricia Klahn Acuña, Clinical Pharmacist- Hospital Carlos Van Buren, Chile - Ilisa Bernstein, Interim Executive Vice President and CEO American Pharmacists Association, USA - Natalia Sancho-Vargas, Colegio de Farmacéuticos de Costa Rica, Costa Rica - Leticia Caligaris, Uruguay - Catalina Cano Abásolo, Head of the Department of Pharmaceutical Policies and Regulations, Health Providers and Complementary Medicines. Division of Healthy Public Policies and Promotion Assistant Secretary of Public Health, Ministry of Health, Chile - Timothy Aungst, Associate Professor. Freelance Writer and Consultant The Digital Apothecary, USA
Changes in climate constitute a reality that, according to recent projections, is going to worsen in the coming years.1 Increasing air pollution and climate change have an impact on respiratory health and mortality where climate change represents a massive direct threat to respiratory health by promoting or aggravating respiratory diseases or indirectly by increasing exposure to risk factors for respiratory diseases.
Overall Aim: To support pharmacists to play a proactive role in respiratory management of the health impact of indoor air pollution by helping to address their practice and education needs to enable them to provide better patient advice and self-care.
Learning objectives:
- Identify the changes in climate as well as the interrelationship between climate change and air pollution - Understand the impact of climate change and air pollution on health particularly respiratory health - Understand how climate change and air pollution affect people living in low- and middle-income countries - Know the intervention, treatment and management strategies including self-care measures to minimize the impact on respiratory health - Recognize the role pharmacists must play to support better health care delivery and patient care
Moderator: - Gonçalo Sousa Pinto, Lead for practice development and transformation, FIP Spain
Panelsists: - Kian Fan Chung, Professor of Respiratory Medicine, National Heart & Lung Institute, Imperial College London, United Kingdom - Sundeep Salvi, Founder and Director The Chest Research Foundation, India - Lina Bader, FIP Lead for Equity, sustainability policy and development International Pharmaceutical Federation (FIP), Saudi Arabia - Ravijyot Saggu, Lead clinical pharmacist and CPhO clinical fellow ’21/’22, NHS England, UK
Influenza and COVID-19 can have an important impact in health, productivity and quality of life, especially for vulnerable populations. Likewise, both diseases have vaccines that are available and support a lower risk of transmission of the disease.
Pharmacists can play a major role in reminding people to get vaccinated, building vaccine confidence and supporting their decision making, dispensing vaccines and, in some countries, administering those vaccines. The coadministration of these vaccines can lead to an efficient and convenient way of improving vaccine uptake against both diseases. Community pharmacies’s accessibility and credibility put them in an ideal situation to provide this important service, thus making a valuable contribution to disease prevention.
This digital event will discuss the importance of promoting the coadministration of COVID-19 and flu vaccines as well as strategies for pharmacies’ involvement.
By the end of the session participants should be able to:
Understand the benefits of vaccine coadministration
Recognize the need for vaccination coverage in both flu and COVID-19
Present the FIP Guideline on this topic
Moderator:
- Daragh Connolly, President, Community Pharmacy Section, Ireland
Panellist:
- Mitchel Rothholz, Immunization Consultant, Three-C Consulting, USA - Lisa Nissen, Professor (Program Director) – Health Workforce Optimisation, Centre for Business and Economics of Health, (Faculty of Business), Australia - Sham Moodley, Pharmacist, Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa - Paula Teixeira, Scientific Information Manager, Center for Medicines Information and Health Interventions (CEDIME) in the Portuguese National Association of Pharmacies (ANF), Portugal - Rúben Viegas, FIP Practice Development and Transformation Projects Coordinator, Portugal
Webinar video • 5 September 2022, 10:00 - 11:30 CEST
‘How can digital health support national pharmaceutical care delivery?’ A regional and global assessment of priorities and challenges in the South East Asian region
Substandard and falsified medicines, along with a lack of adherence to medication regimens, pose a threat to public health worldwide. It is possible to deliver pharmaceutical care services that address these challenges using digital healthcare techniques and approaches. Globally, digital health faces many challenges and concerns, despite its potential to impact pharmaceutical care.
FIP and the Global Pharmaceutical Observatory are launching a new needs assessment programme entitled "How can digital health support national pharmaceutical care delivery? A regional and global assessment of priorities and challenges", with an emphasis on medication adherence and fighting SF medicines.
This regional and global needs assessment programme will include a series of six regional events, culminating in a private global roundtable and a summary report.
In this regional event we will facilitate a regional discussion about ongoing digital health interventions or solutions that detect, report, and act against false or substandard medicines, and how to facilitate patient adherence, as well as the challenges leadership bodies and nations face in implementing digital health solutions in pharmaceutical care delivery in South East Asia.
Moderator: -Tanniru V Narayana, President SEARPharm Forum, India
Panelists: -Rao Vadlamudi, Professional Secretary/Immediate past president SEARPharm Forum/ the Indian Pharmaceutical Association, India -Hilwan Yuda Teruna, Vice President Indonesian Pharmacist Association, Indonesia -Kelum Jayasuriya, Group Manager Pharmacy Operations Asiri Group of Hospitals, Sri Lanka -Chinta Abayawardana, Past President, Pharmaceutical Society of Sri Lanka, Sri Lanka
Webinar video • 2 September 2022, 13:00 - 14:30 CEST
‘How can digital health support national pharmaceutical care delivery?’ A regional and global assessment of priorities and challenges in the European region
Substandard and falsified medicines, along with a lack of adherence to medication regimens, pose a threat to public health worldwide. It is possible to deliver pharmaceutical care services that address these challenges using digital healthcare techniques and approaches. Globally, digital health faces many challenges and concerns, despite its potential to impact pharmaceutical care. FIP and the Global Pharmaceutical Observatory are launching a new needs assessment programme entitled "How can digital health support national pharmaceutical care delivery? A regional and global assessment of priorities and challenges", with an emphasis on medication adherence and fighting SF medicines. This regional and global needs assessment programme will include a series of six regional events, culminating in a private global roundtable and a summary report.
Aim: Facilitate a regional discussion about ongoing digital health interventions or solutions that detect, report, and act against false or substandard medicines, and how to facilitate patient adherence, as well as the challenges leadership bodies and nations face in implementing digital health solutions in pharmaceutical care delivery in Europe
This event will focus on pharmacists’ roles in influenza prevention through vaccination and increasing influenza vaccination coverage rate. The event will focus on the risks of influenza and showcase good practices from pharmacists across the continent on pharmacists’ public health role through influenza vaccination, digital health solutions in pharmacy on influenza vaccination and effective communication with patients to deliver flu vaccines on the right time. This event aims to improve pharmacists' knowledge, improve pharmaceutical services delivery and overall health outcomes of the public in the context of influenza vaccination.
Learning objectives: 1. Improve knowledge of pharmacists on the risks of influenza 2. Exploring pharmacists’ roles in influenza prevention through vaccination and increasing influenza vaccination coverage rate within the African region; 3. Showcase country cases from pharmacists across the continent on influenza vaccination, digital vaccination solutions and patient communication on vaccines.
Moderator: - ArinolaJoda, Assistant Secretary and Editor-in- Chief, African Pharmaceutical Forum, Faculty of Pharmacy, University of Lagos, Nigeria
Guests: - Cheryl Cohen, Professor & Head Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases and School of Public Health, University of the Witwatersrand, Johannesburg, South Africa, South Africa - Gonçalo Sousa Pinto, Lead for practice development and transformation, FIP, Portugal - Redouane Soualmi, Chairperson of external relations Algerian Pharmaceutical Federation - Fédération Algérienne de Pharmacie, Algeria - Merilynn Steenkamp, General Manager Sanofi Vaccines, South Africa - Wael Ali, General Secretary, EMRPharm Forum , President Egyptian organization of pharmacy, Egypt
Facilitators: - Nilhan Uzman, Lead for Education and Primary Health Policies, FIP, Turkey - Alison Etukakpan, Educational Partnership Specialist, FIP, Nigeria
This event will focus on pharmacists’ roles in influenza prevention through vaccination and increasing influenza vaccination coverage rate. The event will focus on the risks of influenza and showcase good practices from pharmacists across the continent on pharmacists’ public health role through influenza vaccination, digital health solutions in pharmacy on influenza vaccination and effective communication with patients to deliver flu vaccines on the right time. This event aims to improve pharmacists' knowledge, improve pharmaceutical services delivery and overall health outcomes of the public in the context of influenza vaccination.
Learning objectives: 1. Improve knowledge of pharmacists on the risks of influenza 2. Exploring pharmacists’ roles in influenza prevention through vaccination and increasing influenza vaccination coverage rate within the African region; 3. Showcase country cases from pharmacists across the continent on influenza vaccination, digital vaccination solutions and patient communication on vaccines.
Moderator: - Arinola Joda, Assistant Secretary and Editor-in- Chief, African Pharmaceutical Forum, Faculty of Pharmacy, University of Lagos, Nigeria
Guests: - Cheryl Cohen, Professor & Head Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases and School of Public Health, University of the Witwatersrand, Johannesburg, South Africa, South Africa - Gonçalo Sousa Pinto, Lead for practice development and transformation, FIP, Portugal - Redouane Soualmi, Chairperson of external relations Algerian Pharmaceutical Federation - Fédération Algérienne de Pharmacie, Algeria - Merilynn Steenkamp, General Manager Sanofi Vaccines, South Africa - Wael Ali, General Secretary, EMRPharm Forum , President Egyptian organization of pharmacy, Egypt
Facilitators: - Nilhan Uzman, Lead for Education and Primary Health Policies, FIP, Turkey - Alison Etukakpan, Educational Partnership Specialist, FIP, Nigeria
This will be a 2-part workshop to introduce the FIP YPG Career Development toolkit. Part 1 will review the toolkit, the available resources, and discuss how it will benefit the user. Attendees will then be instructed to work through the toolkit over the next few weeks.
Part 2 of the workshop will be an engaging session where participants are asked to return with their completed toolkits to discuss what they learned with other attendees, review their toolkits in breakout rooms, and have the opportunity to ask questions.
Facilitar el acceso a los medicamentos: Bioequivalencia - Metodologías In Vitro para la Demostración de Equivalencia Terapéutica
Sesión V: Bioequivalencia - Estudios de Permeabilidad: principios, metodologías y análisis de datos
Sesión en Español
Este webinar tiene como objetivo presentar los conceptos:
• Rutas de absorción oral de fármacos • Transportadores intestinales • Estudios de permeabilidad in vitro • Impacto de excipientes sobre la absorción oral de fármacos • Aplicaciones de los estudios de permeabilidad
Moderadora: -Talita Ferreira, FIP Coordinadora de Proyectos de bioexención en Latinoamérica, Brasil
Panelista: -Pablo González, CEO Innovation and Biopharmaceutical Evaluation Center-Chile
Pharmacy needs to build sustained data and analytics capabilities that support evidence-based decision making and advocacy interventions that inform policy development. Improving capacity in data and intelligence across FIP and its member organisations, is essential to advance pharmacy world-wide. This event explores challenges and opportunities that maximise the use of data to generate evidence of impact across safe and effective use of medicines, pharmacy practice and the pharmacy workforce..
Aim To describe approaches for delivering the required data and intelligence to generate evidence of impact for the profession and current and future policy: enablers and barriers that will support this through practical approaches.
Learning objectives:
1) Explain how health information systems can be strengthened; 2) Describe approaches to evidence generation; 3) List current enablers/opportunities and barriers for using pharmacy data and intelligence to their full potential; 4) Discuss how the pharmacy profession makes better use of data and intelligence.
Moderator: - Christopher John, FIP Lead for Data and Intelligence FIP, UK
Panellists: - Sallie Pearson, Professor of Health Systems Research UNSW Sydney, Australia - Astrid Czock, FIP Global Lead for DG8: Working with others, CEO Qauliccare, Switzerland - Saja A. Alnahar, Assistant Professor Yarmouk University, Jordan - Hong Anh Chu, Technical Officer, WHO, Switzerland
Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, people living with cardiovascular diseases have particular vaccination needs that will be highlighted at this event.
Learning objectives: By the end of the session participants should be able to: • Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated • Understand the main recommended vaccines for people living with cardiovascular diseases • Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group
Moderator: - Renly Lim, FIP YPG Immediate Past President, Research Fellow University of South Australia, Australia
Panellists: - Alvaro Sosa Liprandi, President Interamerican Society of Cardiology, Argentina - Tolulope Osigbesan, Senior Policy and Advocacy Officer NCD Alliance, Switzerland - John D. Grabenstein, RPh, PhD, Director of Scientific Communications Immunize.org, USA
Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups for vaccine-preventable diseases, people living with cardiovascular diseases have particular vaccination needs that will be highlighted at this event.
Learning objectives: By the end of the session participants should be able to: • Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated • Understand the main recommended vaccines for people living with cardiovascular diseases • Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group
Moderator: - Renly Lim, FIP YPG Immediate Past President, Research Fellow University of South Australia, Australia
Panellists: - Alvaro Sosa Liprandi, President Interamerican Society of Cardiology, Argentina - Tolulope Osigbesan, Senior Policy and Advocacy Officer NCD Alliance, Switzerland - John D. Grabenstein, RPh, PhD, Director of Scientific Communications Immunize.org, USA
Several factors can influence digestive wellness and gut wellness, including stress, nutrition or medication. Disruptions to the microbiota homeostasis can lead to gastrointestinal symptoms and have an impact in immunity. This event will discuss dysbiosis and the role that pharmacists can have in improving gut wellness and immunity.
By the end of the session participants should be able to: • Understand dysbiosis and gut wellness • Identify tips to manage abdominal pain • Understand the role of diet in immunologic modulation • Understand the use of probiotics for gut wellness
Moderator: - Bidhata Khatri, FIP Health and Medicines Information Section (HaMIS) Secretary FIP, India
Panelists: - Saman Khalesi, Senior Lecturer and Discipline Lead – Nutrition Central Queensland University (CQUniversity); Postdoctoral Fellow of the National Heart Foundation of Australia, Australia - Ana Faria, Assistant Professor Nova Medical School - Universidade Nova de Lisboa, Portugal - Ender Pehlivanoglu, Professor of Pediatric Gastroeneterology&Nutrition Istanbul Kent University, Turkey - Metehan Özen, Pediatric Infectious Disease Specialist Acibadem University, School of Medicine, Turkey
Several factors can influence digestive wellness and gut wellness, including stress, nutrition or medication. Disruptions to the microbiota homeostasis can lead to gastrointestinal symptoms and have an impact in immunity. This event will discuss dysbiosis and the role that pharmacists can have in improving gut wellness and immunity.
By the end of the session participants should be able to: • Understand dysbiosis and gut wellness • Identify tips to manage abdominal pain • Understand the role of diet in immunologic modulation • Understand the use of probiotics for gut wellness
Moderator: - Bidhata Khatri, FIP Health and Medicines Information Section (HaMIS) Secretary FIP, India
Panelists: - Saman Khalesi, Senior Lecturer and Discipline Lead – Nutrition Central Queensland University (CQUniversity); Postdoctoral Fellow of the National Heart Foundation of Australia, Australia - Ana Faria, Assistant Professor Nova Medical School - Universidade Nova de Lisboa, Portugal - Ender Pehlivanoglu, Professor of Pediatric Gastroeneterology&Nutrition Istanbul Kent University, Turkey - Metehan Özen, Pediatric Infectious Disease Specialist Acibadem University, School of Medicine, Turkey
Several factors can influence digestive wellness and gut wellness, including stress, nutrition or medication. Disruptions to the microbiota homeostasis can lead to gastrointestinal symptoms and have an impact in immunity. This event will discuss dysbiosis and the role that pharmacists can have in improving gut wellness and immunity.
By the end of the session participants should be able to: • Understand dysbiosis and gut wellness • Identify tips to manage abdominal pain • Understand the role of diet in immunologic modulation • Understand the use of probiotics for gut wellness
Moderator: - Bidhata Khatri, FIP Health and Medicines Information Section (HaMIS) Secretary FIP, India
Panelists: - Saman Khalesi, Senior Lecturer and Discipline Lead – Nutrition Central Queensland University (CQUniversity); Postdoctoral Fellow of the National Heart Foundation of Australia, Australia - Ana Faria, Assistant Professor Nova Medical School - Universidade Nova de Lisboa, Portugal - Ender Pehlivanoglu, Professor of Pediatric Gastroeneterology&Nutrition Istanbul Kent University, Turkey - Metehan Özen, Pediatric Infectious Disease Specialist Acibadem University, School of Medicine, Turkey
This event will showcase how nations have coordinated pharmacy support for person-centred care in the fight against COVID-19 with a focus on strategy, policy and practice. Barriers and enablers to pharmacy’s involvement in the pandemic will be discussed as well as insights for countries wanting to advocate for pharmacy’s greater contribution in health systems. The future role of pharmacy in pandemics will be highlighted.
Aim To describe current and future pharmacy practice in delivering person-centred care during the fight against COVID-19 and possible future pandemics.
Learning objectives:
1. List policy and professional enablers and barriers for developing pharmacy practice during the COVID-19 pandemic; 2. Give examples of pharmacy services used in the fight against COVID-19; 3. Describe approaches for advocating for pharmacy support in pandemics; 4. Predict the role of the pharmacist and their teams in future pandemics.
Moderators: -Nadia Bukari, FIP Global Lead/Associate Professor, University College London FIP/UCL, UK -Abby Kahaleh, PhD, MS, BPharm, MPH, FAACP, FIP Global Lead on Quality Assurance for Pharmacy Education, Tenured Associate Professor for Clinical and Administrative Sciences; Board of Trustees Faculty, Roosevelt University, USA
Panelsits: -Suzete Costa, PharmD, MPH, PhD Executive Director & Senior Research Director Institute for Evidence-Based Health (ISBE), Portugal -Michael Ganio, Senior Director, Pharmacy Practice and Quality ASHP, USA -Shepard Mhlaba, FIP Global Lead, FIP Workforce Development Hub, WDG2: Early career training strategy, Drug Information Pharmacist/Research Assistant, Drug and Toxicology Information Services (DATIS), Harare, Zimbabwe
Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disorder that affects people of all ages. Pharmacists can play an important role in symptom management, referral to other healthcare professionals and provision of advice to improve quality of life. This event will provide an overview of the main roles pharmacists can have in supporting people living with IBS, from a community pharmacy perspective.
By the end of the session participants should be able to: • Discuss the role of community pharmacists around IBS • Understand the difference in symptoms between abdominal cramping pain and IBS • Identify red flag symptoms for referral of IBS patients
Consumers throughout the world are increasingly looking to the internet to purchase their drugs. The worldwide pandemic has caused many consumers, who had not done so previously, to look to the internet for healthcare, healthcare information and medicinal products. However, at any given time, 95% of the roughly 35,000 online drug sellers worldwide operate illegally, in violation of laws and placing consumers at risk. Drugs purchased through an illegal drug seller on the internet may contain no drug, subtherapeutic levels of a drug, a completely different drug, or toxic chemicals. These websites will appear to be “pharmacies” or other “medical centres” providing credible health care, drug information and safe and approved medications, but are not and present risk to the unknowing consumer.
Regulators throughout the world are monitoring the level of nefarious drug sellers and “medical clinics” on the internet. Regulatory solutions to combat and remove the presence of these harmful vendors and sites have not been widely implemented. Public awareness is an important step, but also raising the awareness among healthcare providers, law makers and social media platforms.
Learning Objectives: -To identify the level of illegal online drug sellers and bogus medical clinics on the internet and impact on the unsuspecting public -To identify the barriers to overcome and better protect the public. To identify programs and initiatives currently in place to combat misinformation, poor virtual care and falsified medication to enhance the safety and protect the internet consumer -To encourage and support standards for virtual care.
Moderator: -Ronald Guse, Chair FIP Regulators Forum - Canada Panelists: -Mike Isles,Director Alliance for Safe Online Pharmacy-EU-UK -Justin Macy,Digital Health Senior Manager National Association of Boards of Pharmacy-USA -Libby Baney,Senior Advisor to ASOP Global; Partner, Faegre Drinker LLP, Alliance for Safe on Pharmacy Global-USA
Overall Aim: To support pharmacists to play a proactive role in respiratory management of the health impact of indoor air pollution by helping to address their practice and education needs to enable them provide better patient advice and self-care.
Learning objectives: • Identify the sources of indoor air pollution and its increasing threat to health • Understand the short- and long-term impact of indoor air pollution particularly on children • Understand clinical, pharmacological, and non-pharmacological treatments including self-care measures to minimize the impact of air pollution on respiratory health • Illustrate how advocacy can impact behavior change to support adoption of better self-care practices aimed at reducing health impact of air pollution.
Moderator: - Lina Bader, FIP Lead for Equity, sustainability policy and development International Pharmaceutical Federation, Saudi Arabia
Facilitator: - Nour Eltahla, FIP Projects Coordinator for Equity, sustainability policy and development International Pharmaceutical Federation, Saudi Arabia
Panelists: - Lidia Morawska, Director International Laboratory for Air Quality and Health (WHO CC for Air Quality and Health), Queensland University of Technology, Australia - Gary WK Wong, Professor and honorary consultant, Department of Paediatrics, Chinese University of Hong Kong, Hong Kong - Tyler Knowlton, Director of Communications, Communities, and Partnerships Plume Labs, France
The demand for travel health and travel medicine services is rapidly growing with the return levels of international travel. Patients are frequently turning to community pharmacies for advice on disease reduction and maintaining personal health whilst travelling. Pretravel preparation is important for many reasons one of which is supporting Global Health policies and strategies.
In some countries legislation has been devolved to allow pharmacists to prescribe medication and vaccinate travellers. However, this is not the situation globally and the many countries place restrictions on this type of pharmacy practice.
Learning objectives: - To raise the awareness of pretravel consultation service that can be provided in a community setting without prescribing or vaccination. - To identify over-the-counter products that can be supplied to support travellers visiting a pharmacy - Compare and contrast classes of over-the-counter products for selected conditions and identify/select appropriate patients for their use. - Showcase the collaborations with the International Institute of Travel Medicine through membership of ISTM and completion of Certificate of Health
Moderator: - Daragh Connolly, President Community Pharmacy Section, Ireland
Panelists: - Derek Evans, Pharmacist Specialist in Travel Medicine Evans Travel Health consultancy, UK - Karl Hess, Director, Community Pharmacy Practice Innovations Department of Pharmacy Practice, Chapman University School of Pharmacy, Irvine, California, USA - Sheila Seed, Professor and Chair of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, USA - Larry Goodyer, Professor of Pharmacy Practice, Leicester School of Pharmacy Faculty of Health and Life Sciences, De Montfort University, UK
The importance of good mental health and wellbeing has gained attention over the last decade due to an increased burden of disability and loss of quality of life associated with mental health conditions. Pharmacists have a significant role in the support and management of persons with mental health illnesses and in reducing the commonly associated stigma. FIP has developed a new handbook to support pharmacists and their organisations in providing a range of mental health-related services. In addition, the handbook will be accompanied by the knowledge and skills (K&S) reference guide in mental health which identifies the K&S that pharmacists require for the provision of such services, thus offering guidance to pharmacists, academic institutions and CPD providers. Both publications will be launched at this event and they are part of the FIP Practice Transformation Programme on Non-Communicable Diseases.
Attendees will learn about:
The role of pharmacists in the prevention, identification, care and management of mental health illnesses;
Challenges and opportunities for pharmacists in addressing mental health illnesses;
The knowledge and skills pharmacists need to acquire to support their role in mental health.
Moderator: - Inês Nunes da Cunha, FIP Practice Development and Transformation Projects Manager, Portugal
Panelsits: - Claire O’Reilly, Senior Lecturer School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia - Sarira El-Den, Senior Lecturer The University of Sydney School of Pharmacy, Australia - Jiahui (Jeff) Dong, PharmD Candidate The University of North Carolina, Eshelman School of Pharmacy, United States - Dalia Bajis, FIP Lead for provision and partnerships, Australia
The Universal Health Coverage (UHC) Competency Framework was published by WHO as a guide to progress towards building more holistic and integrated health systems. Critically, this includes human resources education and the implementation of Competency-Based Education (CBE) for healthcare workers to ensure adequate, and integrated, education and training.
WHO Universal Health Coverage Competency Framework: https://www.who.int/publications/i/item/9789240034686
Learning Objectives:
Overview of the principles and objectives of the WHO universal health coverage competency framework
Understand competency-based education and its role in developing the global healthcare workforce for UHC
Contextualize the UHC competency development guide to fulfil training needs - based on country of practice
Focus on pharmacy and pharmacy support workforce role in UHC
Moderator: - Abigail Tan Ming Li, Staff training and the planning of continuing education topics. KK Women's and Children's Hospital, Singapore
Panelists: - Ian Bates, Director of the FIP Global Pharmaceutical Observatory, Chair of pharmacy education University College London, United Kingdom - Siobhan Fitzpatrick, WHO technical officer WHO, Switzerland
This first event in the FIP 2022 series 'Food for thought: Pharmacists' role in health nutrition' aims to describe the basics of nutrition for pharmacists, and the role of pharmacists in providing nutrition services for better health outcomes, expanding from the 2021 FIP report "Nutrition and weight management services: A toolkit for pharmacists".
Moderator: - Jaime Acosta, Community Pharmacist, Farmacia Acosta, Spain
Panellists: - Joanna Harnett, Senior Lecturer, Sydney Pharmacy School, Australia - Rúben Viegas, Practice Development Projects Coordinator, FIP, Portugal
Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups, people living with chronic respiratory conditions have specific vaccination needs that will be discussed in this event.
By the end of the session participants should be able to:
-Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated -Understand the main recommended vaccines for people living with chronic respiratory diseases -Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group
Moderator: -Peter Guthrey, Executive Committee Member of the Social and Administrative Pharmacy Section of FIP; Senior pharmacists - strategic policy The Pharmaceutical Society of Australia - Australia
Panelists: -Ema Paulino, President National Association of Pharmacies, Portugal (ANF), Portugal -Fiona Mosgrove, General Practitioner NHS Grampian, UK -Carmen Baldonedo Mosteiro, Community Pharmacist. Member of the Respiratory task force of the Spanish Society of community Pharmacy (SEFAC), Spanish society of clinical, familiar and community Pharmacy (SEFAC), Spain
Vaccination is one of the most effective measures to prevent disease transmission and protect populations from a variety of diseases that heavily impact individuals and health systems. Overall, through the provision of person-centred pharmaceutical services, pharmacists play a key role ensuring healthy lives and promoting wellbeing, as well as promoting more effective, rational, and widespread use of vaccines. Among the different special-risk population groups, people living with chronic respiratory conditions have specific vaccination needs that will be discussed in this event.
By the end of the session participants should be able to:
-Understand the risks that this particular population group is exposed to with regards to vaccine-preventable diseases, as well as the benefits of being vaccinated -Understand the main recommended vaccines for people living with chronic respiratory diseases -Discuss the role of pharmacists in supporting health literacy and vaccination of this special risk group
Moderator: -Peter Guthrey, Executive Committee Member of the Social and Administrative Pharmacy Section of FIP; Senior pharmacists - strategic policy The Pharmaceutical Society of Australia - Australia
Panelists: -Ema Paulino, President National Association of Pharmacies, Portugal (ANF), Portugal -Fiona Mosgrove, General Practitioner NHS Grampian, UK -Carmen Baldonedo Mosteiro, Community Pharmacist. Member of the Respiratory task force of the Spanish Society of community Pharmacy (SEFAC), Spanish society of clinical, familiar and community Pharmacy (SEFAC), Spain
‘How can digital health support national pharmaceutical care delivery?’ A regional and global assessment of priorities and challenges in the Eastern Mediterranean region
Substandard and falsified medicines, along with a lack of adherence to medication regimens, pose a threat to public health worldwide. It is possible to deliver pharmaceutical care services that address these challenges using digital healthcare techniques and approaches. Globally, digital health faces many challenges and concerns, despite its potential to impact pharmaceutical care.
FIP and the Global Pharmaceutical Observatory are launching a new needs assessment programme entitled "How can digital health support national pharmaceutical care delivery? A regional and global assessment of priorities and challenges", with an emphasis on medication adherence and fighting SF medicines.
This regional and global needs assessment programme will include a series of six regional events, culminating in a private global roundtable and a summary report.
In this regional event we will facilitate a regional discussion about ongoing digital health interventions or solutions that detect, report, and act against false or substandard medicines, and how to facilitate patient adherence, as well as the challenges leadership bodies and nations face in implementing digital health solutions in pharmaceutical care delivery in the EMR.
Moderator:
- Samira Shammas, Bureau Liaison - EMR, FIP, Jordan
Co-Moderator & Facilitators :
- Meshkat Torkamanian, FIP - YPG Early Career Regional Supporter, Iran - Farah Aqqad, FIP Regional Engagement, Support and Development Manager, Jordan - Hamsa Hassan, FIP - YPG Early Career Regional Supporter, Egypt
Panellists:
- Akbar Abdollahiasl, Assistant Professor, Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Iran - Saleh Hanash, Pharmapreneur/Founder of Agonist Consult, Agonist Consult, Jordan - Ali Omeiat, Head of pharmacies and drug stores inspection section, Inspection and control department, Jordan Food & Drug Administration, Jordan - Ahmed Hamdan Aljedai, Assistant Deputy Minister for Medical support Services, Ministry of Health, Saudi Arabia
This event will discuss pharmacists’ roles in diabetes prevention, screening and management by showcasing best practices in pharmaceutical care, identifying needs and priorities of pharmacists, digital health applications, new trends and practices across Africa. According to WHO, diabetes in the region is a serious, chronic, and costly disease that is estimated to rise to 23.9 million cases by 2030, and up to 15% of adults aged 25 to 64 have diabetes in the African region. s. Pharmacists are uniquely positioned to provide a wide array of services to prevent, identify and manage both type 1 and type 2 diabetes as well as support the care provided by other members of the healthcare team. This event aims to improve pharmacists' knowledge, improve pharmaceutical services delivery and overall health outcomes of the public in the context of diabetes.
Learning objectives:
Improve knowledge of pharmacists by exploring the role of pharmacists in the prevention, screening and management of diabetes within the African region;
Showcase emerging digital health trends, new applications for patients and innovative pharmaceutical services delivery for diabetes within the African region;
Identify the needs and priorities of pharmacists in the prevention and management of diabetes within the African region.
Moderator: - Prosper Hiag, President African Pharmaceutical Forum, Cameroon
Guests: - Danielle Munene, Head of Consulting African Health Business, Kenya - Imraan Bismilla, Head of Pharmacy Centre for Diabetes and Endocrinology in South Africa, South Africa - Mohamed Yacine Achouri, President of the scientific communication Fédération Algérienne de Pharmacie, Algeria - Khadir Sarra, Pharmacy resident, FIP YPG remote intern, Algeria - Gonçalo Sousa Pinto, FIP Lead for practice development and transformation, Spain
Facilitators: -Nilhan Uzman, Lead for Education and Primary Health Policies FIP, Turkey -Alison Etukakpan, Educational Partnership Specialist International Pharmaceutical Federation, Nigeria
This event will discuss pharmacists’ roles in diabetes prevention, screening and management by showcasing best practices in pharmaceutical care, identifying needs and priorities of pharmacists, digital health applications, new trends and practices across Africa. According to WHO, diabetes in the region is a serious, chronic, and costly disease that is estimated to rise to 23.9 million cases by 2030, and up to 15% of adults aged 25 to 64 have diabetes in the African region. s. Pharmacists are uniquely positioned to provide a wide array of services to prevent, identify and manage both type 1 and type 2 diabetes as well as support the care provided by other members of the healthcare team. This event aims to improve pharmacists' knowledge, improve pharmaceutical services delivery and overall health outcomes of the public in the context of diabetes.
Learning objectives:
Improve knowledge of pharmacists by exploring the role of pharmacists in the prevention, screening and management of diabetes within the African region;
Showcase emerging digital health trends, new applications for patients and innovative pharmaceutical services delivery for diabetes within the African region;
Identify the needs and priorities of pharmacists in the prevention and management of diabetes within the African region.
Moderator: - Prosper Hiag, President African Pharmaceutical Forum, Cameroon
Guests: - Danielle Munene, Head of Consulting African Health Business, Kenya - Imraan Bismilla, Head of Pharmacy Centre for Diabetes and Endocrinology in South Africa, South Africa - Mohamed Yacine Achouri, President of the scientific communication Fédération Algérienne de Pharmacie, Algeria - Khadir Sarra, Pharmacy resident, FIP YPG remote intern, Algeria - Gonçalo Sousa Pinto, FIP Lead for practice development and transformation, Spain
Delayed access cost lives. Many low- and middle-income countries lack the regulatory tools for timely access to medical products for unmet public health needs. The current COVID-19 pandemic has shown that it is important to have available regulatory flexibilities to authorize new medical products for use and rapidly manufactured them at scale. Expedited regulatory pathways (ERP) can help countries to accelerate the approval and access to new medical products with positive benefit-risk balance. To best meet those objectives of ERP, developing countries require strong reliance practices and post-authorization surveillance systems as pre-requisite for the timely introduction and safe use of new medical products for unmet public health needs and health emergencies.
Learning Objectives: 1) How regulatory flexibility in low and middle- income countries makes it possible to get expedited drug approvals 2) Why post- authorization surveillance is necessary to enable safe introduction of drugs approved by expedited pathway
Expedited Regulatory Pathways – possible in developing countries with strong reliance practices and post-authorization surveillance systems (French translation)
Delayed access cost lives. Many low- and middle-income countries lack the regulatory tools for timely access to medical products for unmet public health needs. The current COVID-19 pandemic has shown that it is important to have available regulatory flexibilities to authorize new medical products for use and rapidly manufactured them at scale. Expedited regulatory pathways (ERP) can help countries to accelerate the approval and access to new medical products with positive benefit-risk balance. To best meet those objectives of ERP, developing countries require strong reliance practices and post-authorization surveillance systems as pre-requisite for the timely introduction and safe use of new medical products for unmet public health needs and health emergencies.
Learning Objectives: 1) How regulatory flexibility in low and middle- income countries makes it possible to get expedited drug approvals 2) Why post- authorization surveillance is necessary to enable safe introduction of drugs approved by expedited pathway
Expedited Regulatory Pathways – possible in developing countries with strong reliance practices and post-authorization surveillance systems (Spanish translation)
Delayed access cost lives. Many low- and middle-income countries lack the regulatory tools for timely access to medical products for unmet public health needs. The current COVID-19 pandemic has shown that it is important to have available regulatory flexibilities to authorize new medical products for use and rapidly manufactured them at scale. Expedited regulatory pathways (ERP) can help countries to accelerate the approval and access to new medical products with positive benefit-risk balance. To best meet those objectives of ERP, developing countries require strong reliance practices and post-authorization surveillance systems as pre-requisite for the timely introduction and safe use of new medical products for unmet public health needs and health emergencies.
Learning Objectives: 1) How regulatory flexibility in low and middle- income countries makes it possible to get expedited drug approvals 2) Why post- authorization surveillance is necessary to enable safe introduction of drugs approved by expedited pathway
This event is to update pharmacy professionals about managing workforce demand in a pandemic – now and in future. Case studies will be presented from countries across the globe. These will address how we ensure continuity of workforce supply during this and future pandemics, how can we reduce demand on the workforce and the role of healthcare regulators play.
Aim To present to attendees approaches for managing workforce demand in a pandemic.
Learning objectives 1. Discuss how continuity of workforce supply can be managed during pandemics 2. Discuss how demand for the pharmaceutical workforce can be reduced during pandemics 3. Describe the impact of COVID-19 pandemic on the pharmacy workforce 4. Explain how pharmacists can be prepared for the role of vaccinator.
Moderator: - Christopher John, FIP Lead for Data and Intelligence, FIP, UK
Panelists: - Mariet Eksteen, Global Lead for FIP Development Goal 7: Advancing Integrated Services; Professional Development Officer, Pharmaceutical Society of South Africa (PSSA), South Africa - Chima Amadi, Global Lead, FIP Development Goal 13 (Workforce Policy Formation); Education and Training Personnel Pharmacists’ Council Nigeria, Nigeria - Rula Darwish, Exco committee FIP academic section WDG9 Lead; Professor School of Pharmacy/ The University of Jordan, CPD Chair in JPA, Jordan - Bärbel Holbein, FIP Global Lead for DG7 Advancing integrated services; Lecturer University of Bremen, Germany
The Pharmacy Education Journal (PEJ) continues to publish peer-reviewed manuscripts in the general scope of practise domain of pharmacy education (at all stages) and workforce development research and evaluation. PEJ is planning for widening scope by introducing educationally-related short, rapid response articles targeting non-traditional authors (non-academics) in Practice and Science sectors. PEJ is a key global dissemination route.
Event outcomes:
1 Showcase what did PEJ achieve during 20 years, how it was done and present the new plans. 2 Highlight the importance of publishing in the pharmaceutical workforce and education field. 3 Explain the steps from submission to publication: what happens behind the screen and who does it and provide some tips for authors.
Moderators: - Marwan Akel, Projects Manager – Workforce development, evidence & impact Journal Editor – PEJ, FIP, Lebanon - Sherly Meilianti, FIP Data and Intelligence Specialist, FIP, Indonesia
Panelists: - Ian Bates, Director of the FIP Global Pharmaceutical Observatory, Chair of pharmacy education University College London, UK - Lilian M. Azzopardi, Prof. of Pharmacy Department of Pharmacy, Faculty of Medicine and Surgery, University of Malta President, European Association of Faculties of Pharmacy, Malta - Judilynn L. Niedo-Solidum, Prof. at University of the Philippines Manila College of Pharmacy, Philippines - Rudi Hendra, Associate professor Indonesian Pharmacists Association, Indonesia - Shane Desselle, RPh, PhD, FAPhA Professor of Social and Behavioral Pharmacy Touro University California College of Pharmacy, USA - Jennifer Marriott, Adjunct Associate Professor, Australia
‘How can digital health support national pharmaceutical care delivery?’ A regional and global assessment of priorities and challenges in the African region
Substandard and falsified medicines, along with a lack of adherence to medication regimens, pose a threat to public health worldwide. It is possible to deliver pharmaceutical care services that address these challenges using digital healthcare techniques and approaches. Globally, digital health faces many challenges and concerns, despite its potential to impact pharmaceutical care.
FIP and the Global Pharmaceutical Observatory are launching a new needs assessment programme entitled "How can digital health support national pharmaceutical care delivery? A regional and global assessment of priorities and challenges", with an emphasis on medication adherence and fighting SF medicines.
This regional and global needs assessment programme will include a series of six regional events, culminating in a private global roundtable and a summary report.
In this regional event we will facilitate a regional discussion about ongoing digital health interventions or solutions that detect, report, and act against false or substandard medicines, and how to facilitate patient adherence, as well as the challenges leadership bodies and nations face in implementing digital health solutions in pharmaceutical care delivery in Africa.
Facilitators: -Anyango Esther, FIP - YPG Early Career Regional Supporter Africa Health Business (AHB), Kenya -Farah Aqqad, FIP Regional Engagement, Support and Development Manager, Jordan
Panelists: -KWABENA ASANTE OFFEI, Vice-President Pharmaceutical Society of Ghana (PSGH), Ghana -Vigil Edward Prah-Ashun, Head of Intelligence Food and Drugs Authority, Ghana -Redouane Soualmi, Secretary general Algerian Pharmaceutical Federation, Algeria -Brent Sin Hidge, Hospital Pharmacist / Project Co-ordinator Netcare Blaauwberg Hospital, Cape Town, South Africa -Mariet J Eksteen, Professional Development and Support Pharmaceutical Society of South Africa, South Africa
Constipation is a common symptom pharmacists encounter in daily practice. It is often a self-limiting symptom that can be adequately managed in the community through the use of non-prescription medicines, as well as dietary and lifestyle measures. This event will explore how community pharmacists may support the management of constipation and empower individuals for optimal self-care.
By the end of the session participants should be able to: • Understand the role of pharmacists in managing constipation in the community • Understand the influence of fibre, exercise, and fluids in constipation • Explore the complications of constipation medicines, especially in older adults
- Safwan Jihan, Assistant Dean, Lebanese International University / School of Pharmacy, Lebanon - Madisch, Ahmed, Senior Consultant and Head, Center of Gastroenterology Bethanien, Germany - João Rafael Gonçalves, Community pharmacist, Portugal
In order to ensure pharmacists maintain currency and quality in their practice, mandatory continuing professional development (CPD) programmes have been implemented by regulatory authorities as part of the licence renewal requirements for continuing practice. This webinar will provide information on the countries having a mandatory CPD programme, the various types of programmes, the regulations and the overall value and monitoring. In addition, information will be provided on CPD for specialized areas of practice, as part of returning to practice and some new concepts to insure currency and quality.
The attendees will learn: -the overall importance of a mandated CPD programme from a quality assurance and patient safety perspective ; -the variations of CPD programmes currently in place in various countries; -the legislation/regulations in place mandating a CPD programme to maintain currency and enhance competence, quality assurance and patient safety; -recertification programs for "specialization" and "return to practice"; and, -other innovative way to insure quality and currency of pharmacists.
Moderator: - Brett Simmonds, Chair Pharmacy Board of Australia, Australia
Panelists: - Carine Wolf-Thal, Chair of the National Council of the French Chamber of Pharmacists, France - Michael Pead, Chief Executive Pharmacy Council of New Zealand, New Zealand - Trish Farrelly, Manager Registration and Competence Assurance, Pharmacy Council of New Zealand, New Zealand - Joe R. Anderson, Assistant Dean for Curricular Affairs and Associate Professor of Pharmacy Practice and Administrative Sciences, The University of New Mexico College of Pharmacy, USA
Gastrointestinal health and digestive wellness can be influenced by several lifestyle factors, including diet and stress, and using certain types of medicines. It is important for pharmacists to consider these factors when interacting with patients who present with such symptoms. Different non-prescription medicines are available to treat symptoms related to GI complaints and digestive wellness, rendering pharmacies key access points for trusted advice and access to self-care products which can provide relief and care to affected individuals. This event marks the World Digestive Wellness Day (29 May).
By the end of the session participants should be able to: • Understand the role of pharmacists in providing advice on digestive wellness • Understand the relationship between gut wellness and immunity • Identify practical ways to support better digestive wellness in the community
This event discusses current evidence for the impact of the pharmaceutical workforce, pharmacy practice and pharmaceutical science. It discusses and evidence-based approach and identifies challenges and opportunities for generating evidence that will advance the profession.
Aim To showcase how data and intelligence can be used to provide evidence of impact of pharmaceutical practice, science and education/workforce.
Learning objectives
Discuss approaches to securing evidence for the impact of the pharmaceutical workforce and pharmaceutical services.
Discuss strategies and programmes in place to enable timely access to safe, effective and affordable medicines.
Identify challenges and opportunities for generating evidence of impact.
Moderator: - Christopher John, FIP Lead for Data and Intelligence, UK
Panellist:
- Noe Garin Escriva, Hospital Pharmacist, Hospital de la Santa Creu i Sant Pau, Spain - Harriet Rachel Kagoya, Uganda - Safa Damiati, Assistant Professor, King Abdulaziz University, Suadi Arabia - Sherly Meilianti, FIP Data and Intelligence Specialist, Indonesia - Hilwan Yuda Teruna, Vice President, Indonesian Pharmacists Association, Indonesia
The FIP Hospital Pharmacy Section (HPS) has set out to develop its strategy for the next 5 years. In early 2022, the FIP HPS developed a survey to identify how the FIP HPS can assist FIP Vision/Mission and FIP Development Goals. This survey was sent to FIP Hospital Pharmacy Executive Committee members, Chairs of Committees/Observers, Past Executive Committee members, Hospital Pharmacy Member organisations and regional forums. Results of the survey will be presented with a discussion on the FIP HPS strategy.
Learning objectives: - To know the results of the FIP HPS strategy survey - To identify priorities areas for the FIP HPS over the next 5 years - To participate in the future direction of the FIP HPS
Chair: -Jonathan Penm, Secretary, FIP Hospital Pharmacy Section, Senior Lecturer The University of Sydney- Australia
Panelist: -Robert Moss, President, FIP Hospital Pharmacy Section- the Netherlands
With the COVID-19 pandemic, effective use of educational technologies has become essential. Many different aspects of technology have been introduced or further expanded, including remote experiential learning or simulations for virtual patient care. At the same time, artificial intelligence enabled faculties to accelerate and advance research and clinical care in the pharmaceutical sciences and clinical pharmacy practice.
Introduction and implementation of any technology-enabled education and training includes many success factors such as technology literacy amongst educators and students. To enhance technology-enabled pharmaceutical education, this digital event will outline good practices and engage participants in identifying a SWOT (Strengths, Weaknesses, Opportunities, and Threats) of technology and AI use in education.
At the end of this session, participants will: 1.Learn about current and future good practices about the educational technologies used in higher/pharmaceutical education 2.Contribute to the development of a SWOT in using Technology & AI in pharmaceutical education 3.Identify ways to enhance quality of education and academic capacity by utilizing technology and AI in pharmaceutical education
Co-chairs: - Lilian Azzopardi, Dean Department of Pharmacy, University of Malta, Malta - Jaime Acosta Gómez, FIP Community Pharmacy Section, FIP Technology Forum co-chair, FIP COVID19 Expert Advisory Group member; Community Pharmacist and pharmacy owner Farmacia Acosta, Spain
Panelists: -Mia Sivén, Vice-Dean University of Helsinki, Finland -Francesca Wirth, Senior Lecturer University of Malta, Malta -Daniel Malone, Pharmacy Course Director Monash University, Australia
Facilitator: -Aysu Selcuk, FIP AIM Advisory Committee Member, FIP Education and Primary Health Care Policies Specialist, Turkey
This event will discuss the role of community pharmacists in promoting oral health and the links between oral health and other non-communicable diseases. Also, the event will address the needs for additional training, interprofessional education and collaborative practice models between dentistry and pharmacy. Key interventions by community pharmacists in oral health care from different parts of the world will be presented.
Aim: To discuss the role of pharmacists in oral health, describe how pharmacists’ interventions in oral health can contribute to the prevention of non-communicable diseases, and explore interprofessional education and collaborative practice models between dentistry and pharmacy.
Learning objectives: 1. Understand the importance of oral health in the prevention of non-communicable diseases (NCD), such as cardiovascular and respiratory diseases, cancer and diabetes; 2. Explore the role of community pharmacists in promoting oral health care; 3. Discuss the need for oral health care training and education resources that support pharmacists deliver improved and responsive oral health care interventions; 4. Explore interprofessional collaborative practice models between dentists and pharmacists.
This webinar will announce a new partnership between FIP and Curriculo Solutions to introduce our members to the newly FIP Seal-awarded programme: “Pharmacists for the Future Programme” (PFP).
Curriculo is a UK based training company specialising in leadership and management skills development and career management. They work across various sectors including corporate, health care, education and sport.
The PFP focuses on the development of personal, social and professional skills and provides a strong foundation in the development of key leadership capabilities. The programme aligns with Development Goal 9: Continuing professional development strategies and addresses a skill gap that has been identified by members in leadership development.
During the event, FIP and Curriculo will:
announce the new partnership for the FIP-sealed PFP.
describe aspects of the provision and partnerships programme at FIP.
describe the PFP and hear from previous participants in the programme through the sharing of testimonials.
describe how FIP members can benefit from this programme.
Moderator: -Dalia Bajis, Lead for Provision and Partnerships FIP, Bahrain
Panelists: -Karen Glen, Director Curriculo Solutions, UK -David Morrison, Director Curriculo Solutions, UK -Catherine Duggan, FIP CEO, the Netherlands -Amanda Cavness, Clinical Pharmacy Specialist, Pediatric Hematology/Oncology Children’s Hospital of The King’s Daughters, USA -Rhys Llewellyn, Trainee Pharmacist North Bristol NHS Trust, UK -Amna Suleman, 4th year student pharmacist, De Montfort University, UK
This event is to update pharmacy professionals about the range of therapeutic options currently available for COVID-19. It will take an evidence-based approach and also look at future development of therapeutic agents.
Aim To update attendees on the latest therapeutic advances against COVID-19
Learning objectives 1. Explain which medicines are available that target the virus or provide symptom control 2. Discuss which medicines will be effective against new variants. 3. Describe what other medicines are available and what is the evidence for them. 4. List medicines in the pipeline for treating COVID-19
Moderator: -Christopher John, FIP Lead for Data and Intelligence, FIP - UK
Panelists: -Syed Shahzad Hasan, Senior Research Fellow University of Huddersfield-UK -Trevor Jones, Visiting Professor King’s College London - UK
Early feasibility clinical study was performed to assess the feasibility and tolerability of syringe pump-driven, constant rate (20µl/s), 1-20cP, 5 and 10ml subcutaneous placebo injections to the thigh (5ml only) and abdomen in 32 healthy adults. Endpoints include injection feasibility, depot location, pressure, subject pain tolerability/acceptability and the corresponding tissue effects.
Session Outline:
• Demonstrate the feasibility and broad acceptability of subcutaneous injections up to 10ml and 20cP administered without a permeation enhancer
• Determine if injection site tissue effects are visible and transient as well as the impact of injection site, volume and viscosity on these patterns
• Explore the relationship between subjects’ pain/acceptability and the injection site, volume and/or viscosity
Moderator
- Mathew Cherian, Consultant, Executive Committee Member (IPS), USA
Panellist
- Wendy D Woodley, Staff Scientist II, Translational & Clinical Sciences, BD Technologies and Innovation, USA
Around the world, community pharmacies play an increasingly consolidated role in vaccination. During the pandemic, pharmacies’ accessibility made them a convenient place for vaccination against COVID-19 in several countries, increasing vaccination coverage and helping achieve herd immunity. As the world slowly begins to emerge from the pandemic, this event will discuss the role of community pharmacies in COVID-19 booster vaccination, and their challenges in vaccine supply logistics and cold storage solutions, particularly in a post-pandemic scenario. Key interventions by community pharmacists in vaccine supply logistics linked to COVID-19 from different parts of the world will be presented.
Learning objectives:
1. Understand the supply chain and distribution process of COVID-19 vaccines from manufacturer to hospitals, community pharmacies, and the public;
2. Explore the role of community pharmacies in vaccine supply logistics for COVID-19;
3. Discuss the challenges of COVID-19 booster vaccination supply logistics and cold storage solutions in community pharmacies, particularly in a post-pandemic scenario;
4. Explore supply models that involve community pharmacies contributing to population vaccination coverage in a post-pandemic scenario.
Moderator: - Catherine Duggan, Chief Executive Officer FIP, the Netherlands
Panellists: - Vibhu Paudyal, Associate Professor in Clinical Pharmacy University of Birmingham, UK - Ronald T. Piervincenzi, Ph.D., Chief Executive Officer USP, USA - Loganathan Fahrni, Senior lecturer and pharmacist Universiti Teknologi MARA, Malaysia
The importance of vaccines creates opportunities for pharmacists and pharmacies to contribute to improving vaccination coverage. Since the publication of FIP’s 2020 report on vaccinations highlighting the role of pharmacists and pharmacies in this area, there has been a significant expansion in pharmacy-based vaccination and the scope of vaccines delivered by pharmacists and the pharmacy workforce. To kick off World Immunisation Week, this digital event will provide an overview of that expansion for tetanus, diphtheria, acellular pertussis booster, COVID-19, and meningitis vaccines. Moreover, it will allow participants to hear from countries in various stages of advocating for a broader role for pharmacists in vaccination.
Learning objectives:
To identify the current role of the pharmacist in tetanus, diphtheria, acellular pertussis booster, COVID vaccination, and meningococcal meningitis vaccination.
To explore needs, drivers, and barriers for expanding that role in countries that have regulated pharmacy-based vaccination services.
To give examples from countries with pharmacy-based vaccination services in advocating a broader role for pharmacists in vaccination
Moderators:
- Ian Bates, Director of the FIP Global Pharmaceutical Observatory, Chair of pharmacy education, University College London, United Kingdom
- Manjiri Gharat, FIP Vice-President, India
Panellists:
- Carine Wolf-Thal, Chair of the National Council of the French Chamber of Pharmacists, French Chamber of Pharmacists, France
- Zhi Shan Sujata, Pharmacist, Malaysian Pharmacists Society, Malaysia
- Sham Moodley, Pharmacist, Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc, South Africa
- Zeid Kilani, President, Jordan Pharmacists Association, Jordan
- Mas Rahman Roestan, Operational Director of PT Biofarma and Expert Council of Indonesian Pharmacists Association, Indonesian Pharmacists Association, Indonesia
- Irma Beatriz Caponi, Farmacéutica, COFA, Argentina
Facilitators & Speakers:
- Christopher John, FIP Lead for Data and Intelligence, UK
- Zheng Kang Lum, PhD candidate, National University of Singapore, Singapore
- Allie Jo Shipman, Director, State Policy, National Alliance of State Pharmacy Associations, USA
- Sherly Meilianti, FIP Data and Intelligence Specialist, Indonesia
This webinar is the first of the Precision Medicine Webinar Series, which will discuss the current state and future of precision medicine in research and practice, including the ongoing technological advances and challenges and opportunities for the pharmacy profession to address. This webinar will introduce:
- The needs, goals and principles of precision medicine
- Examples of current implementation across disease categories
- Safety aspects and challenges
- Limitations of current approaches and needs for development
At the end of this session, participants will:
Understand the goals of precision medicine
Be familiar with some examples of its implementation
Be aware of current limitations and remaining challenges
Co-Chairs:
- Donnacha Fitzgerald, FIP Technology Forum member, Predoctoral Fellow, The European Molecular Biology Laboratory (EMBL) and Heidelberg University Hospital, Germany - Stephanie Huang, Associate Professor, Department of Experimental and Clinical Pharmacology, University of Minnesota, USA
Panellists:
- Ejner Moltzen, Chair, International Consortium for Personalized Medicine, Denmark - Mark Dunnenberger, Director, Pharmacogenomics Center for Personalized Medicine NorthShore University HealthSystem, USA
Over the past 2 decades, virtual education evolved as a new pedagogy within education. Following the experience from the unexpected drastic shift to remote learning and virtual education as a result of the COVID-19 pandemic, educators are faced with dilemmas of how to strike a balance between face-to-face modalities and the virtual platform. Remote learning and virtual education provide opportunities and leadership to develop hybrid models of teaching is now being considered. The webinar will seek to expose experiences and share examples of such opportunities and how to lead faculty towards incorporating the virtual education while ensuring quality education.
The participants who join the webinar will; • Address assessment of quality of virtual education at the schools of pharmacy • Reflect on the extent of remote learning after COVID-19 in pharmacy education • Discuss approaches towards the development of hybrid education in pharmacy schools
Chairs: -Pierre Moreau, FIP AIM Chair, Dean Kuwait University, Kuwait -Lilian Azzopardi, FIP AIM Advisory Committee Member, Dean Department of Pharmacy, University of Malta, Malta -Hanan Refaat, FIP AIM Advisory Committee member, Dean Future University in Egypt, Egypt
Panelists: -Seif El Hadidi, FIP AIM member, Lecturer in Clinical Pharmacy, Future University in Egypt, Egypt -Brian Hemstreet, FIP AIM working group member, Associate Dean for Student Affairs and Professor University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, USA - Jennifer Pham, Clinical Associate Professor, Clinical Pharmacist – Neonatal / Pediatrics, University of Illinois at Chicago College of Pharmacy, USA - Alan Lau, Professor and Director, International Clinical Pharmacy Education University of Illinois at Chicago College of Pharmacy, USA
This is the COVID-19 programme initiator and will set the scene: why this programme; main outcomes; FIP advocacy role. It aligns with 800 days since pandemic and will launch SustainabilityRx website/ Visualisation (FIP’s response to COVID-19) with a focus on pandemic preparedness.
Learning objectives 1. Describe the functionality of the SustainabilityRx website 2. Outline the current COVID-19 situation from the perspectives of practice, science and workforce/education; 3. Consider steps that can be taken to prepare for future pandemics.
Moderators: - Christopher John, FIP Lead for Data and Intelligence, FIP, UK - Dr Lina Bader/Dr Sherly Meilianti FIP Lead for Workforce Transformation/FIP Data and Intelligence Specialist, FIP-Saudi Arabia
Panelists: - Dr Hoai-An Truong, Professor and Director of Public Health, School of Pharmacy & Health Professions, University of Maryland Eastern Shore, USA - Dr John Grabenstein, Member of FIP COVID-19 Expert Advisory Group, President Vaccine Dynamics SP, USA - Prof. Trevor Jones, Visiting Professor King’s College London, UK - Dr Ally Dering-Anderson, Current member of the FIP COVID-19 Expert Advisory Groupm, Clinical Associate Professor in the Department of Pharmacy Practice & Science University of Nebraska College of Pharmacy, USA - Shaun Gleason, FIP Hub DG1 Lead, Member of the COVID-19 Expert Advisory Group, Assistant Dean for Distance Degrees and Programs; Associate Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Anschutz Medical Campus, USA
Epilepsy is a disorder that afflicts approximately 50 million people worldwide and the WHO has declared epilepsy as a public health imperative. Medications are the mainstay of treating epilepsy, so pharmacist have great role to play in improving the care of people with epilepsy. This Webinar will explore the findings of the recent WHO report on epilepsy, describe ways that pharmacists can be involved in caring for patients with epilepsy, consider advances in new medications, and discuss the challenges of access to medications for many people worldwide.
Learning Objectives: 1. Identify the main barriers to appropriate care of patients with epilepsy as described in the 2019 WHO report on epilepsy. 2. Describe ways that pharmacists can improve the care of patients with epilepsy. 3. Incorporate new antiseizure medications into treatment regimens for epilepsy. 4. Take steps to improve patient access to good quality seizure medications.
Moderator: -Filipa Alves da Costa, ExCo member of the FIP Social and Administrative Pharmacy Section, Portugal
Panelists: -Timothy Welty PharmD, College of Pharmacy and Health Sciences Drake University Des Moines, Iowa, USA -McKenzie Grinalds, PharmD School of Pharmacy Cedarville University Cedarville, Ohio, USA -Thanarat Suansanae PharmD, School of Pharmacy, Mahidol University Bangkok, Thailand -Melody Ryan, Professor, University of Kentucky, USA
Approximately 90 percent of prescriptions in the US are generics that often are the product of an intricate global supply chain. The Office of Generic Drugs (OGD) is involved in efforts to advance the international harmonization of scientific, technical and regulatory standards for generic drug development. OGD continues global efforts with a focus on prioritizing future topics for generic harmonization that will include more complex generic drugs. The envisioned outcome of these global efforts is reduced time and cost of product development, consequently improving patient access to more affordable medicines. OGD Global Affairs identifies opportunities and challenges as those national regulations are being developed and implemented positioning regulators proactively on the path of convergence.
Learning Objectives: 1) FDA’s views on global harmonization of regulatory process for generic drugs 2) Identifying opportunities and challenges in arriving at harmonized processes globally.
Moderators: -Dr Mathew Cherian, Executive Committee Member, Industrial Pharmacy Section, Consultant, USA -Mr Desai Kaushik , Associate ExCo Member, Industrial Pharmacy Section (FIP), Secretary General, International Pharmaceutical Excipient Council of India, India
In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.
Learning objectives: - Identify drivers and barriers related to the regulatory landscape of vaccination in the region - Learn about examples of best practices in terms of interprofessional cooperation and task-sharing involving pharmacists in the area of vaccination - Explore the plans for switching from a pandemic to an endemic response in the region, including the role of pharmacist in vaccination, and in patient care and treatment
Moderators: - Dr Samira Shammas, FIP Vice president, Jordan - Jorge Batista, Portuguese Pharmaceutical Society, Portugal
Panelists: - Dr Nadia Al Mazrouei, President, EMRO Pharm Forum, UAE - Dr Pascale Salameh, President, Lebanese Order of Pharmacists, Lebanon - Dr Maha al Jaghbeer, Director of Laboratories directorate, Jordan Food and Drug Administration, Jordan - Dr Dixon Thomas, Associate Professor - Department of Pharmacy Practice, College of Pharmacy, Gulf Medical University, UAE
In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in the region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.
Learning objectives:
- Identify drivers and barriers related to the regulatory landscape of vaccination in the region
- Learn about examples of best practices in terms of interprofessional cooperation and task-sharing involving pharmacists in the area of vaccination
- Explore the plans for switching from a pandemic to an endemic response in the region, including the role of pharmacist in vaccination, and in patient care and treatment.
Moderators:
- Manjiri Gharat, FIP Vice President, India - Al Carter, Executive Director, National Association of Boards of Pharmacy, USA
Panellists:
- Tisara De Silva, President, Pharmaceutical Society of Sri Lanka, Sri Lanka - Rao V. S. V. Vadlamudi, Professional Secretary, SEARPharm Forum, India - Nurul Pariang, President, Indonesian Pharmacists Association, Indonesia - Pramod Yeole, Acting President, Pharmacy Council of India, India
Ongoing learning and professional development are key to components of every occupation. This is especially true for pharmacy technicians working in a constantly-evolving practice landscape. This session will address professional development and advanced training for pharmacy technicians across the world.
Learning Objectives: ● Recognize strategies for continuous learning and professional development ● Identify professional development opportunities designed for pharmacy technicians ● Describe advanced training progams for pharmacy technicians
Moderators:
- Ryan Burke, Director of Professional Affairs, Pharmacy Technician Certification Board, United States
Panelists:
- Nichole Foster, Program Director, Pharmacy Technician Training Program, Vanderbilt Medical Center, United States
- Peter Karegwa Mwangi, National Chairman, Kenya National Union of Pharmaceutical Technologists, Kenya
- Katherine Watkinson, Branch Liaison Executive, Association of Pharmacy Technicians, UK
Para abogar por una implementación más amplia y armonizada del Sistema de Clasificación de Biofarmacéuticos (BCS) en los países de América Latina, la FIP está apoyando a los líderes regionales en la concientización sobre esta vía regulatoria basada en la ciencia diseñada para acelerar la aprobación del mercado de medicamentos genéricos seguros y efectivos. La tercera parte de esta serie de seminarios web diseñada específicamente para la región de América Latina desde la perspectiva de las agencias reguladoras sobre cómo se está implementando la legislación de bioequivalencia. Los expertos abordarán la base legislativa de las regulaciones de bioequivalencia y discutirán las oportunidades de armonización dentro de la región.
Sesión en Español con slides en inglés
Este webinar tiene como objetivo:
• Presentar la legislación de Bioequivalencia de México, Colombia y Perú.
• Alinear cómo las empresas deben establecer los requisitos del BSC.
• Compartir el conocimiento regulatorio del BSC en la región.
Moderadora:
Talita Ferreira, Coordinadora de Proyectos de bioequivalencia en Latinoamérica, FIP, Brazil
Panelistas: -Zulema Rodríguez Martinez, Coordinador del área de Bioequivalencia, Comisión Federal para la Protección contra Riesgos Sanitarios (Cofepris), México -Diego Alejandro Gutierrez Triana, Director de medicamentos y productos biológicos, Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia -David Salirrosas Llanos, Especialista en evaluación sanitaria de medicamentos, Dirección General de Medicamentos (DIGEMID), Perú
Portugués
Para defender uma implementação mais ampla e harmonizada do sistema de classificação de produtos biofarmacêuticos (BCS) em países latino-americanos, a FIP está apoiando os líderes regionais na conscientização para esta via regulatória com base científica projetada para acelerar a aprovação do mercado de medicamentos genéricos seguros e eficazes. A terceira parte desta série de webinars projetada especificamente para a região da América Latina sob a perspectiva das agências regulatórias como está sendo implementada as legislações de bioequivalências. Os especialistas irão abordar a base legislativa dos regulamentos de bioequivalência e discutir as oportunidades de harmonização dentro da região.
Sessão em Espanhol com slides em Inglês
Este webinar tem como objetivos:
Apresentar as legislações de Bioequivalência do México, Colômbia e Peru.
Alinhar como as empresas devem estabelecer os requisitos de BSC.
Compartilhar o conhecimento regulatório de BSC na região.
Moderadora:
Talita Ferreira, Coordenadora do Projeto Bioequivalência da América Latina, FIP, Brasil
Panelistas: -Zulema Rodríguez Martinez, Coordenadora da área de Bioequivalência, Comissão Federal de Proteção contra Riscos Sanitários (Cofepris), México -Diego Alejandro Gutierrez Triana, Diretor de medicamentos e produtos biológicos, Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colômbia -David Salirrosas Llanos, Especialista em avaliação sanitária de Medicamentos, Direção Geral de Medicamentos (DIGIMED), Perú
In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in the region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.
Learning objectives:
- Identify drivers and barriers related to the regulatory landscape of vaccination in the region - Learn about examples of best practices in terms of interprofessional cooperation and task-sharing involving pharmacists in the area of vaccination - Explore the plans for switching from a pandemic to an endemic response in the region, including the role of pharmacist in vaccination, and in patient care and treatment.
- Samuel Adekola, Immediate past national chairman & the executive secretary/ program director of the ACPN foundation. Nigeria - Djamila Reis, CEO, Association of Pharmacists from Portuguese-Speaking Countries, Cape Verde - Portifa Mwendera, President, Pharmaceutical Society of Zimbabwe, Zimbabwe - Lucas Nyabero, Interim CEO, Pharmaceutical Society of Kenya, Kenya - Franck Nana, President, National Council of Pharmacists, Cameroon - Amath Niang, President, Ordre des Pharmaciens du Sénégal, Sénégal - Imoiboho Williams, Project Manager, Adverse Events Following Immunization Surveillance Institute of Human Virology, Nigeria - Redouane Soualmi, Chairperson of External Relations, Algerian Pharmacy Federation, Algeria - Ezinne Onwuekwe, Vaccine Programme Coordinator, Africa CDC, Ethiopia
Dans de nombreux pays, les taux de couverture vaccinale sont sous-optimaux et les services de vaccination sont essentiellement axés sur l'enfance.
Les objectifs visant à développer les parcours de vaccination consistent notamment à disposer de points de vaccination plus nombreux et facilement accessibles, d'un plus grand nombre de professionnels capables de fournir le service à un plus grand nombre de personnes et d'offrir des conseils sur les vaccins fondés sur des données probantes.
Cet événement permettra de discuter des moteurs et des obstacles à la compréhension interprofessionnelle, à la coopération et au partage des tâches dans le domaine de la vaccination dans la région, ainsi que de l'autorité réglementaire accordée aux différents professionnels de la santé pour prescrire et/ou administrer les vaccins.
Objectifs d'apprentissage :
• Identifier les moteurs et les obstacles liés au paysage réglementaire de la vaccination dans la région.
• Découvrez des exemples de bonnes pratiques en matière de coopération interprofessionnelle et de partage des tâches impliquant des pharmaciens dans le domaine de la vaccination.
• Explorer les plans pour passer d'une réponse pandémique à une réponse endémique dans la région, y compris le rôle du pharmacien dans la vaccination, et dans les soins et le traitement des patients.
In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.
Learning objectives: - Identify drivers and barriers related to the regulatory landscape of vaccination in the region - Learn about examples of best practices in terms of interprofessional cooperation and task-sharing involving pharmacists in the area of vaccination - Explore the plans for switching from a pandemic to an endemic response in the region, including the role of pharmacist in vaccination, and in patient care and treatment
Moderators:
- Lars-Åke Söderlund, FIP Vice President, Sweden - Ronald Guse, Chair of FIP Regulators Forum, Canada
Panelists: - Michał Byliniak, Vice president, Polish Pharmaceutical Chamber, Poland - Alain Delgutte, National Board Member, French Chamber of Pharmacists - Inga Lilý Gunnarsdóttir, President, Pharmaceutical Society of Iceland, Iceland - Jean-Pierre Michel, Member, European Union of Geriatric Medicine Society. European Interprofessional Council on Ageing, Switzerland - Ema Paulino, President, National Association of Pharmacies, and member of the National Vaccine Advisory Committee, Portugal - Roberto Tobia, President, Pharmaceutical Group of the European Union, Italy - Mariano Votta, President, Active Citizenship Network, Italy
In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.
Learning objectives: - Identify drivers and barriers related to the regulatory landscape of vaccination in the region - Learn about examples of best practices in terms of interprofessional cooperation and task-sharing involving pharmacists in the area of vaccination - Explore the plans for switching from a pandemic to an endemic response in the region, including the role of pharmacist in vaccination, and in patient care and treatment
Moderators: - Magaly Rodríguez de Bittner, Vice president, Pharmaceutical Forum of the Americas, USA - Anastasia Shiamptanis, Registrar, New Brunswick College of Pharmacists, Canada
Speakers: - Bertrand Bolduc, President, Order of Pharmacists of Quebec, Canada - Josélia da Silva Frade, Advisor on Professional Affairs to the president, Federal Council of Pharmacy, Brazil - Eduardo Savio, President, Pharmaceutical Forum of the Americas, Uruguay - Sofía Segura, Professor, University of Costa Rica, Costa Rica - L. J. Tan, Chief Policy and Partnerships Officer, Immunize.org, USA - Abraham S. Weekes, Council Member, Caribbean Association of Pharmacists, St. Lucia
En muchos países, las tasas de cobertura de vacunación no son óptimas, y los servicios de vacunación se centran principalmente en la infancia. Los objetivos para ampliar las vías de acceso a la vacunación incluyen disponer de más puntos de vacunación de fácil acceso, más profesionales que puedan prestar el servicio a un mayor número de personas y ofrecer asesoramiento basado en la evidencia sobre las vacunas. En este evento se debatirán los factores que impulsan y obstaculizan el entendimiento interprofesional, la cooperación y el reparto de tareas en el ámbito de la vacunación en la región, así como la autoridad normativa concedida a los distintos profesionales sanitarios para prescribir y/o administrar vacunas.
Objetivos de aprendizaje:
- Identificar los impulsores y las barreras relacionadas con el panorama normativo de la vacunación en la región
- Conocer ejemplos de buenas prácticas en materia de cooperación interprofesional y de reparto de tareas con la participación de los farmacéuticos en el ámbito de la vacunación
- Explorar los planes para pasar de una respuesta pandémica a una endémica en la región, incluyendo el papel del farmacéutico en la vacunación, y en el cuidado y tratamiento de los pacientes.
In many countries, vaccination coverage rates are suboptimal, and vaccination services are largely focused on childhood. Goals to expand vaccination pathways include to have more and more easily accessible vaccination points, and more professionals who can deliver the service to more people and offer evidence-based advice on vaccines. This event will discuss the drivers and barriers to interprofessional understanding, cooperation and task sharing in the area of vaccination in each region, and the regulatory authority granted to different healthcare professionals to prescribe and/or administer vaccines.
Learning objectives: - Identify drivers and barriers related to the regulatory landscape of vaccination in the region - Learn about examples of best practices in terms of interprofessional cooperation and task-sharing involving pharmacists in the area of vaccination - Explore the plans for switching from a pandemic to an endemic response in the region, including the role of pharmacist in vaccination, and in patient care and treatment
Moderators: - Parisa Aslani, FIP Vice President, FIP, Australia - Ron Guse, Chair FIP Regulators Forum, FIP, Canada
Panelists: - Amrahi Buang, President, Malaysian Pharmacists Society, Malaysia - John Jackson, President, Western Pacific Pharmaceutical Forum, Australia - Michael Moore AM PhD, Chair of the WFPHA Global Taskforce on Immunization Adjunct Professor University of Canberra, Australia - Tony Nelson, Chair of the Steering Committee, Immunisation Partnership Asia Pacific, Hong Kong - Andi Shirtcliffe, Clinical Chief Advisor Pharmacy, Allied Health and National Immunisation Program. Office of the Chief Clinical Officers, Ministry of Health, New Zealand - Stephanie Tay, Senior Manager, Chief Pharmacist’s Office, Ministry of Health, Singapore
Self-care is an integral part of healthcare systems, contributing to healthcare cost savings, better allocation of resources and improved health outcomes in the population. Pharmacists are well placed in the community to support health-related decisions and facilitate informed self-care. FIP aims to support pharmacists in this role through advocacy and by developing professional resources in the area of self-care. This event will showcase a variety of FIP publications, including the launch of a new handbook.
Learning Objectives: Understand the contribution of self-care to universal health coverage (UHC) Explore the role of pharmacists in supporting informed self-care Showcase FIP’s materials in the area of self-care
Moderator: -Sarah Dineen-Griffin, FIP CPS ExCo member - Australia
Panelists: -Lars-Åke Söderlund, Vice-President, FIP Sweden -Daragh Connolly, President Community Pharmacy Section, FIP Ireland -Christopher John, FIP Lead for Data and Intelligence, FIP UK -Rúben Viegas, FIP Practice Development Projects Coordinator, FIP Spain
The CPS Champion for Change 2021, Dr Odhiambo David, will share his vision on how pharmacists can better serve patients with mental health issues: - Describe what service pharmacies should offer patients and/or healthcare systems to help tackle the mental health burden; - In what ways can pharmacists support self-care and mental health patients having a more autonomous life; and - How can digital health tools (either low or high tech) help community pharmacists improve outcomes and better support patients with mental health problems
Malaria is responsible for approximately 400 thousand deaths annually, resulting in an enormous public health burden on many of the tropical and subtropical countries. Although projects are ongoing in WHO, pharmaceutical companies and foundations, basic university-based research is also essential against for treatment and drug resistance in malaria. Engagement of young pharmaceutical scientists in the field is necessary to overcome this situation.
In this event, young PI and early carrier scientists / PhD students related to this scientific subject will be invited as speaker. Dr Eizo Takashima, Ehime University, Japan was invited as a speaker for preliminary lecture, and provide opportunity for young scientists to discuss about the science of malaria.
Learning objectives:
Describe the development of malaria vaccine candidates.
Defineseroepidemiology of malaria
Recognize how early carrier pharmaceutical scientists can be involved in research on drug and vaccine development of malaria.
Moderators: - Takuya Kumamoto, SIG NM Chair, Prof Hiroshima University, Japan - Rebecka Isaksson, NGPS SIG Chair, Postdoctoral Research Associate UCL Department of Chemistry, UK
Panelists: - Dr Eizo Takashima,Associate Professor, Ehime University, Japan - Dr Wei-Chiao Huang, Post-doc State University of New York at Buffalo, US - Dr Takaya Sakura, Assistant Professor Department of Molecular Infection Dynamics, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Japan - Khalid Garba Mohammed, Lecturer, Bayero University, Kano, Nigeria
At this event on World Cancer Day, we will explore innovations in pharmacy practice in the community and hospital pharmacy settings, in terms of supporting cancer patients throughout their journey. A panel of experts will present and discuss examples of innovative professional services in cancer prevention and screening, access to cancer treatments, adherence and continuity across transitions of care, among others.
The goal is to raise awareness of the important role that pharmacists can play in all areas of practice in terms of cancer prevention and management, in collaboration with other healthcare professionals.
Learning Objectives
Identify and discuss the roles that community and hospital pharmacists can play in cancer prevention and management.
Present examples of best practices of cancer-related professional services by pharmacists from around the world.
Discuss the importance of supporting patients in a multi- and inter-professional approach
Explore issues on the transitions of care, adherence to treatments and prevention and screening in cancer care
Moderators: • Josep M. Guiu Segura, Director of Pharmacy and Medicines, Consortium of Health and Social Care of Catalonia, Spain • Daragh Connolly, President, FIP Community Pharmacy Section, Ireland
Panelists: • Marko Skelin M.Pharm PhD. Board member of the European Society of Oncology Pharmacy; Assistant Professor, Faculty of Medicine, University of Rijeka, Croatia • Robert Duncombe, Chief Pharmacist, Director of Pharmacy, The Christie NHS Foundation Trust, Manchester, UK • Jan de Belie, Professional Affairs Advisor, Pharmaceutical Group of the European Union, Belgium • Kofi Boamah Mensah, Oncology Pharmacist at Komfo Anokye Teaching Hospital (KATH) and adjunct lecturer at the Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Science, Kwame Nkrumah University of Science and Technology (KNUST), Ghana
Establishing a correlation between in vitro tests and in vivo product performance has always been a challenge for the pharmaceutical industry. Without a link between specifications and in vivo performance, drug product manufacturing processes are often performed under unnecessarily tight controls. Furthermore, implementing changes post-product market approval can be challenging in a complex global environment. This webinar will describe traditional and novel approaches towards establishing in vitro in vivo correlations. The main focus will be on solid oral dosage forms, however other dosage forms will also be discussed.
Moderators: -Andreas Abend, Senior Principal Scientist, MSD, USA -Horst-Dieter Friedel, FIP Chair Special Interest Group Regulatory Sciences and Quality, Germany
Panelist: -Patrick Marroum, Senior Director in Clinical Pharmacology and Pharmacometrics AbbVie, USA
Recent technological advancements have revolutionized clinical practice, and there is need for a pharmaceutical workforce that is well-equipped to embrace, innovate, and capitalize on the benefits of digital health. Findings from the 2021 FIP report on digital health in pharmacy education revealed the need to develop courses, training material and experiential learning opportunities to prepare a digitally literate pharmacy workforce.
The Academic Pharmacy Section, supported by the FIP Provision and Partnerships programme, and many FIP constituencies led a ONEFIP project to develop the first FIP-developed online Train the Trainer (TtT) course. At this event, we will reflect on the progress made to date, launch the TtT course, which targets academics as well as educators in any sector in pharmacy, and how this initiative builds on FIP competency frameworks and reports.
Event outcomes: 1. To describe FIP’s response following the release of digital health in pharmacy education report in 2021. 2. To provide an overview of the FIP Global Platform for Provision and Partnerships. 3. To launch the FIP Train the Trainer online course on FIPx and generate interest in the course
Moderators: - Barry Bleidt, Prof. Nova Southeastern University College of Pharmacy, USA - Naoko Arakawa, Assistant Professor in International Pharmacy University of Nottingham, UK
Panelists: - Dr. Catherine Duggan, CEO FIP, the Netherlands - Aukje Mantel-Teeuwisse, Director Utrecht University School of Pharmacy, the Netherlands - Dr. Dalia Bajis FIP Lead for Provision and Partnerships FIP, Australia/Bahrain - Nilhan Uzman, Lead for Education Policy and Implementation FIP, The Netherlands - Jaime Acosta-Gómez, CPS Professional Secretary, Community pharmacist, Farmacia Acosta, Spain - Prof. Lilian Azzopardi Head, AIM Advisory Committee member, Department of Pharmacy University of Malta, Malta - Chu-Chen Cheng, Provision and Partnerships Remote Volunteer, Pharmacist FIP, Chaina Taiwan - Genuine A. Desireh, Provision and Partnerships Remote Volunteer, Pharmacist FIP, Kenya
Medication errors and adverse events cause significant harm to patients’ health and well-being. At this event we will present an overview of the range of Medication Review (MR) services and their definition, highlighting the difference between them and particularly with Medicines Use Review (MUR) in light of recent international updates.
Learning Objectives • Explore medication review services • Define MR and MUR • Present the FIP Toolkit on MR & MUR
Moderator: Tim Chen, President of FIP Social and Administrative Pharmacy Section, President FIP Social and Administrative Pharmacy Section - Australia
Panelists: -Filipa Alves da Costa, Assistant professor University of Lisbon, Portugal -Kurt E. Hersberger, University of Basel, Switzerland -Matthew Hung, Clinical Staff Pharmacist St. Mary’s Hospital, Montreal West Island Integrated University Health and Social Services Centre, Practice Development Projects Assistant (consultancy), Canada
The United Nations General Assembly proclaimed 24 January as International Day of Education, in celebration of the role of education for peace and development. And FIP AIM will be celebrating this special day with a webinar on mental health and wellbeing for academics.
Because the COVID-19 pandemic had led to considerable impact on our physical and mental wellbeing, mental health has become the ‘shadow pandemic’. At this webinar, cultivating mental health and resilience for academics will be highlighted and academic strategies for will be discussed to emphasize the benefits of improved mental health and wellbeing in achieving a better work-life integration.
The participants who join the webinar will; 1. Discover the importance of fostering academic resilience for mental health and wellbeing during unprecedented times and beyond, 2. Address the necessary reasons to raise mental health awareness among academics for students and workplace, 3. Identify institutional strategies in supporting mental health and wellbeing of academic staff and students, 4. Optimize mental health for academic performance in higher education.
Chairs: -Pierre Moreau, Dean FIP, Kuwait University, Kuwait -Toyin Tofade, Dean Howard University College of Pharmacy, USA -Mohamad Rahal, Dean Lebanese International University, Lebanon
Panelists; -Neil MacKinnon, Provost and Executive Vice President for Academic Affairs Augusta University, USA -Betty Exintaris, Senior Lecturer, Monash University, Australia -Fatos Ilkay Alp Yıldırım, Associate professor Istanbul University, School of Pharmacy, Turkey
Facilitators: -Nilhan Uzman, FIP Lead for education policy and implementation FIP, The Netherlands -Ozge Ozer, FIP Educational Partnership Coordinator, Turkey
Pharmacy teams are increasingly providing services that support people to self-care with their sexual health. This webinar will focus particularly on advice, screening and testing, as well as appropriate management of choices of medicines and products to support sexual health. A case study will be presented and the event will conclude with a panel discussion.
Aim: To identify how the community pharmacy team can provide support to people to self-care with their sexual health.
Learning objectives: 1. Increase awareness of sexual health issues, how common they are, what impacts they have and how they can be managed; 2. Learn how to support people with their sexual health; 3. Discuss appropriate management in the choice of medicines and products for the self-care of sexual health. 4. Describe the role that pharmacist and their team can play in screening, testing, advising and educating people sexual health and how they can self-care.
Moderator: - Leonila Ocampo, Member of the FIP Community Pharmacy Section; President, Asia Pacific Institute for Medication Management, Philippines
Panelists: - Irene Serrano, Community Pharmacist, Spain - Wael Ali, Egyptian Organisation of Pharmacy, Egypt - Luna El Bizri, Founder and Manager, Lunapharm Pharmacy, Lebanon
The year 2020 saw the COVID-19 outbreak become a global pandemic which, even by 700 days at the end of 2021, has highlighted how much the world has had to change and we have had to adapt our lives, ways of working, ways of living.
Despite the impact of the pandemic on 2020 business plans and working environments, FIP persevered to deliver and launch the FIP Development Goals for our members and the profession worldwide, understanding the need to provide directions and goals in the coming years as we live with and (hopefully) move out of the pandemic.
In 2021, we ran a full programme to identify the priority goals for the decade ahead across our regions and members. In this event we recap the key outcomes and priorities across the world region which we captured in a new report.
Join us for launch the FIP Development Goals Report 2021 “Setting goals for the decade ahead” which provides a global status update on the goals one year on since their launch and serves as an anchor point that will facilitate the next decade’s roadmap aligned with the UN Agenda 2030.
We will also be launching a new ‘microsite’, a digital platform that serves as a web-based resource for the Development Goals. The microsite collates FIP’s work, publications, events and other outputs mapped to the goals by theme, alongside tools and resources for our members.
Join us in one of FIP’s first events of 2022, where we stand by our commitment now and in the future to support our members to transform pharmacy with clear action, in solidarity with all!
This event discusses how targeted switching of prescription only medicines to non-prescription medicines (Over The Counter medicines) can contribute to self-care of a nation’s population. Availability of diagnostics in the pharmacy and beyond can also make an impact on self-care.
Aim: To discuss which medicines are appropriate to switch from prescription-only to non-prescription (Over The Counter Medicines) and describe how diagnostics can support self-care.
Learning objectives: 1. Describe current approaches to switching medicines from prescription to non-prescription and how this supports self-care ; 2. Discuss which medicines should be available over the counter in the pharmacy; 3. Explain how diagnostics can support self-care.
Moderator: - Jaime Acosta-Gómez, Community Pharmacist and pharmacy owner, Farmacia Acosta, Spain
Panelists: - Natalie Gauld, Innovator in improving access to medicines Northern Regional Alliance, University of Auckland, New Zealand - Andi Shirtcliffe, Clinical Chief Advisor for Pharmacy and Allied Health Ministry of Health New Zealand, New Zealand - Anthony Serracino Inglott, Professor at the Department of Pharmacy Faculty of Medicine and Surgery, University of Malta, Malta
Pharmacy teams are increasingly supporting children and their carers with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support children’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.
Aim: To identify how the community pharmacy team can support self-care of common health problems for children and their carers.
Learning objectives:
Increase awareness of children’s health issues, how common they are, what impacts they have and how they can be managed;
Learn how to support carers and children with common health issues;
Discuss appropriate management in the choice of medicines and products.
Describe the role that pharmacist and their team can play in advising and educating carers and children so they can self-care.
Moderator:
Sarah Dineen-Griffin, Lecturer in health services management and leadership, Charles Sturt University, Australia
Panellist:
Hadi Dassouki, Community Pharmacist, Lebanon
Jack Collins, Postdoctoral Research Associate, The University of Sydney School of Pharmacy, Australia
Joanne Crook, Consultant Pharmacist Paediatrics, Kings College Hospital, UK
The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.
This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.
Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals
The Global Advanced development framework (GADF) was developed to support the professional development and recognition of the pharmacy workforce everywhere and the Global Competency Framework (GbCF) was developed by the FIP as a focused support structure for early career pharmacists. This digital event seeks to create more awareness for the GADF and GbCF and to enable early career pharmacists and pharmaceutical scientists have a better understanding of their structure.
Competency framework- A complete collection of competencies that are thought to be essential to performance.
Competencies – Knowledge, skills, behaviors and attitudes that individuals accumulate, develops, and acquires through the education, training and work experience.
Learning objectives:
Describe the purpose and applications of both the Global Advanced Development Framework (GADF) and the Global competency framework (GbCF);
Summarize the domains and illustrative competencies from the GbCF for pharmaceutical services (scientific knowledge and management knowledge)
Identify an individual learning plan based on their learning needs obtained from the self-assessment of GbCF;
Discuss approach to building a professional practice portfolio.
Andreia Bruno-Tome, Senior Expert Strategist, McCann Health, Portugal
Arijana Meštrović, Director, Professional Services, Pharma Expert, Croatia
Kirstie Galbraith, Director, Experiential Development and Graduate Education, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Australia
In October-2021, FIP-UNITWIN Regional Workshops brought FIP’s member academic institutions, professional organisations, key pharmacy stakeholders and guests across all regions together to co-create a roadmap to advance pharmacy and pharmaceutical sciences in their region through educational partnerships. At the FIP-UNITWIN Global Summit on pharmaceutical education, participants will.
Learning objectives: 1. Learn about their regions’ roadmap on advancing pharmacy and pharmaceutical sciences education; 2. Explore FIP’s global call to action on pharmaceutical education to support it across their regions and countries; 3. Discover country cases and next steps of the FIP-UNITWIN Centres for Excellence programme
Chairs:
Catherine Duggan, FIP CEO
Ralph J. Altiere, FIPEd Chair
Speakers:
Dominique Jordan, FIP President
Luis Lorenco, FIP Professional Secretary
Giovanni Pauletti, FIP Scientific Secretary
Pierre Moreau, FIP AIM Chair
Panellists:
Anne Anderson Vice Chair, UK National Commission for UNESCO
Toyin Tofade, President-Elect of the FIP Academic Pharmacy Section (AcPS) & FIP AIM Advisory Committee Member
Silvana Nair Leite, FIP AIM Advisory Committee member
Lilian Azzopardi, AIM Advisory Committee member
Aukje Mantel-Teeuwisse,FIP Digital Health in Pharmacy Education Report Chair, FIP Technology Forum Member, FIP APS Executive Committee Member
Beom-Jin Lee, AIM Advisory Committee member
Rajani Shakya, AIM Advisory Committee member
Mohamad Rahal, AIM Advisory Committee member
Rula Darwish, Academic Pharmacy Section Exco
Paul J. Gallagher, AIM Advisory Committee member
Mwila Chiluba, AIM Advisory Committee member
Yahya Choonara, AIM Advisory Committee member
Arinola Joda, Asst. Secretary/Editor in Chief, APF
Facilitators:
Nilhan Uzman, FIP Lead for education policy and implementation
The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them. The 20th episode of the Programme focuses on FIP Development Goal 14: Medicines Expertise. The details of the Goal are available here: https://www.fip.org/fip-development-goal-14
The expected outcomes of the event are:
Describe the FIP Development Goals and explain the components of DG 14 (and its three elements: workforce & education, science and practice).
Showcase the FIP tools, evidence, and resources to support DG 14 implementation across the three elements.
Identify priorities across practice, science, and workforce & education within DG 14
Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project
Moderator:
Dalia Bajis, FIP Lead for Provision and Partnership, Bahrain
Panellist:
Hala Fadda, Chair of FIP Pediatric Formulations Focus Group, Associate Professor, College of Pharmacy and Health Sciences Buter University, USA
Sham Moodley, Pharmacist, FIP CPS Exco Member, Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa
Summary There is variability across the globe in the provision of universal healthcare. Self-care is the ability to maintain and improve individual’s health, prevent or limit diagnosed illnesses, and address self-treatable conditions. Self care is not no care and it is not necessarily practised in isolation. It may involve support and advice from others, such as expert pharmacy teams. This event discusses how self-care can contribute to Universal Health Coverage from the perspectives of providers of healthcare services and public and patients.
Aim: To discuss the perspectives of providers of healthcare services and the people accessing them about how self-care can contribute to universal health coverage.
Learning objectives:
Explain the extent to which self-care is embedded in healthcare systems;
Discuss cultural approaches to enabling self-care as part of UHC, such as healthy lifestyles;
List healthcare systems and patients/public’s needs for enabling self-care;
Discuss the contribution of localised self-care delivery to UHC
Moderator:
Sham Moodley, Community Pharmacist, Member of the FIP Community Pharmacy Section, South Africa
Panellist:
K Srinath Reddy, President, Public Health Foundation of India, India
Jacqueline Bowman-Busato, Co-Founder, Belgian Private Foundation Pate Adiposité Adipositas Pacte, Belgium
Traditionally, the distribution of medicines to consumers has been organized through heavily regulated networks of physical pharmacies. The strict regulation of market structure has been in place to ensure the safety, accessibility and affordability of medicines, but it has also limited competition in the pharmacy sector. Nowadays, the regulation of pharmacies differs between countries, and this has created different market conditions for online pharmacies to operate.
In some countries the online sales of medicines have grown considerably during the recent years as consumers have become more accustomed to e-commerce. More lately the Covid-19 pandemic has dramatically shaped the e-commerce landscape. Due to the pandemic, the demand for online services of pharmacies has increased significantly in many countries. It is also likely that this has changed preferences for some consumers permanently and demand should therefore remain at a higher level in the future.
Increased cooperation between countries in developing regulation of online pharmacies is needed, according to the report, “Online pharmacy operations and distribution of medicines”, which will be published by the International Pharmaceutical Federation (FIP) on December 8th, 2021.
Gastrointestinal symptoms have an impact on the health and wellbeing of individuals that can be debilitating, however, the majority of people can be supported by the pharmacy team to self-care and effectively manage their symptoms.
Aim:
To explore: lifestyle factors that can cause or worsen gastrointestinal complaints and the role of pharmacy team in supporting the majority of customers to self-care and effectively manage their symptoms.
Learning objectives:
1. List common GI symptoms and their impact on people; 2. Identify and suggest approaches to addressing lifestyle factors causing GI symptoms. 3. Discuss the role of pharmacy team to support people with GI symptoms to self-care
Moderator: - Manjiri Gharat, FIP Vice-President, India
Panellists: - Ruth Rudling, Advanced Clinical Pharmacist for Specialty Medicines, Mid Yorkshire NHS Trust (MYHT), UK - Anja St. Clair-Jones, Consultant Pharmacist Gastroenterology, University Hospitals Sussex, UK
At this event on World AIDS day, we will explore the different roles pharmacists can have in the prevention and screening of HIV infections, as well as in providing care and support to people living with HIV, namely through medication management. Other roles for pharmacists include HIV prevention through dispensing and providing support to preexposure prophylaxis (PrEP), HIV testing and harm reduction strategies for IV drugs users.
The World Health Organization estimates that around 38 million people live with HIV globally. Although there is still no cure for HIV, with the advancement of therapies and increasing access to effective HIV prevention, diagnosis, treatment and care, including for opportunistic infections, HIV infection has become a manageable chronic health condition, enabling people living with HIV to lead long and healthy lives.
Learning objectives: 1. Describe the burden and characteristics of HIV globally. 2. Understand the possibilities of involvement of pharmacists in the clinical care of people living with HIV. 3. Describe the role of pharmacists in PrEP-related services.
Moderator: - Victoria Garcia Cardenas, FIP Pharmacy Practice Research SIG, Chair Senior Lecturer University of Technology Sydney, Australia / Spain
Panelists: - Sham Moodley, FIP CPS Exco Member, Pharmacist Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa - Nelli Barrière, Project Manager, HIV Programmes and Advocacy International AIDS Society, Switzerland - Pilar Taberner Bonastre, Hospital pharmacist, Hospital Universitario Arnau de Vilanova, Lleida Spain - Katrina F. Ortblad, Assistant Professor Fred Hutchinson Cancer Research Center, United States of America - Tessa Oraro-Lawrence, Project Manager, HIV Programmes and Advocacy International AIDS Society, Switzerland
Para abogar por una implementación más amplia y armonizada de bioexenciones basadas en el sistema de clasificación biofarmacéutica (BCS) en los países de América Latina, la FIP está apoyando a los líderes regionales en la sensibilización sobre esta vía reguladora basada en la ciencia diseñada para acelerar la aprobación del mercado de productos farmacéuticos genéricos seguros y eficaces. La segunda parte de esta serie de seminarios web diseñados específicamente para la región de América Latina destaca ejemplos de vías de aprobación regulatoria de bioexenciones basadas en BCS que se implementan actualmente en países seleccionados de América Latina. Los expertos abordarán la base legislativa de las regulaciones de bioexenciones y discutirán las oportunidades de armonización dentro de la región.
Este webinar tiene los objetivos:
Diferenciar entre la bioequivalencia in vivo y las estrategias reguladoras de bioexención basadas en BCS para la aprobación de medicamentos genéricos.
Comprender las implicaciones para la salud pública de la vía reguladora de la bioexención basada en BCS.
Delinear oportunidades y desafíos para la implementación de un proceso armonizado de aprobación regulatoria de bioexenciones dentro de la región de América Latina.
Delinear las contribuciones de solubilidad, permeabilidad y disolución para aplicaciones de bioexención basadas en BCS.
Moderadora: -Talita Ferreira, Coordinadora de Proyectos de bioexención en Latinoamérica FIP
Panelistas: -Alfredo García Arieta, Jefe del Servicio de Farmacocinética y Medicamentos Genéricos AEMPS -Andrés Figueroa Campos, Gerente SD Registro Sanitario de Productos Farmacéuticos Bioequivalentes ANAMED ISPch–Agencia Nacional de Vigilancia Sanitaria de Chile -Jorge Iliou, Dirección NVVS de Paraguay -Alexis Aceituno,Jefe SD Registro Sanitario de Productos Farmacéuticos Bioequivalentes ANAMED ISPch–ANVSChile -Miguel Angel Cabrera Prof. Asociado Central University of Las Villas
The global session entitled ‘Accelerating AMR Action Through Antimicrobial Stewardship: Are pharmacists the protagonists in the fight against antibiotic resistance?’ takesa debate format with 2 teams of three, protagonists and antagonists, speaking to a case study or personal experience to highlight good (protagonist) or bad (antagonist) practice that reflects the reality of the challenges faced by pharmacy in tackling AMR, with a particular focus on low to middle income countries
Moderators: - Sabiha Essack - Manjiri Gharat
Welcome and Objectives: - Introducing FIP AMR Commission and goals of GRIP partnership; overview of 2020 -2021 roadmap progress Panel Discussion: - ‘Are pharmacists the protagonists in the fight against antibiotic resistance?’ Using case studies to highlight best practice, as well as bad practice, to reflect the reality of the challenges faced by pharmacy in tackling AMR, with a particular focus in low to middle income countries
Regional Highlights: - Highlights of the regional ideas that delivered most change/progress towards the AMR roadmap developed in our FIP Virtual 2020 events
Next steps and close: - Next steps and role of the AMR Commission; renewed commitment to AMR going forward
In 2020, Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events combining efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives to mitigate AMR. The success of this partnership culminated in the FIP Regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.
This year GRIP, FIP and Reckitt continue to share this global commitment as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the South East Asian Region over the past 12 months.
Moderators: - Manjiri Gharat - Wirat Tongord
Welcome and Objectives: - Introducing regional leads and recap of ambitions of the Pharmacy AMR Roadmap
Panel Discussion: - ‘AMR Stewardship in Action’ Regional leads to moderate a panel discussion on a total of 3 good and bad practice case studies from submissions and/or initiatives they have identified. Where possible, those involved in good practice initiatives will be invited to join the panel discussion.
AMR ACCELERATOR: - Audience can interact with good practice initiatives, ‘accelerating’ the idea in their country by making a commitment to adopt or support the initiative.
Thank you and close: - The AMR accelerator idea with the most traction is presented during the global session.
In 2020, Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events combining efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives to mitigate AMR. The success of this partnership culminated in the FIP Regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.
This year GRIP, FIP and Reckitt continue to share this global commitment as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the Eastern Mediterranean Region over the past 12 months.
Moderators: - Dalal Hammoudi, - Khalid Eljaaly - Nada Ahmed
Welcome and Objectives: - Introducing regional leads and recap of ambitions of the Pharmacy AMR Roadmap
Panel Discussion: - ‘AMR Stewardship in Action’ Regional leads to moderate a panel discussion on a total of 3 good and bad practice case studies from submissions and/or initiatives they have identified. Where possible, those involved in good practice initiatives will be invited to join the panel discussion.
AMR ACCELERATOR: - Audience can interact with good practice initiatives, ‘accelerating’ the idea in their country by making a commitment to adopt or support the initiative.
Thank you and close: - The AMR accelerator idea with the most traction is presented during the global session.
In 2020, Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events combining efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives to mitigate AMR. The success of this partnership culminated in the FIP Regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.
This year GRIP, FIP and Reckitt continue to share this global commitment as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the European Region over the past 12 months.
Welcome and Objectives: - Introducing regional leads and recap of ambitions of the Pharmacy AMR Roadmap
Panel Discussion: - ‘AMR Stewardship in Action’ Regional leads to moderate a panel discussion on a total of 3 good and bad practice case studies from submissions and/or initiatives they have identified. Where possible, those involved in good practice initiatives will be invited to join the panel discussion.
AMR ACCELERATOR: - Audience can interact with good practice initiatives, ‘accelerating’ the idea in their country by making a commitment to adopt or support the initiative.
Thank you and close: - The AMR accelerator idea with the most traction is presented during the global session.
In 2020, Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events combining efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives to mitigate AMR. The success of this partnership culminated in the FIP Regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.
This year GRIP, FIP and Reckitt continue to share this global commitment as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the Western Pacific region over the past 12 months.
Moderators: - John Bell - Leonila Ocampo, - Fiona Doukas
Welcome and Objectives: - Introducing regional leads and recap of ambitions of the Pharmacy AMR Roadmap
Panel Discussion: - ‘AMR Stewardship in Action’ Regional leads to moderate a panel discussion on a total of 3 good and bad practice case studies from submissions and/or initiatives they have identified. Where possible, those involved in good practice initiatives will be invited to join the panel discussion.
AMR ACCELERATOR: - Audience can interact with good practice initiatives, ‘accelerating’ the idea in their country by making a commitment to adopt or support the initiative.
Thank you and close: - The AMR accelerator idea with the most traction is presented during the global session.
In 2020, Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events combining efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives to mitigate AMR. The success of this partnership culminated in the FIP Regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.
This year GRIP, FIP and Reckitt continue to share this global commitment as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the African Region over the past 12 months.
Moderators: - Sabiha Essack - Mirfin Mpundu
Welcome and Objectives: - Introducing regional leads and recap of ambitions of the Pharmacy AMR Roadmap
Panel Discussion: - ‘AMR Stewardship in Action’ Regional leads to moderate a panel discussion on a total of 3 good and bad practice case studies from submissions and/or initiatives they have identified. Where possible, those involved in good practice initiatives will be invited to join the panel discussion.
AMR ACCELERATOR: - Audience can interact with good practice initiatives, ‘accelerating’ the idea in their country by making a commitment to adopt or support the initiative.
Thank you and close: - The AMR accelerator idea with the most traction is presented during the global session.
The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.
The 19th episode of the Programme focuses on FIP Development Goal 17: Competency Development. The details of the Goal are available here: https://www.fip.org/fip-development-goal-17
FIP Development Goal 17 calls for workforce and education strategies linked to the use of evidence-based developmental frameworks to support the translation of pharmaceutical practice, science and workforce & education across all settings and according to local/national needs.
The goal calls to support professional career development by using tools, such as competency frameworks, describing competencies and behaviours across all settings.
The expected outcomes of the event are:
Describe the FIP Development Goals and explain the components of DG 17 (and its three elements: workforce & education, science and practice).
Showcase the FIP tools, evidence, and resources to support DG 17 implementation across the three elements.
Identify priorities across practice, science, and workforce & education within DG 17
Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project
Moderator: -Wirat Tongrod, FIP AMR committee, Vice President, The Pharmaceutical Association of Thailand under Royal Patronage, Thailand
Panelists: -Cátia Caneiras, Professor and Coordinator, Microbiology Laboratory of Environmental Health University of Lisbon, Portugal -Chin-Yen Yeo, FIP AMR Commission - Member, Antimicrobial Stewardship Pharmacist Blacktown & Mt Druitt Hospitals, Western Sydney Local Health District, Australia -Mirfin Mpundu, Director, ReAct Africa International Centre for Antimicrobial Resistance, Zambia -Dalal Hammoudi, FIP WiSE steering committee and FIP AMR commission member, Associate Dean for Assessment, Lebanese International University – School of Pharmacy, Lebanon
In 2020, Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events combining efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives to mitigate AMR. The success of this partnership culminated in the FIP Regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.
This year GRIP, FIP and Reckitt continue to share this global commitment as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the Americas Region over the past 12 months.
Moderators: - Eduardo Savio - Doug Burgoyne
Welcome and Objectives: - Introducing regional leads and recap of ambitions of the Pharmacy AMR Roadmap
Panel Discussion: - ‘AMR Stewardship in Action’ Regional leads to moderate a panel discussion on a total of 3 good and bad practice case studies from submissions and/or initiatives they have identified. Where possible, those involved in good practice initiatives will be invited to join the panel discussion
AMR ACCELERATOR: - Audience can interact with good practice initiatives, ‘accelerating’ the idea in their country by making a commitment to adopt or support the initiative.
Thank you and close: - The AMR accelerator idea with the most traction is presented during the global session.
Sore throat is a common self-limiting condition which often leads to patients presenting in the pharmacy for advice, treatment options and reassurance. Sore throat is predominantly a viral condition for which symptomatic management offers the most appropriate course of action. Effective diagnosis, communication and managing expectations can prevent unnecessary onward referral or inappropriate antibiotic use.
Aim: To help pharmacists enhance their role as the primary healthcare professional in the appropriate management of sore throat through improved communication and appropriate management that supports self-care.
Learning objectives: 1. List the presenting symptoms of sore throat 2. Explain the diagnosis of sore throat 3. Describe an evidence-based approach to treatment options
Moderator: -Sabiha Essack, Professor: Pharmaceutical Sciences South African Research Chair in Antibiotic Resistance & One Health, University of KwaZulu-Natal, South Africa
Panellists: -Douglas Bourgoyne, Principal Cooperative Benefits Group, LLC, USA -John Bell, Community pharmacist and Self-care Advisor Pharmaceutical Society of Australia, Australia -Wirat Tongrod, Member of AMR Commission, Lecturer – Faculty of Pharmaceutical Sciences, Huachiew Chalermprakiat University- Thailand
Antimicrobial resistance (AMR) is a major public health threat, which currently kills around 700,000 people each year worldwide. The fight against AMR has been a priority for FIP for many years as it causes a profound impact on global, regional and national health care and economies. The goal of this webinar is to supplement the other FIP webinars being held in November 2021 discussing AMR regionally around the globe. This webinar specifically targets pharmacists involved in hospital and health-system practice settings and will discuss innovative ways to involve pharmacists in infectious disease through AMR and sepsis management.
Learning objectives: 1. Introduce the antimicrobial stewardship program in hospital pharmacy using clinical decision support system 2. Discuss the role and importance of the pharmacist in the management of sepsis 3. Evaluate the use of software and information technology to support antimicrobial stewardship in the critically ill
Panelists: -Esteban Zavaleta, Director of Pharmacy, Hospital Clinica Biblica, Costa Rica -Shu-Wen “Wendy” Lin, Director of Pharmacy, National Taiwan University Cancer Center, Taiwan -Asad “Sid” Patanwala, Professor and Chair of Clinical Pharmacy University of Sydney | Royal Prince Alfred Hospital, Australia
The Leadership Summit– the programme finale – is a high-level event in which we recap the primary outcomes of the 12-event digital series. Together, we will adopt the FIP Commitment to Action on sustainable and equitable access to vaccines through pharmacy which will be launched during the Summit. Global leaders from health and pharmacy join this landmark event.
About the programme:
FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.
Despite all good intentions, all humans carry unconscious biases. How do these impact our ability to provide culturally appropriate care to our patients? This interactive session is meant to target all pharmacists and educators in practice to promote understanding on the influence of unconscious bias on health disparities, like COVID-19. Specifically, experts will share the neuroscience of how implicit bias, strategies to disrupt bias, and address how bias can influence our patient care interactions.
At the end of this session, participants will be able to: 1. Define implicit bias and its impact on health disparities. 2. Discuss the impact of unconscious bias and how it affects our relationships with patients, students, and colleagues. 3. Identify and reflect on own biases. 4. List strategies to mitigate unconscious bias in pharmacy practice to improve patient-centred care.
Moderator: - Mohamed Amin, Associate Professor, Beirut Arab University, Lebanon
Facilitator: - Dalia Bajis, FIP lead for Provision and Partnerships, FIP, Bahrain
Panellist: - Sally Arif, Associate Professor of Pharmacy Practice/ Clinical Pharmacist, Midwestern University College of Pharmacy/ Rush University Medical Center, USA
El documento técnico, Servicios farmacéuticos en inmunización: Aportes, experiencias e implementación en la región de las Américas, elaborado por el Centro de Información de Medicamentos del Instituto de Investigaciones Farmacéuticas de la Facultad de Farmacia de la Universidad de Costa Rica para el Foro Farmacéutico de las Américas (FFA), ofrece una visión general de la participación del profesional en farmacia en temas de vacunas y en servicios farmacéuticos en inmunización en América Latina. En este webinar de presentación, se hará una reseña de sus contenidos y la relación con los objetivos de desarrollo de la Federación Internacional Farmacéutica (FIP). Este documento tiene la pretensión de constituirse en una herramienta para la implementación de servicios farmacéuticos en inmunización en la región que complementa las formuladas y emitidas por la FIP.
1) Reconocer la contribución del farmacéutico a las estrategias de vacunación y su relación con los objetivos de desarrollo de la FIP y las prioridades de salud globales.
2) Describir los beneficios, el impacto y las barreras de la inmunización en general y la vacunación en particular, así como experiencias de éxito del farmacéutico como inmunizador a nivel global.
3) Identificar experiencias de éxito del farmacéutico en América Latina en vacunas y su participación en las distintas etapas de la cadena de inmunización-
4) Reconocer las áreas de servicio de la inmunización en el quehacer farmacéutico y las herramientas disponibles para el desarrollo de servicios farmacéuticos de inmunización desde los diferentes ejes de su competencia.
The document "Pharmaceutical services in immunisation: Contributions, experiences and implementation in the Americas region", authored by the Drug Information Centre of the Pharmaceutical Research Institute of the Faculty of Pharmacy of the University of Costa Rica for the Pharmaceutical Forum of the Americas, provides an overview of the involvement of the pharmacy profession in immunisation in Latin America. This introductory webinar will provide an overview of the document’s content and how it relates to the FIP Development Goals. This document is intended to be a tool for the implementation of pharmaceutical services in immunisation in the region, which also complements other reports issued by FIP. The document is available in Spanish, English and Portuguese.
1) Recognise the pharmacist's contribution to immunisation strategies and their relationship to FIP Development Goals and global health priorities.
2) Describe the benefits, impact and barriers of immunisation in general and vaccination in particular, as well as successful experiences of pharmacists as immunisers globally.
3) Identify successful experiences of pharmacists in Latin America in vaccines and their participation in the different stages of the immunisation chain.
4) Recognise the service areas of immunisation in pharmacy and the tools available for the development of pharmaceutical immunisation services from the different areas of their competence.
Covid-19 complications include a wide spectrum of clinical manifestations. COVID-19 -associated invasive mould infections have been identified as a serious global health problem. These invasive infections present differently and vary in their risk factors. Pharmacists can play a vital role in raising awareness, prevention, and treatment of these emerging pathogens. In addition, pharmacists’ role is vital to providing care to patients suffering from Long Covid. Long Covid conditions are a wide range of new, returning, or ongoing health problems people can experience for four or more weeks after contracting SARS-CoV-2. These complications can occur in individuals with serious, mild, or no symptoms during the SARS-CoV-2 infection. However, the burden is not well understood and treatment approaches need further study.
This webinar will raise awareness of the pharmacist's role in supporting patients with COVID-19 associated mould infections and Long Covid.
Learning objectives: 1. Recognize manifestations and risk factors of Long Covid. 2. Provide actionable steps to care for people with post-covid conditions -as part of multi-disciplinary teams. 3. Describe common manifestations and risk factors of COVID-19-associated mould infections. 4. Identify prevention measures for COVID-19 associated mold infections. 5. Recognize treatments for COVID-19-associated mould infections.
Moderator: - John Hertig, VP Americas (PAHO), Assoc. Prof. and Vice-Chair of Pharmacy Practice, Butler University, USA
Panelists: -Dallas James Smith, Epidemic Intelligence Service Officer/Pharmacist Mycotic Diseases Branch, Centers for Disease Control & Prevention, United States -Stacey L. Konkle, Epidemic Intelligence Service Officer/Epidemiologist Field Officer, Epidemiology Workforce Branch, Centers for Disease Control & Prevention, United States
This webinar aims to identify the challenges and opportunities for pharmacists in addressing diabetes, highlight the different ways pharmacists can advocate for increased recognition and visibility of roles in providing diabetes-related services, understand the role that pharmacists can play in achieving global diabetes goals, in commemoration of the 2021 World Diabetes Day (WDD). The event will culminate with the launch of the ONE FIP Practice Transformation Programme on Diabetes.
This event will also close the series of five webinars organised by FIP to explore the role of pharmacists in the prevention and management of diabetes and its complications; the advancement in therapeutic options; the competencies and workforce development opportunities; and the policy barriers and facilitators in providing diabetes-related services.
At the end of this webinar, participants will: • Identify the challenges and opportunities for pharmacists in addressing diabetes • Recognize the different ways pharmacists can advocate for increased recognition and visibility of roles in providing diabetes services • Understand how the role of pharmacists can be elevated in achieving global diabetes goals, in commemoration of the 2021 World Diabetes Day (WDD) 14 November
Moderator: -Paul Sinclair, FIP Chair Board of Pharmaceutical Practice, Community Pharmacist, Australia
Panelists: -Tolulope Osigbesan, Advocacy and Partnerships Officer, NCDs Alliance, Switzerland -Iryna Vlasenko, Vice president International Diabetes Federation, Ukraine -Jean-Baptiste Nikiema, Regional advisor, EDM, WHO Regional Office for Africa, Republic of Congo -Gonçalo Sousa Pinto, FIP Lead for Practice Development and Transformation, Spain -Lauren Blum, Global engagement fellow, UNC Eshelman School of Pharmacy, USA -Rúben Viegas,FIP Practice Development Projects Coordinator, Spain -Aniekan Ekpenyong, Practice Transformation Projects Coordinator FIP, Nigeria -Michael Donohoe, Global Patient Advocate, A1C Wellness {Diabetes...], USA
The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.
The 18th episode of the Programme focuses on FIP Development Goal 3: Quality Assurance.
Learning objectives: 1. Describe the FIP Development Goals and explain the components of DG 3 (and its three elements: workforce & education, science and practice). 2. Showcase the FIP tools, evidence, and resources to support DG 3 implementation across the three elements. 3. Identify priorities across practice, science, and workforce & education within DG 3 4. Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project Moderator: -Banan Mukhalalati, Global Lead for Development Goal 3 “Quality Assurance” Assistant Professor, Qatar University, Qatar Panelists: -Mike Rouse, Former FIP Education Development Team Lead for Quality Assurance, Director, International Services, Accreditation Council for Pharmacy Education, USA -Abby A. Kahaleh, DG3 Lead, PhD, MS, BPharm, MPH, FAACP Tenured & Board of Trustees Faculty Roosevelt University College of Science, Pharmacy, & Health, USA -Bronwyn Clark, DG3 Lead Chief, Exec. Officer Australian Pharmacy Council, Australia -Abeer Alghananeem, DG3 global lead, Prof & Director of Research Sullivan University College of Pharmacy & Health Sciences, USA & Jordan -Aline Hajj, Assoc. Prof, PharmD, PhD Researcher and Lecturer, Saint Joseph University, Lebanon -Marwan Akel, Projects Manager Workforce FIP, Lebanon
Cytotoxic drugs compounding is one of the most risky activity among all pharmaceutical operations in a Pharmacy. This has led pharmacists to multiply check points at each critical step and in-process controls to keep that risk at the lowest, as reported in numerous publications. What can technology bring in terms of safety, speed, convenience, and reliability in such complex environments ? Three exemples will be discussed in this webinar: CSTDs, IV workflow management system with IA technology and video recording, and robotic compounding. And if you are addicted to serious games, come and see how you can increase your competencies while training in immersive virtual reality in a real cytotoxic drugs compounding environment
Moderators: -Jacqueline Surugue, Chair of the FIP Pharmaceutical Technology Forum, Immediate past FIP Vice President and Liaison Officer for the African Region Hospital Pharmacist, Hospital Practitioner, Centre Hospitalier Georges Renon, Niort, France -Josep M. Guiu Segura, HPS ExCo, Head of pharmaceutical planning and pharmacotherapy coordination Consortium of Health and Social Care of Catalonia, Spain
Panelists: -Benoit Le Franc, Pharmacist Pharmacien hospitalier gérant PUI GHLRRA-co-fondateur chez EUREKAM SAS-inventeur Drugcam, France -Agnés Bobay-Madic, Pharmacist Centre Hospitalier Robert Bisson, Lisieux, France -Mirjam Crul, Pharmacist, Board Member, European Cancer Organisation, Special Network on the impact of COVID-19 on Cancer Co-Chair and workforce Network Co-Chair, The Netherlands -Shao-Chin Chiang, Pharmacist Sun Yat-Sen Cancer Centre, Taiwan
This webinar aims to highlight strategies for developing a diabetes competent workforce, explore success stories of countries that have developed competency framework for diabetes-related roles and to identify relevant competencies essential for the delivery of diabetes services by pharmacists.
Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes.
At the end of this webinar, participants will: -Understand the strategies for developing a diabetes competent workforce -Learn from successful experiences on how to develop competency framework for diabetes related roles -Identify relevant competencies facilitating the delivery of diabetes-related services
Moderator: -Ralph Altiere, Chair of FIP Education (FIPEd) University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, USA
Panelists: - Sallianne Kavanagh, Senior Lecturer- Clinical Pharmacy and Pharmacy Practice. Advanced Clinical Pharmacist. University of Huddersfield. Sheffield Teaching Hospitals NHSFT, United Kingdom - Andreia Bruno-Tomé, Global Lead for DG 5 - Competency Development, Senior Expert Strategist, McCann Health, Portugal - Diana Isaacs, Endocrine Clinical Pharmacy Specialist, Cleveland Clinic, USA
In the final sixth of six regions we dissect, event 11 focuses on the regional needs and drivers for transforming vaccination in the African region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the African region join us for a true regional perspective.
About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.
Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.
The event will be moderated by: - Dr. Prosper Hiag – President of the African Pharmaceutical Forum (APF) - Mrs. Jacqueline Surugue – Chair of the FIP Technology Forum and Hospital Practicioner and Pharmacist, France - The speakers at the event are: - Dr. Daniella Munene – CEO of the Pharmaceutical Society of Kenya - Dr. Samuel Adekola – Community Pharmacist at His Grace KSP Pharmacy Group and Immediate Past National Chairman of Association of Community Pharmacists of Nigeria - Dr. Redouane Soualmi - Vice president of international relations of Algerian Pharmaceutical Federation FAP - Dr. Mariet Eksteen - Professional Development and Support at the Pharmaceutical Society of South Africa
This webinar aims to describe the advancement in diabetes therapeutics for managing diabetes, highlight the role of technology in improving health outcome of individuals living with diabetes and identify the different services employed in the optimization of diabetes treatment.
Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes
At the end of this webinar, participants will:
• Describe the advancement in diabetes therapeutics for managing diabetes • Explain the role of technology in improving health outcome of individuals living with diabetes • Identify the different services employed in the optimization of diabetes treatment
Moderator: Ross McKinnon, Chair of BPS, Chair of Board of Pharmaceutical Sciences, FIP Australia
Panelists: -Antria Pavlidou, YPG PharmSci Promotion, PhD Candidate, Clinical Pharmacist Pharmaceutical Services, Ministry of Health, Cyprus / PhD Candidate UCL, Cyprus -Kalyan Venkata, Assistant Professor, Medicinal Chemistry, Pharmaceutical and Administrative Sciences, University of Health Sciences and Pharmacy in St. Louis, USA -Anna Busquets Casso, Community pharmacist, SEFAC, Spain
In the fifth of six regions we dissect, event 10 focuses on the regional needs and drivers for transforming vaccination in the Western Pacific region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Western Pacific region join us for a true regional perspective.
About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.
Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.
The event will be moderated by: • Mr. John Jackson - President of the Western Pacific Pharmaceutical Forum, Australia • Professor Parisa Aslani - Professor in Medicines Use Optimisation at The University of Sydney and FIP Vice President
Panelists: - Dr. Amrahi Buang - President of the Malaysian Pharmacists Society (MPS) - Dr. Stephanie Tay - Senior Manager at the Ministry of Health, Singapore - Mrs. Leonila M. Ocampo - Former President and Member of the Council of Advisers, Philippine Pharmacists’ Association - Mr. Chris Campbell - General Manager, Policy & Program Delivery and Queensland State Manager at the Pharmaceutical Society of Australia
The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.
The expected outcomes of the event are: 1. Describe the FIP Development Goals and explain the components of DG 5 (and its three elements: workforce & education, science and practice). 2. Showcase the FIP tools, evidence, and resources to support DG 5 implementation across the three elements. 3. Identify priorities across practice, science, and workforce & education within DG 5 4. Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project
Moderators: -Elizabeth McCourt, Health Professional Research Coordinator Queensland Health, Australia -Marwan Akel, FIP projects manager- workforce, FIP Lebanon
Panelists: -Arijana Meštrović, FIP ACPS Vice President, FIP WDH Global Lead for Competency Development Director, Professional services Pharma Expert, Croatia -Sylvain Grenier, MEPS president Director Plasma Protein and related products Canadian Blood Services, Canada -Andreia Bruno-Tome, Global Lead for DG 5 - Competency Development ,Senior Expert Strategist McCann Health, Portugal -Naoko Arakawa, Global Lead for Competency Development, Assistant Professor in International Pharmacy, University of Nottingham, UK
In the fourth of six regions we dissect, event 9 focuses on the regional needs and drivers for transforming vaccination in the South East Asian region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the South East Asian region join us for a true regional perspective.
About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.
Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.
The event will be moderated by: • Chinta Abaywardana – Editor, Pharmaceutical Society of Sri Lanka • Sherly Meilianti – Data and Intelligence Specialist, FIP
The speakers at the event are: • Rao Vadlamudi – Professional Secretary of SEARPhorum • Bhojraj Suresh - Pro Chancellor, JSS Academy of Higher Education and Research, India • Keri Lestari - Lecturer and Pharmacist, Universitas Padjadjaran, Indonesia • Vindya Pathiraja - General Secretary of the Pharmaceutical Society of Sri Lanka • Sanjeev Sharma Kattel - Pharmacy Officer/Acting Chief, Department Of Drug Administration, Kathmandu, Nepal
3D printing offers the potential to revolutionise the production of pharmaceuticals targeted to the gastrointestinal tract by offering a flexible drug product manufacturing platform that can adapt readily to changing market and patient needs. When will a pharmacist be able to use each patient’s individual information — such as age, race, gender or constitution — to produce their optimal medication dose, rather than relying on a standard set of doses? Could there be a time when a pharmacist will be able to print drugs in a complex construct of layers? When will patients be able to print their medicines at home?
Describe the generalities related to 3D printing of medicines. Understand the opportunities, issues and regulation related to 3D printing of medicines. Learn how different technological tools allow personalised 3D printed medicines. Outline a practical experience in 3D printing in pharmacies
Panellists: - Alvaro Goyanes Goyanes, Co-founder and Director of Development, FabRx Ltd, United Kingdom - Patrick van Oirschot, Director | Consultant, GPP Support, Netherlands - Jan Saevels, Scientific Director, Association of Pharmacists Belgium (APB), Belgium
On 25 October 2021, it will be the third anniversary of the World Health Organization’s Astana Declaration on Primary Health Care (PHC), for which FIP pledged its commitment to accelerate progress in strengthening PHC. In 2020, the WHO published its Operational Framework for PHC to translate the vision of the Astana Declaration into actions. To mark this date and showcase how pharmacists can utilise and contribute to the WHO operational framework, FIP is organizing the digital FIP Global Summit on Primary Health Care. The summit will host a high-level discussion with the WHO to explore the strategic levers needed for pharmacists to strengthen primary health care.
At the end of this session, participants will:
1. Learn about WHO’s operational framework on primary health care to translate vision into actions 2. Explore initiatives from FIP member organizations on primary health care 3. Engage in a high-level discussion on strategic priorities needed for pharmacists to strengthen primary health care
Co-Moderator: - Dominique Jordan, President FIP - Switzerland
Co-Moderator: - Paul Sinclair, Chair of the Board of Pharmaceutical Practice, FIP - Australia
Facilitator: - Nilhan Uzman, FIP Lead for Education Policy and Implementation, FIP - The Netherlands - Aysu Selcuk, FIP Educational Partnership Coordinator, FIP - Turkey
Panellists: - Catherine Duggan, CEO, FIP - The Netherlands - Nisa Masyitah, Master's Student, The Graduate Institute of International and Development Studies (IHEID) - Switzerland - Shannon Barkley, Technical Officer, Primary health care World Health Organization/HQ - Switzerland - Anne L. Burns, Vice President of Professional Affairs, American Pharmacists Association - United States - Eric Muringu, Projects Lead, Pharmaceutical Society of Kenya - Kenya - Yong Pei Chean, President, Pharmaceutical Society of Singapore - Singapore - Anoushka Schut, Heading the Policy & Development Cluster, Member of the Management Team of pharmacist association - The Netherlands - Roy Himawan, Head of Program and Information Section Secretariat of the Directorate General of Pharmacy and Medical Devices at Ministry of Health, Indonesian Pharmacists Association / Ministry of Health, Indonesia - Zeid Kilani, President, JAP, Jordan
This webinar aims to describe the different services provided by pharmacists to manage diabetes, explore the role of pharmacists in preventing the complications of diabetes, and highlight the importance of collaboration with other health professionals in achieving treatment goals
Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes.
At the end of this webinar, participants will:
• Describe the different services provided by pharmacists to manage diabetes • Identify the role of pharmacists in preventing the complications of diabetes • Understand the importance of collaboration with other diabetes health professionals in achieving treatment goals
Modarator: Tim Chen, President FIP Social and Administrative Pharmacy Section, Australia
Panelists: -Sanah Hasan, President of FIP Social and Administrative Pharmacy Section, Associate Professor Ajman University, College of Pharmacy and Health Sciences, United Arab Emirates -Astrid Czock, FIP Global Lead for DG8: Working with others, CEO QualiCCare, Switzerland -Francisco Javier Jiménez Ramírez, Professor / Pharmacist University of Puerto Rico School of Pharmacy, Puerto Rico - Mara Pereira Guerreiro, Invited Professor, Nursing School of Lisbon & Instituto Universitário Egas Moniz Nursing School of Lisbon & Instituto Universitário Egas Moniz, Portugal
Vaccination coverage rates for several diseases are suboptimal and remain below WHO targets in many countries of all income levels. For FIP, it is essential to engage with civil society organisations representing different constituencies – from patient advocacy groups to older adult organisations and to vaccination advocates – to discuss and outline synergistic and complementary advocacy actions for broader access and convenience of vaccination services through a diversity of providers and pathways. This event will gather different civil society organisations to express their concerns, best practices and expectations, namely with regards to the role of pharmacists, for improving vaccination coverage, and to identify potential alignments in advocacy strategies.
Learning objectives: 1. Understand the role of the various civil society organisations in contributing to increased vaccination coverage. 2. Explore drivers and barriers to diversifying vaccination pathways and providers, allowing for better access to vaccination services. 3. Discuss possible actions and synergies by the different stakeholders in addressing vaccine hesitancy and complacency.
Moderator: - Catherine Duggan, CEO, FIP
Panellists: - Jane Barratt , Secretary General, International Federation on Ageing - Mariano Votta, Director, Active Citizenship Network - Iryna Vlasenko, Vice president, International Diabetes Federation - Siân Williams, CEO, International Primary Care Respiratory Group - Gary Finnegan, Editor, Vaccines Today
Ten years after the first FIP Pharmacy Technicians’ Symposium, we invite you to attend this year’s virtual event. The 2021 Pharmacy Technicians’ Symposium will take place on 19 and 20 October in celebration of World Pharmacy Technician Day (October 19). Take a look at the full programme here: https://bit.ly/3a8fGfa
Symposium Programme
13:00 - 14:30 CEST
Trends in digital health technologies require the entire pharmacy workforce to prepare for and adapt to constant change. This session will explore how pharmacy technicians can best engage in advances in digital health.
Learning Objectives: ● Recognize emerging trends in digital health technologies ● Identify digital tools that aid in the delivery of patient care ● Describe the role of pharmacy technicians in digital health
Chairs: Christina Durinck (Denmark) & Ryan Burke (US)
14:35 - 15:50 CEST Unique Pharmacy Technician Activities “Things you didn't know pharmacy technicians do”
Pharmacy technicians across the globe play a key role in all aspects of pharmacy practice. Some roles are well known, while others are less common but equally important in terms of patient care.
This presentation will focus on unique roles for pharmacy technicians, including academia, radiopharmaceuticals, transplant, medicines administration, and more.
Learning Objectives: ● Identify unique roles for pharmacy technicians ● Describe the education, training, and experience required for pharmacy technicians to engage in certain areas of pharmacy practice ● Recognize the key tasks and responsibilities of pharmacy technicians working in transplant, medication administration, smoking cessation, and pharmaceutical manufacturing and distribution.
“This webinar is part of the FIP virtual Global Pharmacy Technicians’ Symposium 2021 programme! The symposium will continue on 19 October at 15:00 CEST and on 20 October at 13:00 CEST. Take a look at the full programme and register for each day here: https://bit.ly/3a8fGfa”
Panelists: -Silvana Nair Leite, DG 8 Leads, Hub, Professor Universidade Federal de Santa Catarina, Brazil -Victoria Garcia Cardenas, Chair, Pharmacy Practice Research SIG, Senior Lecturer, Pharmacy University of Technology Sydney, Australia -Mujahidhussein G Valji, Vice President, Hospital Pharmacy Section, Africa Region Chief Pharmacist Aga Khan Health Services, Tanzania -Susan James, Lead for the FIPEd Pharmacy Technicians and Support Workforce Strategic Platform and Chair, Pharmacy Technician Advisory Committee Director, Quality Ontario College of Pharmacists, Canada -Daragh Connolly, Interim President, Community Pharmacy Section, FIP ExOfficio President Irish Pharmacy Union, Ireland -Astrid Czock, FIP Global Lead for DG8: Working with others, CEO QualiCCare, Switzerland -Jill Martin Boone, Associate Director, HUB DG8 lead, Director of Interprofessional Education James L. Winkle College of Pharmacy University of Cincinnati, USA
Ten years after the first FIP Pharmacy Technicians’ Symposium, we invite you to attend this year’s virtual event. The 2021 Pharmacy Technicians’ Symposium will take place on 19 and 20 October in celebration of World Pharmacy Technician Day (October 19). Take a look at the full programme here: https://bit.ly/3a8fGfa
15:30 - 17:00 CEST Leadership and Pharmacy Technician Workforce Development
Description: A strong pharmacy support workforce is a key component of FIP’s workforce development initiatives. This session will explore leadership roles and opportunities for pharmacy technicians and highlight strategies for further developing the pharmacy technician workforce.
Learning Objectives: ● Identify FIP Workforce Development Goals related to the pharmacy support workforce. ● Review leadership roles and opportunities for pharmacy technicians ● Describe pharmacy technician career ladders ● Discuss professional development strategies for pharmacy technicians
Chairs: Liz Fidler (UK) & Zachary Green (US)
Speakers: ● Kate Thorndike (UK) ● Vibhuti Arya (US) ● Jill Boone (US) ● Abigail Tan Ming Li (Singapore)
Pharmacy and pharmaceutical sciences encompass a very diverse field. The options are almost infinite as science and practice evolves. It is therefore of great advantage for young pharmacists if they can discover their path early on in their careers. In this webinar, information about different career paths and opportunities will be shared with participants with the aim of helping them navigate the career paths and opportunities in diverse settings and specialist areas.
By the end of the webinar, participants will be able. 1. To understand the possible career paths and opportunities for young pharmacists in industrial pharmacy. 2. To understand the possible career paths and opportunities for young pharmacists in Academia. 3. To understand the possible career paths and opportunities for young pharmacist in regulatory pharmacy.
Panelists: -Clement Haeck, FIP YPG Twitter Manager, FIP YPG Subcommittee 2021 Researcher The Population Council, USA -Yoonjung Choi, Member/Previous Career Development Toolkit Working Group, Research Scientist Korea Institute for Pharmaceutical Policy Affairs Republic of Korea -Anisha Sandhu, FIP YPG Workforce Development Hub Liaison, Assistant Lecturer Monash University Malaysia, Malaysia -Angeliki Kopsini, Medical Science Liaison Cardiovascular Bayer Hellas, Pharmaceutical Division, Greece
Hygiene practices including hand and surface disinfection form part of our first line of defence by helping to reduce the spread of the infections such as COVID-19. These interventions also have an impact on many common infections such as cold and seasonal flu. The pharmacy team are the most accessible healthcare provider and are a convenient source of advice for patients and public in the maintenance of appropriate hand and surface hygiene practices.
Aim: To explain the benefits of hand and surface disinfection in stopping the transmission of a range of common infections that are transmitted in the home and everyday life setting and profile the role the pharmacy team can play in providing patient and public education on disinfection in disease containment and management.
Learning objectives: 1. Explain the importance of hand and surface disinfection 2. List common infections/conditions where hand or surface transmission plays a role 3. Discuss the evidence-base for disinfection practice including use of appropriate disinfectants 4. Describe the role that pharmacist and their team can play in advising and education patients and public about disinfection.
Moderator: -Cátia Caneiras, Professor and Coordinator, Microbiology Laboratory of Environmental Health University of Lisbon, Portugal
Panelists: -Sally Bloomfield, Honorary Professor London School of Hygiene and Tropical Medicine, UK -Dalal Hammoudi, Assistant Professor Chairperson; Pharmaceutical Sciences Department School of Pharmacy; Lebanese International University, Lebanon -Mirfin Mpundu, Director, ReAct Africa International Centre for Antimicrobial Resistance, Zambia
In the third of six regions we focuses on the regional needs and drivers for transforming vaccination in the European region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the European region join us for a true regional perspective.
About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.
Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access, and sustainability of vaccinations through policy development and implementation.
The event will be moderated by: • Ema Paulino – Immediate Past Professional Secretary at the International Pharmaceutical Federation (FIP) – Portugal • Stephanie Kohl - Policy & Advocacy Officer at the European Association of Hospital Pharmacists (EAHP) – Belgium
The speakers at the event are: - Koen Straetmans - President of the Belgian Pharmaceutical Association (APB) - Piotr Merks – Adjunct professor at the Faculty of Medicine, Cardinal Stefan Wyszynski University in Warsaw, - Vibhu Paudyal - Senior Lecturer in Clinical Pharmacy, University of Birmingham and Chair of the Research Committee at the European Society of Clinical Pharmacy (ESCP) - Monika Derecque-Pois - Director General of the European Healthcare Distribution Association (GIRP) - Mary Ann Sant Fournier - President of Malta Chamber of Pharmacists
Anticoagulant therapy requires appropriate monitoring and management to ensure safety and effectiveness of the treatment, avoid complications and to achieve optimal clinical outcomes. Pharmacists can play an important role in anticoagulation therapy management through their expert knowledge of medicines. This role also includes the provision of patient education, identification of drug interactions, monitoring for dose appropriateness and checking for adverse effects. This webinar will explore the various roles that pharmacists can play in providing anticoagulation management services.
At the end of this webinar, participants will: 1. Identify the different issues impacting anticoagulation management 2. Recognize the crucial role of pharmacists in enhancing the management of anticoagulation 3. Explain the role technology can play in supporting anticoagulation management 4. Describe the barriers and opportunities for pharmacists in leading anticoagulation management services
Moderator: Carlos Lacava Fernández, Vice President of FIP, Uruguay
Panelists: -Sahimi Mohamed, Clinical Pharmacist Hospital Serdang, Ministry of Health, Malaysia -Nida Najmi, Founder of Online Anticoagulation Management Services & Mahir-e-Adviyat, Pakistan -Rose Anne, Coordinator, Anticoagulation Stewardship Program, University of Wisconsin Hospital and Health System (UW Health), Madison, Wisconsin, USA
To advocate for broader, harmonized implementation of biopharmaceutics classification system (BCS)-based biowaivers in Latin American countries, FIP is supporting regional leaders in raising awareness for this science-based regulatory pathway designed to accelerate market approval of safe and effective generic drug products. The first part of this webinar series specifically designed for the Latin American region centers on the fundamental scientific concepts underlying the BCS-based biowaiver regulatory pathway. Experts will address the different tools that can be applied to generate valid scientific evidence in support of BCS-based biowaiver applications.
In collaboration with Sindusfarma, Legis Consultoria, and Innovation and Biopharmaceutical Evaluation Center.
This webinar has the objectives:
To differentiate between in vivo bioequivalence and BCS-based biowaiver regulatory strategies for approval of generic drug products.
To understand the scientific principles guiding the BCS-based biowaiver regulatory pathway.
To delineate the contributions of solubility, permeability, and dissolution for BCS-based biowaiver applications.
Moderator: - Talita Ferreira, Latin America Biowaiver Project Manager, International Pharmaceutical Federation (FIP) - Brazil
Panellists: - Maria del Val (Marival) Bermejo Sanz, Professor, Miguel Hernández University - Spain - Isabel González, Professor, Miguel Hernández University - Spain - Gladys Granero, Professor, University of Córdoba - Argentina - Pablo González, CEO, Innovation and Biopharmaceutical Evaluation Center, Chile - Miguel Angel Cabrera-Pérez, Associate Professor, Central University of Las Villas, Cuba
Building on World Health Professions Alliance (WHPA), Positive Practice Environments Campaign, the “FIPWiSE toolkit for positive practice environments in education & science” is developed to identify and address inequalities in the workplace environments which affects women in pharmaceutical science and pharmacy education, with transferable learnings across the pharmaceutical workforce. The toolkit is designed to raise awareness and provide possible solutions for individuals, employers and institutions that can enable positive practice environments for women in pharmaceutical science and pharmacy education.
Learning objectives: 1. Explore the key factors that enable positive practice environments for women in pharmaceutical science and pharmacy education, and the entire pharmaceutical workforce 2. Learn about practical solutions for professionals, employers and policy makers in creating positive practice environments for women in pharmaceutical science and pharmacy education 3. Discuss with the toolkit authors and high-level speakers how to take action and standi up for positive practice environments
Moderator: - Claire Thompson, Chair of FIPWiSE - UK Facilitator: - Nilhan Uzman, FIP Lead for Education Policy and Implementation - Netherlands
Panellists: - Dominique Jordan, President FIP,Switzerland - Catherine Duggan, CEO FIP, FIPWiSE Executive Sponsor,Netherlands - Dalal Hammoudi, FIP WiSE steering committee member & FIP AMR commission member,Lebanon - Ecehan Balta, FIPWiSE working group member,Turkey - Nisa Masyitah, FIPWiSE Remote volunteer,Switzerland - Alison Etukakpan, FIPWiSE working group member, Educational partnership coordinator FIP,Nigeria - Aysu Selcuk, FIP Educational Partnerships Coordinator, FIPWiSE project coordinator,Turkey - Belma Pehlivanović, FIPWiSE Remote volunteer,Bosnia and Herzegovina - Esther Anyango, FIPWiSE Remote volunteer,Kenya - Iris Mwanza, WGH Co-chair,USA - Lina Bader, FIP Lead for EquityRx Program,SA
This digital event will discuss how important it is to promote confidence in influenza vaccines and avoid complacency towards vaccination due to lower influenza rates in the past year. Harnessing the convenience of access to pharmacies will be paramount to achieve these goals. Due to the widespread adoption of disease prevention measures to reduce transmission of COVID-19, the prevalence of the seasonal influenza lowered drastically around the world. However, as more people become vaccinated against COVID-19 and measures such as mask wearing, social distancing and home-based working or schooling are eased, the flu could return with high incidence rates and people could be more susceptible to the influenza virus due to lack of recent exposure. Developing flu vaccines this year has also been more challenging than usual due to less data available. This uncertainty around the return of influenza makes vaccination all the more critical, and it essential to communicate this to the population.
Learning objectives: 1. Discuss the impact of COVID-19 pandemic on the prevalence and evolution of the seasonal influenza around the world. 2. Explore relevance and importance of the influenza vaccination in the coming seasons. 3. Discuss ways to effectively develop confidence in influenza vaccines among the public. 4. Share learnings to address complacency towards the influenza vaccination including harnessing the role of community pharmacists.
Moderator: -Luís Lourenço, Professional Secretary FIP, Portugal
Panellists: -Lyn Morgan, Coordinator, Policy & Communications group, Influenza Vaccines Suppliers International Federation of Pharmaceutical Manufacturers’ Associations, France -Samantha Marsh, Research fellow University of Auckland, National Institute for Health Innovation, New Zealand - Dermot Twomey, President Irish Pharmacy Union, Ireland - Danielle Paes, Chief Pharmacist Officer Canadian Pharmacists’ Association, Canada
New niche & digital actors as well as on-line pharmacies are entering the pharmacy market. Healthcare is becoming more and more digital, and the development is partly exponential, and partly driven by the consumers – as such there is a consumerism of healthcare. How will this affect the patients, the current pharmacy model & the healthcare systems?
Learning objectives:
Understand the changing landscape of healthcare and pharmacy
Identify how new actors use technology to transform pharmacy services
Understand how digital transformation and tools support new business models and services, as well as is shaping a new patient/consumer behaviour
Describe how FIPs PHC strategy and the DGs can be used to transform pharmacy practice
Define a strategy for transform pharmacy linked to the "new normal"
Moderator:
Lars-Åke Söderlund, President the FIP Community Pharmacy Section, Executive Advisor at Apoteket AB, Sweden
Jacqueline Surugue, FIP Vice President, FIP Technology Forum Chair, Hospital Pharmacist at a 1300 beds hospital, France
Co-moderator:
Charlotte Rossing, Vice - Chair FIP SIG Pharmacy Practice Research, Director Research and Development, Pharmakon – Danish College of Pharmacy Practice, Denmark
Panellists:
Carl Schneider BN, Member of Technology Forum, Senior Lecturer in Pharmacy Practice, The University of Sydney School of Pharmacy, Australia
Kenneth C Hohmeier, Associate Professor of Clinical Pharmacy, University of Tennessee, Health Science Center, USA
Ardi Mirzaei, PhD student, The University of Sydney, School of Pharmacy, Australia
This webinar aims to highlight the different services provided by pharmacists in the prevention, screening and detection of diabetes. It will also demonstrate how pharmacists are providing such services in a time of pandemic.
Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes.
At the end of this webinar, participants will: 1. Become familiar with services that pharmacists can provide in promoting the awareness of diabetes and adoption of healthy lifestyle 2. Recognise the role of pharmacists in the screening and detection of diabetes 3. Describe how the pandemic has influenced the delivery of diabetes services by pharmacists.
Moderator: - Manjiri Gharat, FIP Vice-President, FIP, India
Panellists: - Paula Teixeira, Scientific Information Manager, Center for Medicines Information and Health Interventions (CEDIME) in the Portuguese National Association of Pharmacies (ANF), Portugal - Margaret Wonah, Pharmacist, The Diabetes Care Network, Nigeria - Mohamed Hassan Elnaem, Assistant Professor of Clinical Pharmacy, Department of Pharmacy Practice, Faculty of Pharmacy, International Islamic University, Malaysia
In the second of six regions we dissect, event 7 focuses on the regional needs and drivers for transforming vaccination in the Eastern Mediterranean region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Eastern Mediterranean region join us for a true regional perspective.
About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.
Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.
The event will be moderated by: - Dr. Ayman Noreddin - EMRO Education Leader and Dean at the College of Pharmacy, Galala University - Dr. Lina Bader - Lead for Workforce Transformation & Development at FIP
The speakers at the event are: - Dr. Ziad Nassour - Former President of the Lebanese Order of Pharmacists - Dr. Madeeha Malik - Director/Professor - Hamdard Institute of Pharmaceutical Sciences - Dr. Mohammed Al-Nuzili - Governing Board President of Yemen Community Pharmacy Syndicate - Mr. Ahmed Abdulbary - Senior Regulatory Affairs Pharmacist at the National Health Regulatory Authority - Prof. Rula Darwish – Professor at the University of Jordan. WDG9 Lead and member of executive committee of FIP academic section, and CPD chair of Jordan Pharmacist Association
This event will ask how healthcare can be rebuilt amidst a global pandemic and focus on the important role that selfcare will play. It will also look at the enablers that will accelerate self-care through community pharmacy and how this builds towards Universal Health Coverage.
Aim: To identify mechanisms that will enable the acceleration of self-care to achieve UHC.
Learning objectives: 1. Discuss approaches to rebuilding healthcare during the COVID-19 pandemic 2. List factors that enable self-care through community pharmacy; 3. Describe trends in self-care; 4. Explain how to integrate self-care as a building block to Universal Health Coverage.
Target audience: Healthcare professionals – particularly the pharmacy team, who support people to self-care.
Moderator: Sham Moodley, Community pharmacist
Panellists: - Jurate Svarcaite, Director General Association of the European Self-Care Industry - Ruben Viegas, FIP Practice Development Projects Coordinator - Padmaja Kamath, Director – Regulatory and Scientific Affairs, Global Self-care Federation
The COVID-19 pandemic has exacerbated the existing mental health crisis. People have reportedly been affected by worry, anxiety and fear due to the pandemic. This has placed a huge strain on health systems and their ability to deliver mental health care. Pharmacists are the most accessible healthcare providers and consistently rank among the most trusted health professionals. Hence, they can play an important role in the provision of mental health services to the public, thereby helping improve health outcomes and ameliorate the impact on health systems. This webinar explores the different services offered by pharmacists to improve mental health in an era of COVID-19 and beyond.
At the end of this webinar, participants will: 1. Recognize the role of pharmacists in addressing the mental health crisis. 2. Understand the needs of people living with mental health illness 3. Describe the various services offered by pharmacists to members of the public in the area of mental health. 4. Be familiar with the tools and resources available for pharmacists to improve the mental health of their patients.
Moderator: -Sarira El-Den, Lecturer School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia
Panellists: - Claire O’Reilly, Senior Lecturer School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia - David Odhiambo, Pharmacist, Kenya - Andrea Murphy, Associate Professor, Dalhousie University, Canada - David Gardner, Professor, Dalhousie University, Canada - Helena Roennfeldt, Consumer Mentor, Griffith University, Australia
This webinar will present the professional practice in the hospital setting using health digital technologies. Digital Innovation, how to develop digital skills in pharmacy personnel Telepharmacy and mHealth is the content of the first part. It is relevant to discuss “mHealth” because the access to mobile phones is almost universal and the costs of this technology will be able to be addressed by many countries. The objective of the second part will be: “Discuss current use of mHealth by patients and providers and the impact on hospital care in Midwestern United States” "Medication use technology" would complete the webinar.
Learning objectives: 1. Compare the “European” model of digital technologies for hospital pharmacy with the “American” one. 2. Explain the concept of medication error risk mitigation. 3. Get aware with Medication Use Technology employed throughout the medication use process
Moderator: - Jacqueline Surugue, Chair of the FIP Pharmaceutical Technology Forum, France
Panellists: - José Manuel Martínez Sesmero, Director of Pharmacy in Hospital Clínico San Carlos (Madrid), Spain - Katherine A. Miller, Sr. Director – Acute Care Pharmacy and Clinical Nutrition,The University of Kansas Health System, USA - Dr. Johlee S. Odinet, Johlee S. Odinet Medication Safety Supervisor Ochsner Medical Center, USA
En la primera de las seis regiones que analizaremos, este evento se centrará en las necesidades y los catalizadores a nivel regional para transformar las estrategias de vacunación en las Américas. Se trata de identificar las prioridades de los países de la región en materia de equidad y acceso a la vacunación. También discutiremos las barreras, los desafíos y las necesidades regionales en relación con el establecimiento de políticas de vacunación. Los miembros de la FIP, y otras organizaciones y socios relevantes de la región de las Américas participarán conjuntamente para obtener una verdadera perspectiva regional sobre este asunto.
Acerca del programa - El programa digital 2021 de la FIP para transformar la vacunación a nivel mundial, regional y nacional comprende dos series, con un total de 12 eventos que se desarrollarán entre junio y noviembre.
In the first of six regions we dissect, event 6 focuses on the regional needs and drivers for transforming vaccination in the Americas. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Americas region, join us for a true regional perspective.
This event will be moderated by:
Eduardo Savio – President of the Pharmaceutical Forum of the Americas, Uruguay
Carlos Lacava – Vice President of Uruguayan Association of Chemistry and Pharmacy
The speakers at the event are:
Dr. Kasey Thomspon - Chief Operating Officer and Senior Vice President of the American Society of Health-System Pharmacists (ASHP), USA
Martha Rebour - Executive Director at Shot@Life, United Nations Foundation, USA
Dr. Magaly Rodriguez de Bittner - Vice-President Pharmaceutical Forum of the Americas, USA
Facillitator:
Rúben Viegas, Practice Development Projects Coordinator FIP, Spain
mRNA technology was used in developing the first ever COVID vaccine, developed by Pfizer / BioNtech. A number of vaccine or therapeutic products are in developing this technology. This webinare will address the following:
• What is mRNA? (structure and chemistry) • How does it work in a cell (as either a therapeutic or vaccine)? • How is it made and at what scale? • How is it analyzed and characterized? • By what means can it be delivered to the patient? • What were the biggest challenges to get mRNA vaccines out to the public in 2020? • What other notable clinical advances have been made for mRNA based medicines? • What future directions do we see for mRNA as a therapeutic tool?
Moderator:
Mathew Cherian, ExCo Member, Industrial Pharmacy Section Consultant, USA
Panellists:
Michael McCaman PhD (U Cal at Davis), Managing Director, BDO USA
Seth Alexandert PhD (Yale), Associate Director, Resilience, USA
This event will focus on the role that pharmacists can play in providing pharmaceutical care for people with hearing impairment or a disability linked to hearing loss. Pharmacists must provide clear messages and adapt their communication strategies to this particular population group to ensure optimal use of medicines and medical devices, and they need to have the knowledge and skills to do so. Also, people with hearing loss face different challenges and this problem becomes more relevant with age. Pharmacists can support patients in detecting early signs of hearing loss and taking the appropriate actions.
Learning objectives:
Understand how hearing impairment or deafness impact a patient’s quality of life and their capacity to communicate with healthcare professionals.
Learn about what pharmacists can do to support patients and carers with these conditions.
Improve communication strategies to advise patients with hearing impairment on how to achieve an optimal use of medicines and medical devices.
Moderator:
Tara Hehir, SAPS Secretary, Consultant Pharmacist, Australia
Panellists:
Kasper Bergmann, Vice President World Federation of the Deaf, Denmark
Kenneth Bitrus David, MSc Pharmacology and Drug Development Candidate Hull York Medical School, University of Hull, Nigeria/ United Kingdom
Fiorella Donato Zúñiga, Pharmacist, Coordinator of "Programa Salud Inclusiva" (Inclusive Health Program) Acceso Visual , Costa Rica
Poor medication adherence has emerged as a major public health concern in the last decade, and pharmacists may play a vital role in medication adherence by implementing many of the solutions demonstrated at COVID-19.
FIP adapted the theme "Pharmacy: Always trusted for your health" for World Pharmacy Week; and expanding on that theme, FIP would like to welcome your attendance to this event. The event has been sponsored by an unrestricted educational grant by Pfizer.
The expected outcomes of the event are: 1 to discuss the role of pharmacists in medication adherence and communication. 2 to share some regional and global thoughts on the common communication gaps and challenges that are experienced in all patient facing sectors 3 to highlight various regional and global strengths, accomplishments, and success stories in terms of medication adherence and communication in pharmacy.
FIP Technology Forum brings you the webinar about Virtual reality (VR). VR has been widely studied and applied in numerous medical applications. In pharmacy, VR can potentially be applied in wide range of activities, from drug design and discovery, though pharmacist education, to in-patient counseling and behavior modification. In this webinar we bring you the examples of VR technology applications in pharmacy. In our webinar, we will showcase and immersive virtual reality in a virtual environment with experience from Finland with our speaker Mia Siven from Helsinki University, where the VR was successfully applied in pharmacy education. We will then present a showcase of immersive virtual reality in a real environment, with speakers Agnes Bobay Madic and Paul Besnier with their example from France. VR technology has become increasingly affordable, flexible, and portable, enabling its use for therapeutic purposes in both inpatient and outpatient environments. But despite the compelling features of VR, a number of challenges exist, such as validation of clinical efficacy, cost/accessibility and usability issues, technical capabilities, acceptance, among others. You will have the opportunity to ask questions in the panel discussion part of the webinar.
Moderator:
Jacqueline Surugue, FIP Vice President, Hospital Pharmacist, France
Panellists:
Eeva Teräsalmi, Community Pharmacist, Owner Seven Brothers Pharmacy, Helsinki, Finland
Mia Siven, FIP Technology Forum Chair Vice-Dean, University of Helsinki, Finland
Agnès Bobay-Madic. Pharmacist Centre Hospitalier Robert Bisson, Lisieux, France
Paul Besnier, Pharmacy Intern, Centre Hospitalier Universitaire de Caen Normandie, France
This event will describe Development Goal 12: Pharmacy Intelligence and explore latest developments in data and intelligence that supports health care. It will identify practical approaches to progress towards Development Goal 12.
Aim: To discuss development goal 12 and how to ensure it supports health care.
Learning objectives: 1. Define pharmacy intelligence and explain priorities for its development (FIP Development Goal 12) 2. Discuss approaches to community pharmacy data collection 3. Explain the METNA project and its approach to data collection and needs assessment 4. List the functions of the GPO Atlas 5. Analyse and comment on possible indicators for DG12
Moderator Professor Robert Sindelar, Chair – One FIP Data and Intelligence Commission, Professor and Dean Emeritus, Faculty of Pharmaceutical Sciences, The University of British Columbia, Canada
Panelists and Speakers - Christopher John, Lead for Data and Intelligence, FIP, UK
- António Rodrigues, Executive Director - Portuguese Association of Pharmacies, Portugal
- Farah Aqqad, Regional Engagement and Project Coordinator, FIP, Jordan
- Dr Mira Zugic, President of the Pharmaceutical Chamber of Montenegro
- Dr Tanniru Narayana/Dr Rao Vadlamudi – Indian Pharmaceutical Association
- Mr. Nurul Falah Eddy Pariang, President – Indonesian Pharmacists Association.
- Sherly Meilianti, Data and Intelligence Specialist, FIP, UK/Indonesia
Webinar video • 23 September 2021, 14:00 - 15:30 CEST
Working together across systems to transform vaccination policy: working with others in our professions, with other disciplines and agencies to establish sustainable policies
This event will focus on intra and interprofessional alliances to ensure that we can work together to deliver the areas of policy addressed in this series. Panellists will also discuss working together with other agencies and policymakers to establish sustainable policies on vaccines access and equity, including how pharmacy can be a force of good in supporting vaccinations for all health workers.
About the programme: Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access, and sustainability of vaccinations through policy development and implementation.
Moderator: - Lina Bader - FIP Lead for Workforce Transformation & Development, Saudi Arabia
Co-Moderator: - Eduardo Savio – President of the Pharmaceutical Forum of the Americas, Uruguay
Panellists: - Daphne Holt, Chair of Coalition for Life-course Immunisation, France
- Meghna Joshi-Von Heyden, Strategic Development Advisor, Commonwealth Pharmacists Association (CPA), Switzerland
- Suresh Bhojraj, Patron at Indian Association of Colleges of Pharmacy and Pro Chancellor at JSS Academy of Higher Education and Research, Mysuru, India
- Marleen Haems, Director of Professional Management, KOVAG / VAN, Belgium
- Katarina Milosevic Konstadinovic, Community Pharmacist, Chairman of Assembly of Pharmaceutical Chamber of Montenegro, Montenegro
Counterfeit, substandard and falsified medications and medical products endanger public health and FIP believes that pharmacists and pharmaceutical scientists should contribute to patient safety by actively participating in the fight against counterfeit, substandard, and falsified medicines. Adapting and expanding on the theme of World Pharmacy Week (Pharmacy: Always trusted for your health), we would like to invite you to attend this webinar and learn more about the role of pharmacists in the emerging threat of counterfeit, falsified, and substandard medicines. The event has been sponsored by an unrestricted educational grant by Pfizer.
The expected outcomes of the event are: 1- to discuss the role of pharmacists in combating counterfeit, falsified, and substandard medicines. 2- to highlight various regional and global strengths, accomplishments, and success stories in the fight against counterfeit medications. 3- to identify emerging regional and global threats and challenges related to counterfeit medication.
Moderator: - Lars-Åke Söderlund, President Swedish pharmaceutical society - Sweden
Panellists: - Catherine Duggan, CEO FIP, The Netherlands - John Hertig, Vice-Chair and an Associate Professor of Pharmacy Practice, USA - Manjiri Gharat, Vice-President, Indian Pharmaceutical Association, India - Stephanie Kohl, Policy & Advocacy Officer, Belgium - Sally Galal, Associate Professor, Alexandria University, Egypt - Dieudonne NZEYIMANA, Pharmacist and Sales Manager, Rwanda - Renae Beardmore, Acting National President, Australia - John Jackson, President, Western Pacific Pharmaceutical Forum, Australia - Pierre Souverain, Pfizer - Caitriona Scott, Pfizer - Gudrun Hubinger, Pfizer - Zuzana Kusynová, Lead for Policy, Practice and Compliance, FIP, The Netherlands
Pharmacists are uniquely positioned to help communities and patients protect themselves from vector-borne diseases (VBDs). This webinar will describe the most prevalent VBDs in the European region and identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment.
Learning objectives: 1. Describe the characteristics and epidemiology of the main VBDs in the European region; 2. Determine the roles that pharmacists can play in the prevention, detection, control and management of pharmacotherapy of VBDs; and 3. Identify the experiences developed by countries in Europe to support the actions of pharmacists in the fight against VBDs.
Moderator: - Sari Westermarck, Community pharmacist, Finland
Panellists: - Elkhan Gasimov, Technical Officer, Malaria, Neglected Tropical Diseases and other Vector-borne Diseases, World Health Organization Regional Office for Europe, Division of Country Health Programmes, Denmark
- Maria Dolores Bargues, Professor of Parasitology, University of Valencia and President of the Spanish Society of Tropical Medicine and International Health, University of Valencia, Spain
- Pınar Erkekoğlu, Head of Department of Toxicology, Hacettepe University Faculty of Pharmacy Department of Toxicology, Turkey
- Venelin Sapunarov, Chairman of the Board of the Regional Pharmaceutical College of Sofia, Bulgarian Pharmaceutical Union, Bulgaria
The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.
The expected outcomes of the event are:
1. Describe the FIP Development Goals and explain the components of DG 13 (and its three elements: workforce & education, science and practice). 2. Showcase the FIP tools, evidence, and resources to support DG 13 implementation across the three elements. 3. Identify priorities across practice, science, and workforce & education within DG 13 4. Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project
Moderator: Catherine Duggan, CEO FIP, Netherlands
Panellists: -Mahmoud Abdelrahman, President Egyptian Foundation of Clinical pharmacy EFCP, Egypt
- Paul Sinclair, Chair of the Board of Pharmaceutical Practice, FIP Australia
- Ramesh Walpola, Senior Lecturer School of Population Health, UNSW Sydney, Australia
-Virginia Olmos, Vice President AQFU, Uruguay
- Subhash Mandal, Vice President, Indian Pharmaceutical Association, India
- Ema Paulino, FIP Professional Secretar; Policy committee for statement on Women and RUM (Chair); General Manager, Ezfy, Portugal
- Eeva Teräsalmi, FIP Foundation Director Immediate Past Vice President of FIP, Finland
- Allie Jo Shipman, YPG Liaison to FIP Community Pharmacy Section; Director, National Alliance of State Pharmacy Associations, USA
- Luna Elbizri, Founder and Manager, Lunapharm Pharmacy, Lebanon
- Mary Ann Kliethermes, Director of Medication Safety and Quality, American Society of Health-System Pharmacists, USA
- Certina Ho, Assistant Professor; Director, Educational Program Evaluation and Scholarship; Medication Safety Advisor, Department of Psychiatry; Leslie Dan Faculty of Pharmacy; University of Toronto; Institute for Safe Medication Practices Canada (ISMP Canada)
- Mariet Eksteen, Professional Development Officer, Pharmaceutical Society of South Africa (PSSA), South Africa
The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.
This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.
Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals
Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.
Learning objectives: 1. Provide insights of the therapeutic approaches and advancements used in the management of headaches. 2. Understand the role of non-prescription medicine as a tool in headache self-care 3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.
Moderator: -T.V. Narayana, President SEAR Pharm Forum, India
Panellists: - Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan - Luminita Constantin, Global Medical Lead CHC Pain, Sanofi, France - Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK), United Kingdom -Raj Vaidya, Community Pharmacist, Hindu Pharmacy, India
Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.
Learning objectives: 1. Provide insights of the therapeutic approaches and advancements used in the management of headaches. 2. Understand the role of non-prescription medicine as a tool in headache self-care 3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.
Moderator: - Nadia Al Mazrouei, Assistant Professor, Sharjah University, United Arab Emirates (UAE)
Panellists: -Takuya Kumamoto, Professor, Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan -Luminita Constantin, Global Medical Lead CHC Pain, Sanofi, France -Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK)-United Kingdom -Abdulaziz khaled Alkhaledi, Member of Executive Committee, Kuwait Pharmaceutical Association, Kuwait State
Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.
Learning objectives:1. Provide insights of the therapeutic approaches and advancements used in the management of headaches. 2. Understand the role of non-prescription medicine as a tool in headache self-care 3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.
Moderator: -Luis Lourenço, Professional Secretary, Community Pharmacy Section, Portugal
Panellists: - Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan - Luminita Constantin, Global Medical Lead CHC Pain, Sanofi, France - Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK), United Kingdom - Charlotte Verner Rossing, Vice-chair, FIP Special Interest Group on Pharmacy Practice Research FIP, Denmark
Webinar video • 15 September 2021, 13:00 - 14:30 CEST
Host Madsen Medal winner 2021 - Multifunctional Envelope-type Nano Device from Controlled Intracellular Trafficking to Clinical Application for Nanomedicines
The Høst-Madsen Medal is the highest pharmaceutical science award of FIP and it is awarded every second years. The award is named after Danish pharmaceutical scientist and former FIP president Dr Erik Høst-Madsen and is made possible with the support of the Association of Danish Pharmacies (Danmarks Apotekerforening). This year we will present the award, during a digital event, to Prof. Hideyoshi Harashima, of Hokkaido University, Japan.
The event will start with short presentations on the nanomedicine/drug delivery theme from three young researchers from different countries, after which Prof. Harashima will provide some commentary. The event will continue with the president of FIP presenting the medal and certificate to Prof. Harashima, after which Prof. Harashima will give a lecture on “Multifunctional envelope-type nano devices: From controlled intracellular trafficking to clinical application for nanomedicines”.
Participants in the event will have the opportunity to send their messages and congratulations to Prof. Harashima via the Q&A box or chatbox in Zoom.
Moderator: - Ross McKinnon, Chair of Board of Pharmaceutical Sciences, FIP - Australia
Panellists: - Dominique Jordan, President FIP - The Netherlands - Hideyoshi Harashima, Professor of Pharmaceutics and chair of Laboratory of Molecular Design of Pharmaceutics, Hokkaido University - Japan - Dr Schultz, Research Associate, University of South Australia - Australia - Dr Yamada, Associate Professor, Hakkaido University - Japan
All three domains of pharmacy; science, education, and practice are crucial for pharmacists to solidify and expand their role in various health systems. As early-career pharmacists, we sometimes lack professional direction and well-defined opportunities in our profession. FIP is actively involved in all aspects of pharmacy practice, pharmaceutical science, and education, mostly via the work of member associations and committed volunteers.
The purpose of this webinar is to introduce early career pharmacists and pharmaceutical scientists in Bahrain to the International Pharmaceutical Federation, the Young Pharmacy Group, and the FIP Development Goals.
Join us for an interactive session to discover more about how you, as a Bahraini pharmacist, can stand in solidarity with pharmacists all over the world to advance pharmacy. **The event is also open to pharmacy students.**
Moderators: -Farah Aqqad, FIP Regional Engagement and Project Coordinator International Pharmaceutical Federation, Jordan -Sherly Meilianti, FIP Data and Intelligence Specialist, International Pharmaceutical Federation, Indonesia
Facilitator: -Abrar Husaini, Volunteer Pharmacist Al Shamil Field Hospital, Bahrain
Panellists: -Lucas Ercolin, FIP YPG Chairperson of Public Relations, PUI Health Project Manager, FIP Young Pharmacists Group (YPG), Première Urgence Internationale (PUI), Brazil - Ikwaibom Umoiyoho, FIP YPG Chairperson of Projects, Hospital Pharmacist Zenith Medical and Kidney Center, Nigeria - Dalia Bajis, FIP Lead for Provision and Partnerships, International Pharmaceutical Federation, Bahrain - Lina Bader, FIP Lead for Workforce Transformation & Development, International Pharmaceutical Federation, Saudi Arabia - Abrar Husaini, Volunteer Pharmacist, Al Shamil Field Hospital, Bahrain
Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.
Learning objectives: 1. Provide insights of the therapeutic approaches and advancements used in the management of headaches. 2. Understand the role of non-prescription medicine as a tool in headache self-care 3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.
Moderator: - Prosper Hiag, Member of the Council of the FIPm President African Pharmaceutical Forum (APF), Cameroon Panellists: -Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan - Luminita Constantin, Global Medical Lead CHC Pain Sanofi, France - Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology King’s College (UK), United Kingdom - Machi Hampango, Head Of Pharmacy Practice and Clinical Pharmacy, Faculty of Pharmacy, Nutrition and Dietetics, Lusaka Apex Medical University, Zambia
Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient. Learning objectives: 1. Provide insights of the therapeutic approaches and advancements used in the management of headaches. 2. Understand the role of non-prescription medicine as a tool in headache self-care 3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.
Moderator: -John Jackson, President Western Pacific Pharmaceutical Forum, Australia Panellists: -Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan -Luminita Constantin, Global Medical Lead CHC Pain Sanofi, France -Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK), United Kingdom - Daniel Malone, Director of Pharmacy Education Monash University, Melbourne, Australia
Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.
Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.
Learning objectives: 1. Provide insights of the therapeutic approaches and advancements used in the management of headaches. 2. Understand the role of non-prescription medicine as a tool in headache self-care 3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.
Moderator: -Eduardo Savio, President Pharmaceutical Forum of the Americas, Uruguay
Panellists: -Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima - Japan - Luminita Constantin, Global Medical Lead CHC Pain Sanofi, France - Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology King’s College (UK), United Kingdom - Willington Montenegro, Manager Lider Pharmacy, Ecuador
he COVID-19 pandemic has had detrimental effects on healthcare professionals and in diverse ways including physically, mentally, socially, and financially. The new and unique challenges directly associated with the COVID-19 pandemic are exacerbating an already stressful work environment for pharmacists too. Pharmacists are reporting high level of stress and burnout in practice. Hence, there is an urgent need for pharmacists to be equipped with the knowledge, tools, and resources to cope and thrive in crises. This webinar aims to provide perspectives from research and practice on the impact of workplace burnout on pharmacist mental health and highlight evidence-based supportive mechanisms and prevention tools to improve the mental health and wellbeing.
Learning objectives: Describe the impact of the COVID-19 pandemic on pharmacists’ wellbeing using case studies from different countries. Discuss potential strategies to address burnout among pharmacists. Describe the gaps in mental health education in pharmacy education. Learn about the role of pharmacists in suicide prevention in the community.
Moderator: -Claire O’Reilly, Senior Lecturer School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia
Panellists: -Sarira El-Den, Lecturer School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia -Karlee Johnston, Associate Lecturer Pharmacology Australian National University, Australia -Aiwen Wang, Principal Clinical Pharmacist, Lecturer Singapore General Hospital (SGH), Singapore. National University of Singapore (NUS), Singapore -Lita Chew, Group Director (Allied Health) Singhealth, Singapore -Hayley Gorton,Senior Lecturer in Pharmacy Practice University of Huddersfield, UK
Pharmacy teams are increasingly supporting patients with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support women’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.
Aim: To identify how the community pharmacy team can support self-care for women with common health problems.
Learning objectives: 1. Increase awareness of women’s health issues, how common they are, what impacts they have and how they can be managed; 2. Learn how to support women with their common health issues across their life course; and 3. Discuss appropriate management in the choice of medicines and products.
Moderator: - Ema Paulino, FIP Professional Secretary, General Manager Ezfy, Portugal Panellists: - Nsovo Mayimele, Pharmacist Freelance, South Africa - Gayle Anderson, Advanced Pharmacist Practitioner (Women's Health) Dr Gray's Hospital, Scotland, UK - Safeera Hussainy, Adjunct Senior Lecturer Department of General Practice, Monash University, Australia
Pharmacy teams are increasingly supporting patients with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support women’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.
Aim: To identify how the community pharmacy team can support self-care for women with common health problems.
Learning objectives: 1. Increase awareness of women’s health issues, how common they are, what impacts they have and how they can be managed; 2. Learn how to support women with their common health issues across their life course; and 3. Discuss appropriate management in the choice of medicines and products.
Moderator: - Ema Paulino, FIP Professional Secretary, General Manager Ezfy, Portugal Panellists: - Nsovo Mayimele, Pharmacist Freelance, South Africa - Gayle Anderson, Advanced Pharmacist Practitioner (Women's Health) Dr Gray's Hospital, Scotland, UK - Safeera Hussainy, Adjunct Senior Lecturer Department of General Practice, Monash University, Australia
Pharmacy teams are increasingly supporting patients with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support women’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.
Aim: To identify how the community pharmacy team can support self-care for women with common health problems.
Learning objectives: 1. Increase awareness of women’s health issues, how common they are, what impacts they have and how they can be managed; 2. Learn how to support women with their common health issues across their life course; and 3. Discuss appropriate management in the choice of medicines and products.
Moderator: - Ema Paulino, FIP Professional Secretary, General Manager Ezfy, Portugal Panellists: - Nsovo Mayimele, Pharmacist Freelance, South Africa - Gayle Anderson, Advanced Pharmacist Practitioner (Women's Health) Dr Gray's Hospital, Scotland, UK - Safeera Hussainy, Adjunct Senior Lecturer Department of General Practice, Monash University, Australia
Pharmacy teams are increasingly supporting patients with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support women’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.
Aim: To identify how the community pharmacy team can support self-care for women with common health problems.
Learning objectives: 1. Increase awareness of women’s health issues, how common they are, what impacts they have and how they can be managed; 2. Learn how to support women with their common health issues across their life course; and 3. Discuss appropriate management in the choice of medicines and products.
Moderator: - Ema Paulino, FIP Professional Secretary, General Manager Ezfy, Portugal Panellists: - Nsovo Mayimele, Pharmacist Freelance, South Africa - Gayle Anderson, Advanced Pharmacist Practitioner (Women's Health) Dr Gray's Hospital, Scotland, UK - Safeera Hussainy, Adjunct Senior Lecturer Department of General Practice, Monash University, Australia
Pharmacy teams are increasingly supporting patients with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support women’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.
Aim: To identify how the community pharmacy team can support self-care for women with common health problems.
Learning objectives: 1. Increase awareness of women’s health issues, how common they are, what impacts they have and how they can be managed; 2. Learn how to support women with their common health issues across their life course; and 3. Discuss appropriate management in the choice of medicines and products.
Moderator: - Ema Paulino, FIP Professional Secretary, General Manager Ezfy, Portugal Panellists: - Nsovo Mayimele, Pharmacist Freelance, South Africa - Gayle Anderson, Advanced Pharmacist Practitioner (Women's Health) Dr Gray's Hospital, Scotland, UK - Safeera Hussainy, Adjunct Senior Lecturer Department of General Practice, Monash University, Australia
La reticencia a las vacunas fue considerada como una de las 10 principales amenazas para la salud mundial en 2019 por la OMS. La reticencia es uno de los principales factores que impactan en la tasa de cobertura vacunal. La información veraz y rigurosa es una herramienta crucial para combatir la actual infodemia a la que nos enfrentamos. La comunicación directa con los pacientes es una oportunidad clave para que los farmacéuticos desbloqueen los posibles temores a las vacunas y proporcionen mensajes claros y basados en la evidencia para apoyar la adopción de las vacunas. En este evento se presentan estrategias basadas en la evidencia para desarrollar intervenciones dirigidas por los farmacéuticos que se centran en la comunicación con los pacientes con el fin de fomentar la confianza en las vacunas y mejorar su aceptación.
Objetivos de aprendizaje
- Comprender los temores sobre las vacunas a nivel individual
- Discutir posibles herramientas para los farmacéuticos en la construcción de una conversación efectiva .
- Comprender los esfuerzos concretos en las farmacias comunitarias para la promoción de la vacunación a través de estrategias de comunicación eficaces
The World Health Organization has listed vaccine hesitancy — concerns related to vaccination or outright refusal to receive vaccines despite availability — as one of the top 10 threats to global health in 2019. This threat is evidenced by recent outbreaks of vaccine-preventable diseases in many high-income countries and the sheer volume of disinformation circulating regarding the recently approved vaccines against COVID-19.
Often “one-size-fits-all” vaccine promotion efforts can backfire when they are presented to individuals who are already sceptical of vaccines. This event will outline evidence-based strategies for developing pharmacist-led interventions which focus on communication with patients in order to build vaccine confidence and improve uptake.
This event will be offred in Eglish with live translation in Spanish and French.
Learning Objectives: Understanding vaccine hesitancy and common reasons behind hesitancy; and Building effective conversation through evidence-based tools.
Moderator: -Boyan Todorov, President of the FIP Health and Medicines Information Section, President of the FIP Health and Medicines Information Section FIP, Switzerland Panellists: - Helen Petousis-Harris, Associate Professor and Vaccinologist University of Auckland, New Zealand - Amy Chan, Global Lead – Workforce Transformation, Senior Clinical Research Fellow, and Lead of the Academic Practice Unit, University of Auckland, and Auckland District Health Board, New Zealand - Rosario Cáceres, Community pharmacist, vaccines expert and vaccine confidence advocate, Royal Pharmaceutical College of Seville and Andalusian Council of Pharmacists, Spain
L'Organisation mondiale de la Santé a classé l'hésitation vaccinale parmi les 10 principales menaces pour la santé mondiale en 2019. Les récentes épidémies de maladies évitables par la vaccination dans de nombreux pays à revenus élevés et l’ampleur de la désinformation au sujet des vaccins récemment approuvés contre la COVID-19 témoignent de cette menace. La réticence est l'un des principaux facteurs qui influent sur les taux de couverture vaccinale. Une information véridique et rigoureuse est un outil essentiel pour lutter contre l'infodémie actuelle à laquelle nous sommes confrontés. La communication directe avec les patients est une occasion clé pour les pharmaciens de révéler les craintes potentielles liées aux vaccins et de fournir des messages clairs, fondés sur des preuves, pour soutenir l'adoption des vaccins. Cet événement présente des stratégies fondées sur des données probantes pour développer des interventions dirigées par des pharmaciens et axées sur la communication avec les patients afin de renforcer la confiance dans les vaccins et d'améliorer leur utilisation.
Objectifs d'apprentissage
- Comprendre les craintes que suscitent les vaccins au niveau individuel.
- Discutez des outils possibles pour les pharmaciens afin d'établir une conversation efficace.
- Comprendre les efforts concrets des pharmacies communautaires pour promouvoir la vaccination par des stratégies de communication efficaces.
There is an evolving role for community pharmacists, not only in reactive respiratory illness, but also in supporting proactive individual and community respiratory wellness. However, what needs to change in terms of policy and regulation for these roles to become part of mainstream pharmacy practice? This symposium will mark the United Nations' International Day of Clean Air for Blue Skies, by addressing the drivers and barriers for the full deployment of these services, and discuss the key points of the FIP call to action on this global health priority.
learning objectives: - Identify prevailing barriers limiting the deployment of services to reduce the impact of air pollution by community pharmacists. - Describe facilitators and enablers that can influence air pollution service delivery by community pharmacists. - Understand the policy and regulatory landscape that needs to be established to promote air pollution mitigation services by community pharmacists.
Moderator: - Lars-Åke Söderlund, President, Community Pharmacy Section FIP, Sweden
Panellists: -Ema Paulino, Professional Secretary FIP, Portugal -Paul Sinclair, Chair of the Board of Pharmaceutical Practice FIP, Australia -Deana Lykins, Policy & Government Affairs Consultant The Clean Breathing Institute, USA -Anna Murphy, Consultant Respiratory Pharmacist University Hospitals of Leicester NHS Trust, United Kingdom -Job F.M. van Boven, Chair of the Dutch Respiratory Pharmacists Group, Royal Dutch Pharmacist Association (KNMP), The Netherlands
Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. Supporting patients in adequately managing pain and using medicines to alleviate it in an optimal way is a common and important part of pharmacists’ daily practice.
A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Contemporary lifestyles and ways of working – especially at such challenging times as we are experiencing in many parts of the world, with lockdowns and confinements – lead to increased stress, increased use of technology and screen time, and often a lack of good sleep, which all frequently lead to headaches.
Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.
Learning Objectives: 1. Provide an understanding of 21st century headaches and their impact on patient health and wellbeing. 2. Highlight patients’ expectations from pharmacists in addressing headaches. 3. Demonstrate the role that pharmacists can play in enabling self-care of headaches.
Moderator: - Prof. Parisa Aslani, FIP Vice President - Australia
Panellist: - Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK) - United Kingdom - Kerrie Smyres, writer and patient advocate, “The Daily Headache” - USA - Ema Paulino, FIP Professional Secretary - Portugal